{"chunk_id": "adenomyosis_nhs__0000", "doc_id": "adenomyosis_nhs", "title": "Adenomyosis - NHS", "url_or_doi": "https://www.nhs.uk/conditions/adenomyosis/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menstrual_cycle", "sx:pelvic_pain", "possible:adenomyosis", "triage:see_gp_routine"], "text_path": "corpus/text/adenomyosis_nhs.txt", "n_tokens_est": 835, "preview": "Adenomyosis\n- NHS\nSkip to main content\nAdenomyosis\nAdenomyosis is a condition where the lining of the womb (uterus) starts growing into the muscle in the wall of the womb. There are treatments that can help with any symptoms.\nAdenomyosis is more commonly diagnosed in women over the age of 30. It can affect anyone who has periods.\nCredit:\nMultimedia Team - nhs.uk\nSymptoms of adenomyosis\nSome sympto..."}
{"chunk_id": "endometriosis_nhs__0000", "doc_id": "endometriosis_nhs", "title": "Endometriosis - NHS", "url_or_doi": "https://www.nhs.uk/conditions/endometriosis/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:pelvic_pain_conditions", "sx:pelvic_pain", "possible:endometriosis", "triage:see_gp_routine"], "text_path": "corpus/text/endometriosis_nhs.txt", "n_tokens_est": 998, "preview": "Endometriosis\n- NHS\nSkip to main content\nEndometriosis\nEndometriosis is where cells similar to those in the lining of the womb (uterus) grow in other parts of the body. It can have a big impact on your life, but there are treatments that can help.\nCredit:\nMultimedia Team - nhs.uk\nSymptoms of endometriosis\nEndometriosis is often found in areas around the womb, such as the ovaries, fallopian tubes a..."}
{"chunk_id": "endometriosis_nhs__0001", "doc_id": "endometriosis_nhs", "title": "Endometriosis - NHS", "url_or_doi": "https://www.nhs.uk/conditions/endometriosis/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:pelvic_pain_conditions", "sx:pelvic_pain", "possible:endometriosis", "triage:see_gp_routine"], "text_path": "corpus/text/endometriosis_nhs.txt", "n_tokens_est": 645, "preview": "s. They include:\npainkillers, such as paracetamol and ibuprofen\nhormones, such as the\ncombined contraceptive pill\nor other medicines that change the amount of hormones in your body – these can help ease pain\nYou will not be given hormones if you're trying to get pregnant.\nSurgery for endometriosis\nIf other treatments are not working or you have lots of endometriosis, you may be offered surgery. Su..."}
{"chunk_id": "heavy_periods_nhs__0000", "doc_id": "heavy_periods_nhs", "title": "Heavy periods - NHS", "url_or_doi": "https://www.nhs.uk/conditions/heavy-periods/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menstrual_cycle", "sx:heavy_periods", "triage:see_gp_routine"], "text_path": "corpus/text/heavy_periods_nhs.txt", "n_tokens_est": 664, "preview": "Heavy periods\n- NHS\nSkip to main content\nHeavy periods\nMany women have heavy periods (also called menorrhagia) and they may be normal for you. They can affect anyone who has periods. Treatment can help if they're affecting your daily life.\nWhat are heavy periods?\nYou may have heavy periods if you:\nneed to change your pad or tampon every 1 to 2 hours, or empty your menstrual cup more often than is ..."}
{"chunk_id": "headaches_nhs__0000", "doc_id": "headaches_nhs", "title": "Headaches - NHS", "url_or_doi": "https://www.nhs.uk/symptoms/headaches/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/headaches_nhs.txt", "n_tokens_est": 799, "preview": "Headaches\n- NHS\nSkip to main content\nHeadaches\nMost headaches go away on their own and are not a sign of something more serious.\nHow you can ease headaches yourself\nHeadaches can last 30 minutes, several hours, or sometimes several days.\nDo\ndrink plenty of water\nget plenty of rest if you also have a cold or the flu\ntry to relax – stress can make headaches worse\ntake\nparacetamol\nor\nibuprofen\ntry to..."}
{"chunk_id": "irregular_periods_nhs__0000", "doc_id": "irregular_periods_nhs", "title": "Irregular periods - NHS", "url_or_doi": "https://www.nhs.uk/symptoms/irregular-periods/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menstrual_cycle", "sx:irregular_periods", "triage:see_gp_routine"], "text_path": "corpus/text/irregular_periods_nhs.txt", "n_tokens_est": 678, "preview": "Irregular periods\n- NHS\nSkip to main content\nIrregular periods\nIrregular periods are not usually a sign of a problem. But speak to a GP if your periods are irregular or your normal pattern of periods changes.\nWhat are irregular periods?\nThe average gap between periods starting (the menstrual cycle) is around 28 days. It can sometimes be a bit shorter or longer.\nA woman's periods are irregular if t..."}
{"chunk_id": "missed_or_late_periods_nhs__0000", "doc_id": "missed_or_late_periods_nhs", "title": "Missed or late periods - NHS", "url_or_doi": "https://www.nhs.uk/symptoms/missed-or-late-periods/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menstrual_cycle", "sx:missed_period", "triage:see_gp_routine"], "text_path": "corpus/text/missed_or_late_periods_nhs.txt", "n_tokens_est": 464, "preview": "Missed or late periods\n- NHS\nSkip to main content\nMissed or late periods\nLate or missed periods can be caused by many things. Most of the time it’s nothing to worry about but see a doctor about them just in case.\nCauses of missed or late periods\nMany women will have missed or late periods at some time. Missed or late periods can affect anyone who has periods.\nCommon causes of a missed or late peri..."}
{"chunk_id": "ovulation_pain_nhs__0000", "doc_id": "ovulation_pain_nhs", "title": "Ovulation pain - NHS", "url_or_doi": "https://www.nhs.uk/symptoms/ovulation-pain/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/ovulation_pain_nhs.txt", "n_tokens_est": 464, "preview": "Ovulation pain\n- NHS\nSkip to main content\nOvulation pain\nIt's common to have ovulation pain about 14 days before your period. It usually lasts a short time and is nothing to worry about.\nSymptoms of ovulation pain\nSome women get ovulation pain.\nIt can affect anyone who ovulates, which is when an egg is released as part of your menstrual cycle.\nOvulation pain often:\nfeels like a dull pain or sharp ..."}
{"chunk_id": "periods_nhs__0000", "doc_id": "periods_nhs", "title": "Periods - NHS", "url_or_doi": "https://www.nhs.uk/conditions/periods/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menstrual_cycle", "triage:see_gp_routine"], "text_path": "corpus/text/periods_nhs.txt", "n_tokens_est": 997, "preview": "Periods\n- NHS\nSkip to main content\nOverview\nPeriods\nA period is the part of the menstrual cycle when a woman bleeds from her vagina for a few days.\nFor most women this happens around every 28 days, but it's common for periods to be more or less frequent than this, ranging from every 21 days to every 35 days.\nYour period can last between 2 and 7 days, but it will usually last for about 5 days. The ..."}
{"chunk_id": "periods_nhs__0001", "doc_id": "periods_nhs", "title": "Periods - NHS", "url_or_doi": "https://www.nhs.uk/conditions/periods/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menstrual_cycle", "triage:see_gp_routine"], "text_path": "corpus/text/periods_nhs.txt", "n_tokens_est": 695, "preview": "g pregnant\nWorking out when you can get pregnant – your fertile time – can be difficult. It's around the time you ovulate, which is about 12 to 16 days before the start of your next period.\nBut sperm can survive inside a woman's body for up to 7 days before ovulation occurs. This means your fertile time extends back earlier in your cycle.\nYou can calculate when your period will start and your peak..."}
{"chunk_id": "period_pain_nhs__0000", "doc_id": "period_pain_nhs", "title": "Period pain - NHS", "url_or_doi": "https://www.nhs.uk/symptoms/period-pain/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menstrual_cycle", "sx:period_pain", "triage:see_gp_routine"], "text_path": "corpus/text/period_pain_nhs.txt", "n_tokens_est": 698, "preview": "Period pain\n- NHS\nSkip to main content\nPeriod pain\nIt's common to have pain or discomfort before or during your period. There are things you can do to help ease the pain.\nSymptoms of period pain\nPeriod pain usually happens to women around the start of their period. It can affect anyone who has periods.\nYou may have period pain if:\nyou have pain in your tummy at the start of your period, or several..."}
{"chunk_id": "pms_premenstrual_syndrome_nhs__0000", "doc_id": "pms_premenstrual_syndrome_nhs", "title": "PMS (premenstrual syndrome) - NHS", "url_or_doi": "https://www.nhs.uk/conditions/pre-menstrual-syndrome/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menstrual_cycle", "sx:pms_symptoms", "possible:pms", "triage:self_care"], "text_path": "corpus/text/pms_premenstrual_syndrome_nhs.txt", "n_tokens_est": 914, "preview": "PMS (premenstrual syndrome)\n- NHS\nSkip to main content\nPMS (premenstrual syndrome)\nPMS (premenstrual syndrome) is the name for the symptoms women can experience in the weeks before their period. It can affect anyone who has periods. You can get help if it affects your daily life.\nSymptoms of PMS (premenstrual syndrome)\nEach woman's symptoms are different and can vary from month to month, but most ..."}
{"chunk_id": "polycystic_ovary_syndrome_nhs__0000", "doc_id": "polycystic_ovary_syndrome_nhs", "title": "Polycystic ovary syndrome - NHS", "url_or_doi": "https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:pelvic_pain_conditions", "possible:pcos", "sx:irregular_periods", "topic:sexual_health", "possible:sti", "triage:see_gp_routine"], "text_path": "corpus/text/polycystic_ovary_syndrome_nhs.txt", "n_tokens_est": 780, "preview": "Polycystic ovary syndrome\n- NHS\nSkip to main content\nOverview\nPolycystic ovary syndrome\nPolycystic ovary syndrome (PCOS) is a common condition that affects how a woman's ovaries work.\nThe 3 main features of PCOS are:\nirregular periods\n– which means your ovaries do not regularly release eggs (ovulation)\nexcess androgen – high levels of \"male\" hormones in your body, which may cause physical signs su..."}
{"chunk_id": "toxic_shock_syndrome_nhs__0000", "doc_id": "toxic_shock_syndrome_nhs", "title": "Toxic shock syndrome - NHS", "url_or_doi": "https://www.nhs.uk/conditions/toxic-shock-syndrome/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:sexual_health", "possible:toxic_shock_syndrome", "triage:emergency"], "text_path": "corpus/text/toxic_shock_syndrome_nhs.txt", "n_tokens_est": 966, "preview": "Toxic shock syndrome\n- NHS\nSkip to main content\nToxic shock syndrome\nToxic shock syndrome (TSS) is a rare but life-threatening condition caused by an infection. It can happen when using a tampon or menstrual cup, or from an infected wound. Symptoms develop quickly and you need urgent treatment.\nSymptoms of toxic shock syndrome\nToxic shock syndrome (TSS) can come on quickly.\nSymptoms include:\na hig..."}
{"chunk_id": "vaginal_bleeding_between_periods_or_after_sex_nhs__0000", "doc_id": "vaginal_bleeding_between_periods_or_after_sex_nhs", "title": "Vaginal bleeding between periods or after sex - NHS", "url_or_doi": "https://www.nhs.uk/symptoms/vaginal-bleeding-between-periods-or-after-sex/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menstrual_cycle", "sx:bleeding_between_periods_after_sex", "triage:see_gp_routine"], "text_path": "corpus/text/vaginal_bleeding_between_periods_or_after_sex_nhs.txt", "n_tokens_est": 615, "preview": "Vaginal bleeding between periods or after sex - NHS\nSkip to main content\nVaginal bleeding between periods or after sex\nBleeding from your vagina between periods or after sex can have a lot of different causes. It's not usually serious, but always get it checked by a doctor.\nThis page is about bleeding between periods or after sex. Find out about other kinds of unusual bleeding:\nperiod problems\nvag..."}
{"chunk_id": "methods_of_contraception_nhs__0000", "doc_id": "methods_of_contraception_nhs", "title": "Methods of contraception - NHS", "url_or_doi": "https://www.nhs.uk/contraception/methods-of-contraception/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:contraception", "triage:see_gp_routine"], "text_path": "corpus/text/methods_of_contraception_nhs.txt", "n_tokens_est": 416, "preview": "Methods of contraception - NHS\nSkip to main content\nMethods of contraception\nFind out about the different methods of contraception for preventing pregnancy, how to get them and how well they work\nCombined pill\nContains hormones progestogen and oestrogen\nProgestogen-only pill\nAlso called the mini pill, contains the hormone progestogen\nIUD (intrauterine device, or copper coil)\nInserted into the womb..."}
{"chunk_id": "how_well_contraception_works_at_preventing_pregnancy_nhs__0000", "doc_id": "how_well_contraception_works_at_preventing_pregnancy_nhs", "title": "How well contraception works at preventing pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/contraception/choosing-contraception/how-well-it-works-at-preventing-pregnancy/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "topic:contraception", "triage:see_gp_routine"], "text_path": "corpus/text/how_well_contraception_works_at_preventing_pregnancy_nhs.txt", "n_tokens_est": 447, "preview": "How well contraception works at preventing pregnancy - NHS\nSkip to main content\nHow well contraception works at preventing pregnancy\nSome methods of contraception are more effective than others.\nFor example, the contraceptive implant works very well at preventing pregnancy. It's over 99% effective if used correctly all the time (sometimes called perfect use).\nThis means that if 100 women chose the..."}
{"chunk_id": "how_it_is_used_nhs__0000", "doc_id": "how_it_is_used_nhs", "title": "How it is used - NHS", "url_or_doi": "https://www.nhs.uk/contraception/choosing-contraception/how-it-is-used/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:contraception", "triage:see_gp_routine"], "text_path": "corpus/text/how_it_is_used_nhs.txt", "n_tokens_est": 598, "preview": "How it is used - NHS\nSkip to main content\nHow contraception is used\nHow often you need to use it\nYou need to use some methods of contraception, such as condoms, every time you have sex.\nOther methods can involve taking a pill every day, changing a patch every week or changing a vaginal ring every 3 weeks.\nSome methods, called long-acting methods, can last for several months or years. Sterilisation..."}
{"chunk_id": "side_effects_and_risks_of_hormonal_contraception_nhs__0000", "doc_id": "side_effects_and_risks_of_hormonal_contraception_nhs", "title": "Side effects and risks of hormonal contraception - NHS", "url_or_doi": "https://www.nhs.uk/contraception/choosing-contraception/side-effects-and-risks-of-hormonal-contraception/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:contraception", "triage:see_gp_routine"], "text_path": "corpus/text/side_effects_and_risks_of_hormonal_contraception_nhs.txt", "n_tokens_est": 456, "preview": "Side effects and risks of hormonal contraception - NHS\nSkip to main content\nSide effects and risks of hormonal contraception\nHormonal methods of contraception\nSome methods of contraception contain 1 or 2 hormones.\nSome methods contain 2 hormones, called progestogen and oestrogen. These are:\ncombined pill (the pill)\ncontraceptive patch\nvaginal ring\nSome methods contain only progestogen. These are:\n..."}
{"chunk_id": "side_effects_and_risks_of_non_hormonal_contraception_nhs__0000", "doc_id": "side_effects_and_risks_of_non_hormonal_contraception_nhs", "title": "Side effects and risks of non-hormonal contraception - NHS", "url_or_doi": "https://www.nhs.uk/contraception/choosing-contraception/side-effects-and-risks-of-non-hormonal-contraception/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:contraception", "triage:see_gp_routine"], "text_path": "corpus/text/side_effects_and_risks_of_non_hormonal_contraception_nhs.txt", "n_tokens_est": 312, "preview": "Side effects and risks of non-hormonal contraception - NHS\nSkip to main content\nSide effects and risks of non-hormonal contraception\nNon-hormonal methods of contraception\nSome methods of contraception do not contain hormones (they’re non-hormonal).\nNon-hormonal methods are:\ncondoms, which also help prevent sexually transmitted infections (STIs)\nIUD (copper coil)\ndiaphragm\ncap\nSide effects of non-h..."}
{"chunk_id": "how_contraception_affects_periods_nhs__0000", "doc_id": "how_contraception_affects_periods_nhs", "title": "How contraception affects periods - NHS", "url_or_doi": "https://www.nhs.uk/contraception/choosing-contraception/effects-on-periods/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:menstrual_cycle", "topic:contraception", "triage:see_gp_routine"], "text_path": "corpus/text/how_contraception_affects_periods_nhs.txt", "n_tokens_est": 303, "preview": "How contraception affects periods - NHS\nSkip to main content\nHow contraception affects periods\nSome types of contraception can affect your periods, making them lighter, heavier, more painful or less painful.\nIf you have heavy or painful periods, you may be offered a method of contraception to treat this even if you do not need contraception to prevent pregnancy.\nHelp with painful periods\nMethods o..."}
{"chunk_id": "common_health_problems_in_pregnancy_nhs__0000", "doc_id": "common_health_problems_in_pregnancy_nhs", "title": "Common health problems in pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/common-symptoms/common-health-problems/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "triage:see_gp_routine"], "text_path": "corpus/text/common_health_problems_in_pregnancy_nhs.txt", "n_tokens_est": 975, "preview": "Common health problems in pregnancy - NHS\nSkip to main content\nCommon health problems in pregnancy\nYour body has a great deal to do during pregnancy. Sometimes the changes taking place can cause irritation or discomfort, and sometimes you may be concerned.\nThere's rarely any need for alarm, but you should mention anything that's worrying you to your maternity team.\nConstipation in pregnancy\nThe ho..."}
{"chunk_id": "common_health_problems_in_pregnancy_nhs__0001", "doc_id": "common_health_problems_in_pregnancy_nhs", "title": "Common health problems in pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/common-symptoms/common-health-problems/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "triage:see_gp_routine"], "text_path": "corpus/text/common_health_problems_in_pregnancy_nhs.txt", "n_tokens_est": 694, "preview": "visitor.\nPeeing a lot in pregnancy\nNeeding to pee a lot often starts in early pregnancy and sometimes continues until the baby is born. In later pregnancy, it's caused by the baby's head pressing on your bladder.\nIf you find you need to get up in the night to pee, try cutting out drinks in the late evening. However, make sure you drink plenty of non-alcoholic, caffeine-free drinks during the day t..."}
{"chunk_id": "headaches_in_pregnancy_nhs__0000", "doc_id": "headaches_in_pregnancy_nhs", "title": "Headaches in pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/common-symptoms/headaches/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "sx:headache", "triage:see_gp_routine"], "text_path": "corpus/text/headaches_in_pregnancy_nhs.txt", "n_tokens_est": 484, "preview": "Headaches in pregnancy - NHS\nSkip to main content\nHeadaches in pregnancy\nHeadaches can be common in early pregnancy. They usually improve as your pregnancy goes on.\nThey do not harm your baby, but they can be uncomfortable for you.\nA headache can sometimes be a symptom of\npre-eclampsia\n, which can lead to serious complications if it's not monitored and treated. Pre-eclampsia usually starts after 2..."}
{"chunk_id": "pelvic_pain_in_pregnancy_nhs__0000", "doc_id": "pelvic_pain_in_pregnancy_nhs", "title": "Pelvic pain in pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/common-symptoms/pelvic-pain/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "sx:pelvic_pain", "triage:see_gp_routine"], "text_path": "corpus/text/pelvic_pain_in_pregnancy_nhs.txt", "n_tokens_est": 946, "preview": "Pelvic pain in pregnancy - NHS\nSkip to main content\nPelvic pain in pregnancy\nSome women may develop pelvic pain in pregnancy. This is sometimes called pregnancy-related pelvic girdle pain (PGP) or symphysis pubis dysfunction (SPD).\nPGP is a collection of uncomfortable symptoms caused by a stiffness of your pelvic joints or the joints moving unevenly at either the back or front of your pelvis.\nSymp..."}
{"chunk_id": "pelvic_pain_in_pregnancy_nhs__0001", "doc_id": "pelvic_pain_in_pregnancy_nhs", "title": "Pelvic pain in pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/common-symptoms/pelvic-pain/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "sx:pelvic_pain", "triage:see_gp_routine"], "text_path": "corpus/text/pelvic_pain_in_pregnancy_nhs.txt", "n_tokens_est": 372, "preview": "an ahead and talk about your\nbirth plan\nwith your birth partner and midwife.\nWrite in your birth plan that you have PGP, so the people supporting you during labour and birth will be aware of your condition.\nThink about birth positions that are the most comfortable for you, and write them in your birth plan.\nBeing in water can take the weight off your joints and allow you to move more easily, so yo..."}
{"chunk_id": "vaginal_bleeding_in_pregnancy_nhs__0000", "doc_id": "vaginal_bleeding_in_pregnancy_nhs", "title": "Vaginal bleeding in pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/common-symptoms/vaginal-bleeding/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "sx:vaginal_bleeding_pregnancy", "triage:urgent_same_day"], "text_path": "corpus/text/vaginal_bleeding_in_pregnancy_nhs.txt", "n_tokens_est": 982, "preview": "Vaginal bleeding in pregnancy - NHS\nSkip to main content\nVaginal bleeding in pregnancy\nBleeding during pregnancy is relatively common and does not always mean there's a problem – but it can be a dangerous sign.\nUrgent advice:\nCall your midwife or GP immediately if:\nyou have any bleeding from your vagina\nCauses of bleeding in early pregnancy\nImplantation bleeding\nIn early pregnancy, you might get s..."}
{"chunk_id": "vaginal_bleeding_in_pregnancy_nhs__0001", "doc_id": "vaginal_bleeding_in_pregnancy_nhs", "title": "Vaginal bleeding in pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/common-symptoms/vaginal-bleeding/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "sx:vaginal_bleeding_pregnancy", "triage:urgent_same_day"], "text_path": "corpus/text/vaginal_bleeding_in_pregnancy_nhs.txt", "n_tokens_est": 480, "preview": "a starts to come away from the womb wall. Placental abruption usually causes stomach pain, and this may occur even if there is no bleeding.\nLow-lying placenta (placenta praevia)\nThis is when the placenta is attached in the lower part of the womb, near to or covering the cervix. Bleeding from a low-lying placenta can be very heavy, and put you and your baby at risk.\nYou may be advised to go into ho..."}
{"chunk_id": "vomiting_and_morning_sickness_nhs__0000", "doc_id": "vomiting_and_morning_sickness_nhs", "title": "Vomiting and morning sickness - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/common-symptoms/vomiting-and-morning-sickness/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "sx:morning_sickness_vomiting", "triage:self_care"], "text_path": "corpus/text/vomiting_and_morning_sickness_nhs.txt", "n_tokens_est": 993, "preview": "Vomiting and morning sickness - NHS\nSkip to main content\nVomiting and morning sickness\nNausea and vomiting in pregnancy, often known as morning sickness, is very common in early pregnancy.\nIt can affect you at any time of the day or night or you may feel sick all day long.\nMorning sickness is unpleasant, and can significantly affect your day-to-day life. But it usually clears up by weeks 16 to 20 ..."}
{"chunk_id": "vomiting_and_morning_sickness_nhs__0001", "doc_id": "vomiting_and_morning_sickness_nhs", "title": "Vomiting and morning sickness - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/common-symptoms/vomiting-and-morning-sickness/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "sx:morning_sickness_vomiting", "triage:self_care"], "text_path": "corpus/text/vomiting_and_morning_sickness_nhs.txt", "n_tokens_est": 279, "preview": "ckness medicine.\nRisk factors for morning sickness\nIt's thought hormonal changes in the first 12 weeks of pregnancy are probably one of the causes of morning sickness.\nBut you may be more at risk of it if:\nyou're having twins or more\nyou had severe sickness and vomiting in a previous pregnancy\nyou tend to get motion sickness (for example, car sick)\nyou have a history of migraine headaches\nmorning ..."}
{"chunk_id": "your_baby_s_movements_nhs__0000", "doc_id": "your_baby_s_movements_nhs", "title": "Your baby's movements - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/keeping-well/your-babys-movements/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "ctx:pregnant", "sx:reduced_fetal_movement", "triage:urgent_same_day"], "text_path": "corpus/text/your_baby_s_movements_nhs.txt", "n_tokens_est": 499, "preview": "Your baby's movements - NHS\nSkip to main content\nYour baby's movements\nWhen you'll feel your baby move\nYou should start to feel your baby move between 16 to 24 weeks of pregnancy. If this is your first baby, you might not feel movements until after 20 weeks.\nIf you have not felt your baby move by 24 weeks, tell your midwife. They'll check your baby's heartbeat and movements.\nYou should feel your b..."}
{"chunk_id": "how_long_does_it_usually_take_to_get_pregnant_nhs__0000", "doc_id": "how_long_does_it_usually_take_to_get_pregnant_nhs", "title": "How long does it usually take to get pregnant? - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/trying-for-a-baby/how-long-it-takes-to-get-pregnant/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "topic:fertility", "ctx:trying_to_conceive", "triage:see_gp_routine"], "text_path": "corpus/text/how_long_does_it_usually_take_to_get_pregnant_nhs.txt", "n_tokens_est": 480, "preview": "How long does it usually take to get pregnant? - NHS\nSkip to main content\nHow long does it usually take to get pregnant?\nIt's impossible to say how long it takes to get pregnant because it's different for each woman.\nMany factors can affect a couple's chances of conceiving, such as:\nyour age\nyour general health\nyour reproductive health\nhow often you have sex\nSome women become pregnant quickly, whi..."}
{"chunk_id": "planning_your_pregnancy_nhs__0000", "doc_id": "planning_your_pregnancy_nhs", "title": "Planning your pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/trying-for-a-baby/planning-your-pregnancy/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "topic:fertility", "ctx:trying_to_conceive", "triage:see_gp_routine"], "text_path": "corpus/text/planning_your_pregnancy_nhs.txt", "n_tokens_est": 989, "preview": "Planning your pregnancy - NHS\nSkip to main content\nPlanning your pregnancy\nYou can improve your chances of getting pregnant and having a healthy pregnancy by following the steps on this page.\nTake a folic acid supplement\nIt's recommended that you should take a daily supplement of folic acid when you're pregnant, or when there's a chance you might get pregnant.\nYou should take a 400 microgram suppl..."}
{"chunk_id": "planning_your_pregnancy_nhs__0001", "doc_id": "planning_your_pregnancy_nhs", "title": "Planning your pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/trying-for-a-baby/planning-your-pregnancy/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "topic:fertility", "ctx:trying_to_conceive", "triage:see_gp_routine"], "text_path": "corpus/text/planning_your_pregnancy_nhs.txt", "n_tokens_est": 642, "preview": "ow which medicines you can take\nNot all medicines are safe to take when you're pregnant or planning a pregnancy, whether they're on prescription or medicines you can buy in a pharmacy or shop.\nInformation:\nIf you take prescribed medicine and you're planning to get pregnant, talk to a doctor.\nDo not stop taking your medicine without talking to a doctor.\nFind out about medicines in pregnancy\nVaccina..."}
{"chunk_id": "signs_and_symptoms_of_pregnancy_nhs__0000", "doc_id": "signs_and_symptoms_of_pregnancy_nhs", "title": "Signs and symptoms of pregnancy - NHS", "url_or_doi": "https://www.nhs.uk/pregnancy/trying-for-a-baby/signs-and-symptoms-of-pregnancy/", "tags": ["tier:A_patient_info", "source:NHS", "type:guideline_page", "topic:pregnancy", "topic:fertility", "ctx:trying_to_conceive", "sx:pregnancy_signs", "triage:see_gp_routine"], "text_path": "corpus/text/signs_and_symptoms_of_pregnancy_nhs.txt", "n_tokens_est": 761, "preview": "Signs and symptoms of pregnancy - NHS\nSkip to main content\nSigns and symptoms of pregnancy\nEarly signs of pregnancy\nEvery pregnancy is different and not everyone will notice all of these symptoms.\nIf you're worried about any symptoms you're having, talk to a GP or your midwife.\nMissed or lighter period\nIf you have a regular monthly menstrual cycle, the earliest and most reliable sign of pregnancy ..."}
{"chunk_id": "early_or_premature_menopause_nhs__0000", "doc_id": "early_or_premature_menopause_nhs", "title": "Early or premature menopause - NHS", "url_or_doi": "https://www.nhs.uk/conditions/early-or-premature-menopause/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menopause", "possible:early_menopause", "ctx:perimenopause", "triage:self_care"], "text_path": "corpus/text/early_or_premature_menopause_nhs.txt", "n_tokens_est": 869, "preview": "Early or premature menopause - NHS\nSkip to main content\nEarly or premature menopause\nEarly menopause is when you stop having regular periods before the age of 45. Premature menopause is if this happens before the age of 40. It can happen naturally or be caused by treatment for other conditions.\nSymptoms of early or premature menopause\nMenopause is when your periods stop due to lower hormone levels..."}
{"chunk_id": "menopause_symptoms_nhs__0000", "doc_id": "menopause_symptoms_nhs", "title": "Menopause - Symptoms - NHS", "url_or_doi": "https://www.nhs.uk/conditions/menopause/symptoms/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menopause", "ctx:menopause", "triage:self_care"], "text_path": "corpus/text/menopause_symptoms_nhs.txt", "n_tokens_est": 874, "preview": "Menopause - Symptoms\n- NHS\nSkip to main content\nSymptoms\nMenopause\nCommon symptoms of menopause and perimenopause\nMenopause and perimenopause symptoms can have a big impact on your daily life, including relationships, social life, family life and work.\nIt can feel different for everyone. You may have a number of symptoms or none.\nSymptoms usually start months or years before your periods stop. Thi..."}
{"chunk_id": "menopause_things_you_can_do_nhs__0000", "doc_id": "menopause_things_you_can_do_nhs", "title": "Menopause - Things you can do - NHS", "url_or_doi": "https://www.nhs.uk/conditions/menopause/things-you-can-do/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menopause", "ctx:menopause", "triage:self_care"], "text_path": "corpus/text/menopause_things_you_can_do_nhs.txt", "n_tokens_est": 727, "preview": "Menopause - Things you can do\n- NHS\nSkip to main content\nThings you can do\nMenopause\nLifestyle changes to help menopause and perimenopause\nEating well, exercising and looking after your mental wellbeing can help with symptoms during perimenopause and menopause.\nIt can also help you keep as well as possible in the future.\nDo\nget plenty of rest, including keeping to regular sleep routines\neat a heal..."}
{"chunk_id": "menopause_treatment_nhs__0000", "doc_id": "menopause_treatment_nhs", "title": "Menopause - Treatment - NHS", "url_or_doi": "https://www.nhs.uk/conditions/menopause/treatment/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menopause", "ctx:menopause", "triage:self_care"], "text_path": "corpus/text/menopause_treatment_nhs.txt", "n_tokens_est": 994, "preview": "Menopause - Treatment\n- NHS\nSkip to main content\nTreatment\nMenopause\nTreatment for menopause and perimenopause\nThe main medicine treatment for menopause and perimenopause symptoms is hormone replacement therapy (HRT), which replaces the hormones that are at low levels.\nThere are other treatments if you cannot, or choose not to, have HRT.\nHormone replacement therapy (HRT)\nHRT is a safe and effectiv..."}
{"chunk_id": "menopause_treatment_nhs__0001", "doc_id": "menopause_treatment_nhs", "title": "Menopause - Treatment - NHS", "url_or_doi": "https://www.nhs.uk/conditions/menopause/treatment/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menopause", "ctx:menopause", "triage:self_care"], "text_path": "corpus/text/menopause_treatment_nhs.txt", "n_tokens_est": 884, "preview": "ream or ring. This can also improve any urinary symptoms caused by menopause and perimenopause, like pain when you pee.\nThese vaginal oestrogen treatments do not get into your bloodstream and only work on the bit of the body where you put them. You can use them for the rest of your life. Symptoms usually come back when you stop using them.\nIt's safe to use vaginal oestrogen with HRT.\nRead more abo..."}
{"chunk_id": "menopause_help_and_support_nhs__0000", "doc_id": "menopause_help_and_support_nhs", "title": "Menopause - Help and support - NHS", "url_or_doi": "https://www.nhs.uk/conditions/menopause/help-and-support/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:menopause", "ctx:menopause", "triage:self_care"], "text_path": "corpus/text/menopause_help_and_support_nhs.txt", "n_tokens_est": 232, "preview": "Menopause - Help and support\n- NHS\nSkip to main content\nHelp and support\nMenopause\nSpeak to a healthcare professional\nA GP, nurse or pharmacist can give you advice and help with your menopause or perimenopause symptoms.\nThere are also menopause specialists who have experience in supporting anyone going through perimenopause and menopause.\nFind your nearest NHS or private menopause specialist on th..."}
{"chunk_id": "feelings_symptoms_and_behaviours_nhs__0000", "doc_id": "feelings_symptoms_and_behaviours_nhs", "title": "Feelings, symptoms and behaviours - NHS", "url_or_doi": "https://www.nhs.uk/mental-health/feelings-symptoms-behaviours/", "tags": ["tier:A_patient_info", "source:NHS", "type:patient_page", "topic:mental_health", "triage:see_gp_routine"], "text_path": "corpus/text/feelings_symptoms_and_behaviours_nhs.txt", "n_tokens_est": 178, "preview": "Feelings, symptoms and behaviours - NHS\nSkip to main content\nFeelings, symptoms and behaviours\nFind information about feelings and symptoms that can affect your mental health.\nTop tasks in Feelings, symptoms and behaviours\nGet urgent help now for mental health\nHelp for suicidal thoughts\nFeelings and symptoms\nRead about feelings and symptoms related to mental health problems, including:\nfeelings an..."}
{"chunk_id": "women_s_health_in_2024_change_now_for_tomorrow_will_be_too_late__0000", "doc_id": "women_s_health_in_2024_change_now_for_tomorrow_will_be_too_late", "title": "Women's health in 2024: change now for tomorrow will be too late", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/38154485/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:journal_article", "topic:womens_health_general"], "text_path": "corpus/text/women_s_health_in_2024_change_now_for_tomorrow_will_be_too_late.txt", "n_tokens_est": 808, "preview": "Women's health in 2024: change now for tomorrow will be too late - PubMed\nClipboard, Search History, and several other advanced features are temporarily unavailable.\nSkip to main page content\nThe .gov means it’s official.\nFederal government websites often end in .gov or .mil. Before\nsharing sensitive information, make sure you’re on a federal\ngovernment site.\nThe site is secure.\nThe\nhttps://\nensur..."}
{"chunk_id": "women_s_network_women_s_lip_pubmed__0000", "doc_id": "women_s_network_women_s_lip_pubmed", "title": "Women's network. Women's lip - PubMed", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/8155547/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:journal_article", "topic:womens_health_general"], "text_path": "corpus/text/women_s_network_women_s_lip_pubmed.txt", "n_tokens_est": 843, "preview": "Women's network. Women's lip - PubMed\nClipboard, Search History, and several other advanced features are temporarily unavailable.\nSkip to main page content\nThe .gov means it’s official.\nFederal government websites often end in .gov or .mil. Before\nsharing sensitive information, make sure you’re on a federal\ngovernment site.\nThe site is secure.\nThe\nhttps://\nensures that you are connecting to the\nof..."}
{"chunk_id": "obesity_diabetes_women_s_health_the_perfect_storm_looming_in_the_horizon__0000", "doc_id": "obesity_diabetes_women_s_health_the_perfect_storm_looming_in_the_horizon", "title": "Obesity, diabetes & women's health: the perfect storm looming in the horizon?", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/38804119/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:journal_article", "topic:metabolic_womens_health", "possible:obesity", "possible:diabetes", "topic:womens_health_general"], "text_path": "corpus/text/obesity_diabetes_women_s_health_the_perfect_storm_looming_in_the_horizon.txt", "n_tokens_est": 838, "preview": "Obesity, diabetes & women's health: the perfect storm looming in the horizon? - PubMed\nClipboard, Search History, and several other advanced features are temporarily unavailable.\nSkip to main page content\nThe .gov means it’s official.\nFederal government websites often end in .gov or .mil. Before\nsharing sensitive information, make sure you’re on a federal\ngovernment site.\nThe site is secure.\nThe\nh..."}
{"chunk_id": "obesity_diabetes_women_s_health_the_perfect_storm_looming_in_the_horizon_pubmed__0000", "doc_id": "obesity_diabetes_women_s_health_the_perfect_storm_looming_in_the_horizon_pubmed", "title": "Obesity, diabetes & women's health: the perfect storm looming in the horizon? - PubMed", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/38804119/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:journal_article", "topic:metabolic_womens_health", "possible:obesity", "possible:diabetes", "topic:womens_health_general"], "text_path": "corpus/text/obesity_diabetes_women_s_health_the_perfect_storm_looming_in_the_horizon_pubmed.txt", "n_tokens_est": 838, "preview": "Obesity, diabetes & women's health: the perfect storm looming in the horizon? - PubMed\nClipboard, Search History, and several other advanced features are temporarily unavailable.\nSkip to main page content\nThe .gov means it’s official.\nFederal government websites often end in .gov or .mil. Before\nsharing sensitive information, make sure you’re on a federal\ngovernment site.\nThe site is secure.\nThe\nh..."}
{"chunk_id": "women_s_occupational_health_a_critical_review_and_discussion_of_current_issues__0000", "doc_id": "women_s_occupational_health_a_critical_review_and_discussion_of_current_issues", "title": "Women's occupational health: a critical review and discussion of current issues", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/9302729/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:review_article", "topic:occupational_health"], "text_path": "corpus/text/women_s_occupational_health_a_critical_review_and_discussion_of_current_issues.txt", "n_tokens_est": 1000, "preview": "Women's occupational health: a critical review and discussion of current issues - PubMed\nClipboard, Search History, and several other advanced features are temporarily unavailable.\nSkip to main page content\nThe .gov means it’s official.\nFederal government websites often end in .gov or .mil. Before\nsharing sensitive information, make sure you’re on a federal\ngovernment site.\nThe site is secure.\nThe..."}
{"chunk_id": "women_s_occupational_health_a_critical_review_and_discussion_of_current_issues__0001", "doc_id": "women_s_occupational_health_a_critical_review_and_discussion_of_current_issues", "title": "Women's occupational health: a critical review and discussion of current issues", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/9302729/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:review_article", "topic:occupational_health"], "text_path": "corpus/text/women_s_occupational_health_a_critical_review_and_discussion_of_current_issues.txt", "n_tokens_est": 306, "preview": "Non-U.S. Gov't\nActions\nSearch in PubMed\nSearch in MeSH\nAdd to Search\nReview\nActions\nSearch in PubMed\nSearch in MeSH\nAdd to Search\nMeSH terms\nData Collection\nActions\nSearch in PubMed\nSearch in MeSH\nAdd to Search\nFemale\nActions\nSearch in PubMed\nSearch in MeSH\nAdd to Search\nHealth Services Needs and Demand\nActions\nSearch in PubMed\nSearch in MeSH\nAdd to Search\nHumans\nActions\nSearch in PubMed\nSearch in..."}
{"chunk_id": "vaginal_microbiome_considerations_for_reproductive_health__0000", "doc_id": "vaginal_microbiome_considerations_for_reproductive_health", "title": "Vaginal microbiome: considerations for reproductive health", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/36314380/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:journal_article", "topic:vaginal_microbiome"], "text_path": "corpus/text/vaginal_microbiome_considerations_for_reproductive_health.txt", "n_tokens_est": 997, "preview": "Vaginal microbiome: considerations for reproductive health - PubMed\nClipboard, Search History, and several other advanced features are temporarily unavailable.\nSkip to main page content\nThe .gov means it’s official.\nFederal government websites often end in .gov or .mil. Before\nsharing sensitive information, make sure you’re on a federal\ngovernment site.\nThe site is secure.\nThe\nhttps://\nensures tha..."}
{"chunk_id": "vaginal_microbiome_considerations_for_reproductive_health__0001", "doc_id": "vaginal_microbiome_considerations_for_reproductive_health", "title": "Vaginal microbiome: considerations for reproductive health", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/36314380/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:journal_article", "topic:vaginal_microbiome"], "text_path": "corpus/text/vaginal_microbiome_considerations_for_reproductive_health.txt", "n_tokens_est": 325, "preview": "health and pathological conditions.\nKeywords:\nLactobacillus; bacterial vaginosis; preterm birth; vaginal microbiome.\nPubMed Disclaimer\nPublication types\nReview\nActions\nSearch in PubMed\nSearch in MeSH\nAdd to Search\nMeSH terms\nFemale\nActions\nSearch in PubMed\nSearch in MeSH\nAdd to Search\nHumans\nActions\nSearch in PubMed\nSearch in MeSH\nAdd to Search\nInfant, Newborn\nActions\nSearch in PubMed\nSearch in Me..."}
{"chunk_id": "breast_density_knowledge_in_a_screening_mammography_population_exposed_to_densit__0000", "doc_id": "breast_density_knowledge_in_a_screening_mammography_population_exposed_to_densit", "title": "Breast Density Knowledge in a Screening Mammography Population Exposed to Density Notification", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/35341697/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:journal_article", "topic:breast_health", "possible:breast_density"], "text_path": "corpus/text/breast_density_knowledge_in_a_screening_mammography_population_exposed_to_densit.txt", "n_tokens_est": 832, "preview": "Breast Density Knowledge in a Screening Mammography Population Exposed to Density Notification - PubMed\nClipboard, Search History, and several other advanced features are temporarily unavailable.\nSkip to main page content\nThe .gov means it’s official.\nFederal government websites often end in .gov or .mil. Before\nsharing sensitive information, make sure you’re on a federal\ngovernment site.\nThe site..."}
{"chunk_id": "breast_density_knowledge_in_a_screening_mammography_population_exposed_to_densit__0001", "doc_id": "breast_density_knowledge_in_a_screening_mammography_population_exposed_to_densit", "title": "Breast Density Knowledge in a Screening Mammography Population Exposed to Density Notification", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/35341697/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:journal_article", "topic:breast_health", "possible:breast_density"], "text_path": "corpus/text/breast_density_knowledge_in_a_screening_mammography_population_exposed_to_densit.txt", "n_tokens_est": 1132, "preview": "d feelings about future screening.\nMethods:\nFrom December 2017 to January 2020, we surveyed women aged 40 to 74 years without prior breast cancer, with a normal screening mammogram in the prior year, and ≥1 recorded breast density measures in four Breast Cancer Surveillance Consortium registries with density reporting laws. We measured agreement between self-reported and BI-RADS breast density cat..."}
{"chunk_id": "breast_density_knowledge_in_a_screening_mammography_population_exposed_to_densit__0002", "doc_id": "breast_density_knowledge_in_a_screening_mammography_population_exposed_to_densit", "title": "Breast Density Knowledge in a Screening Mammography Population Exposed to Density Notification", "url_or_doi": "https://pubmed.ncbi.nlm.nih.gov/35341697/", "tags": ["tier:B_peer_reviewed", "source:PubMed", "type:journal_article", "topic:breast_health", "possible:breast_density"], "text_path": "corpus/text/breast_density_knowledge_in_a_screening_mammography_population_exposed_to_densit.txt", "n_tokens_est": 734, "preview": "nse vs. Self-report dense p=0.003 § Self-report non-dense vs. Does not know p=0.02 ∥ Self-report non-dense vs. Self-report dense p=0.01; Self-report non-dense vs. Does not know p=0.01 ^ No statistically significant differences (p≥0.05) ~ Self-report non-dense vs. Self-report dense p<0.001; Self-report dense vs. Does not know p<0.001 # For all comparisons p <0.001 $ Self-report non-dense vs. Self-r..."}
{"chunk_id": "postpartum_depression_medlineplus__0000", "doc_id": "postpartum_depression_medlineplus", "title": "Postpartum Depression: MedlinePlus", "url_or_doi": "https://medlineplus.gov/postpartumdepression.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:postpartum", "ctx:postpartum", "topic:mental_health", "possible:postpartum_depression", "triage:see_gp_routine"], "text_path": "corpus/text/postpartum_depression_medlineplus.txt", "n_tokens_est": 948, "preview": "Postpartum Depression: MedlinePlus\nSkip navigation\nOfficial websites use .gov\n.gov\nwebsite belongs to an official government\norganization in the United States.\nSecure .gov websites use HTTPS\nlock\nLock\nLocked padlock icon\n) or\nhttps://\nmeans you’ve safely connected to\nthe .gov website. Share sensitive information only on official,\nsecure websites.\nYou Are Here:\nHome\nHealth Topics\nPostpartum Depress..."}
{"chunk_id": "postpartum_depression_medlineplus__0001", "doc_id": "postpartum_depression_medlineplus", "title": "Postpartum Depression: MedlinePlus", "url_or_doi": "https://medlineplus.gov/postpartumdepression.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:postpartum", "ctx:postpartum", "topic:mental_health", "possible:postpartum_depression", "triage:see_gp_routine"], "text_path": "corpus/text/postpartum_depression_medlineplus.txt", "n_tokens_est": 1134, "preview": "ine at any time:\nCall or text 988\nChat online with\nLifeline Chat\nTTY users:\nUse your preferred relay service or\ndial 711 then 988\nVeterans can contact the Veterans Crisis Line:\nCall 988, then press 1\nText 838255\nChat online\nCall your mental health provider or other health care provider\nReach out to a loved one or close friend\nIf these symptoms begin during pregnancy and continue after childbirth, ..."}
{"chunk_id": "postpartum_depression_medlineplus__0002", "doc_id": "postpartum_depression_medlineplus", "title": "Postpartum Depression: MedlinePlus", "url_or_doi": "https://medlineplus.gov/postpartumdepression.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:postpartum", "ctx:postpartum", "topic:mental_health", "possible:postpartum_depression", "triage:see_gp_routine"], "text_path": "corpus/text/postpartum_depression_medlineplus.txt", "n_tokens_est": 311, "preview": "Tutorials\nTalking Postpartum Depression\n(Department of Health and Human Services, Office on Women's Health)\nStatistics and Research\nMaternal Postpartum Depressive Symptoms\n(Federal Interagency Forum on Child and Family Statistics)\nClinical Trials\nClinicalTrials.gov: Depression, Postpartum\n(National Institutes of Health)\nJournal Articles\nReferences and abstracts from MEDLINE/PubMed (National Librar..."}
{"chunk_id": "cesarean_section_c_section_medlineplus__0000", "doc_id": "cesarean_section_c_section_medlineplus", "title": "Cesarean Section | C Section | MedlinePlus", "url_or_doi": "https://medlineplus.gov/cesareandelivery.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/cesarean_section_c_section_medlineplus.txt", "n_tokens_est": 992, "preview": "Cesarean Section | C Section | MedlinePlus\nSkip navigation\nOfficial websites use .gov\n.gov\nwebsite belongs to an official government\norganization in the United States.\nSecure .gov websites use HTTPS\nlock\nLock\nLocked padlock icon\n) or\nhttps://\nmeans you’ve safely connected to\nthe .gov website. Share sensitive information only on official,\nsecure websites.\nYou Are Here:\nHome\nHealth Topics\nCesarean D..."}
{"chunk_id": "cesarean_section_c_section_medlineplus__0001", "doc_id": "cesarean_section_c_section_medlineplus", "title": "Cesarean Section | C Section | MedlinePlus", "url_or_doi": "https://medlineplus.gov/cesareandelivery.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/cesarean_section_c_section_medlineplus.txt", "n_tokens_est": 591, "preview": "demy of Pediatrics)\nAlso in\nSpanish\nHaving a C-Section\n(March of Dimes Foundation)\nLabor and Delivery, Postpartum Care (Cesarean Delivery)\n(Mayo Foundation for Medical Education and Research)\nAlso in\nSpanish\nWhat Is a C-Section?\n(Eunice Kennedy Shriver National Institute of Child Health and Human Development)\nRelated Issues\nBreastfeeding after Cesarean Delivery\n(American Academy of Pediatrics)\nAls..."}
{"chunk_id": "menopause_menopause_symptoms_medlineplus__0000", "doc_id": "menopause_menopause_symptoms_medlineplus", "title": "Menopause | Menopause Symptoms | MedlinePlus", "url_or_doi": "https://medlineplus.gov/menopause.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:menopause", "ctx:menopause", "triage:self_care"], "text_path": "corpus/text/menopause_menopause_symptoms_medlineplus.txt", "n_tokens_est": 998, "preview": "Menopause | Menopause Symptoms | MedlinePlus\nSkip navigation\nOfficial websites use .gov\n.gov\nwebsite belongs to an official government\norganization in the United States.\nSecure .gov websites use HTTPS\nlock\nLock\nLocked padlock icon\n) or\nhttps://\nmeans you’ve safely connected to\nthe .gov website. Share sensitive information only on official,\nsecure websites.\nYou Are Here:\nHome\nHealth Topics\nMenopaus..."}
{"chunk_id": "menopause_menopause_symptoms_medlineplus__0001", "doc_id": "menopause_menopause_symptoms_medlineplus", "title": "Menopause | Menopause Symptoms | MedlinePlus", "url_or_doi": "https://medlineplus.gov/menopause.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:menopause", "ctx:menopause", "triage:self_care"], "text_path": "corpus/text/menopause_menopause_symptoms_medlineplus.txt", "n_tokens_est": 1145, "preview": "u do, there are several different types of treatments:\nLifestyle changes\nYou may find that you can manage your symptoms with lifestyle changes. Here are some changes that might make you feel better:\nIf you have hot flashes, dress in layers that can be removed at the start of a hot flash. You may want to carry a portable fan to use when you get a hot flash.\nAvoid\nalcohol\n, spicy foods, and\ncaffeine..."}
{"chunk_id": "menopause_menopause_symptoms_medlineplus__0002", "doc_id": "menopause_menopause_symptoms_medlineplus", "title": "Menopause | Menopause Symptoms | MedlinePlus", "url_or_doi": "https://medlineplus.gov/menopause.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:menopause", "ctx:menopause", "triage:self_care"], "text_path": "corpus/text/menopause_menopause_symptoms_medlineplus.txt", "n_tokens_est": 884, "preview": "Treatments and Therapies\n4 Things to Know about Menopausal Symptoms and Complementary Health Practices\n(National Center for Complementary and Integrative Health)\nBioidentical Hormones: Are They Safer?\n(Mayo Foundation for Medical Education and Research)\nAlso in\nSpanish\nHormone Replacement Therapy: MedlinePlus Health Topic\n(National Library of Medicine)\nAlso in\nSpanish\nHot Flashes: What Can I Do?\n(..."}
{"chunk_id": "heart_disease_in_women_medlineplus__0000", "doc_id": "heart_disease_in_women_medlineplus", "title": "Heart Disease in Women | MedlinePlus", "url_or_doi": "https://medlineplus.gov/heartdiseaseinwomen.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:cardio_womens_health", "possible:heart_disease", "triage:see_gp_routine"], "text_path": "corpus/text/heart_disease_in_women_medlineplus.txt", "n_tokens_est": 962, "preview": "Heart Disease in Women | MedlinePlus\nSkip navigation\nOfficial websites use .gov\n.gov\nwebsite belongs to an official government\norganization in the United States.\nSecure .gov websites use HTTPS\nlock\nLock\nLocked padlock icon\n) or\nhttps://\nmeans you’ve safely connected to\nthe .gov website. Share sensitive information only on official,\nsecure websites.\nYou Are Here:\nHome\nHealth Topics\nHeart Disease in..."}
{"chunk_id": "heart_disease_in_women_medlineplus__0001", "doc_id": "heart_disease_in_women_medlineplus", "title": "Heart Disease in Women | MedlinePlus", "url_or_doi": "https://medlineplus.gov/heartdiseaseinwomen.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:cardio_womens_health", "possible:heart_disease", "triage:see_gp_routine"], "text_path": "corpus/text/heart_disease_in_women_medlineplus.txt", "n_tokens_est": 1145, "preview": "can happen even if you're healthy. It mostly affects women after menopause and usually doesn't cause any lasting damage.\nVariant angina\n- A rare type of strong chest pain from spasms in the heart arteries. The pain usually happens in a pattern during sleep. Variant angina rarely causes a heart attack.\nWhich women are more likely to develop heart disease?\nYour risk for developing heart disease incr..."}
{"chunk_id": "heart_disease_in_women_medlineplus__0002", "doc_id": "heart_disease_in_women_medlineplus", "title": "Heart Disease in Women | MedlinePlus", "url_or_doi": "https://medlineplus.gov/heartdiseaseinwomen.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:cardio_womens_health", "possible:heart_disease", "triage:see_gp_routine"], "text_path": "corpus/text/heart_disease_in_women_medlineplus.txt", "n_tokens_est": 764, "preview": "rt Health Tests: MedlinePlus Health Topic\n(National Library of Medicine)\nAlso in\nSpanish\nPrevention and Risk Factors\nHeart Disease and Stroke\n(Department of Health and Human Services, Office on Women's Health)\nHeart Disease in Women: Understand Symptoms and Risk Factors\n(Mayo Foundation for Medical Education and Research)\nAlso in\nSpanish\nHeart Disease Risk Factors\n(Department of Health and Human S..."}
{"chunk_id": "ovarian_disorders_ovarian_cancer_medlineplus__0000", "doc_id": "ovarian_disorders_ovarian_cancer_medlineplus", "title": "Ovarian Disorders | Ovarian Cancer | MedlinePlus", "url_or_doi": "https://medlineplus.gov/ovariandisorders.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:gynecologic_cancers", "possible:ovarian_disorder", "possible:ovarian_cancer", "triage:see_gp_routine"], "text_path": "corpus/text/ovarian_disorders_ovarian_cancer_medlineplus.txt", "n_tokens_est": 996, "preview": "Ovarian Disorders | Ovarian Cancer | MedlinePlus\nSkip navigation\nOfficial websites use .gov\n.gov\nwebsite belongs to an official government\norganization in the United States.\nSecure .gov websites use HTTPS\nlock\nLock\nLocked padlock icon\n) or\nhttps://\nmeans you’ve safely connected to\nthe .gov website. Share sensitive information only on official,\nsecure websites.\nYou Are Here:\nHome\nHealth Topics\nOvar..."}
{"chunk_id": "ovarian_disorders_ovarian_cancer_medlineplus__0001", "doc_id": "ovarian_disorders_ovarian_cancer_medlineplus", "title": "Ovarian Disorders | Ovarian Cancer | MedlinePlus", "url_or_doi": "https://medlineplus.gov/ovariandisorders.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:gynecologic_cancers", "possible:ovarian_disorder", "possible:ovarian_cancer", "triage:see_gp_routine"], "text_path": "corpus/text/ovarian_disorders_ovarian_cancer_medlineplus.txt", "n_tokens_est": 503, "preview": "r hormonal\nbirth control\n, lifestyle changes to reduce symptoms, or sometimes surgery. Ovarian cancer may require surgery,\nchemotherapy\n, or other targeted therapy.\nDiagnosis and Tests\nDHEA Sulfate Test\n(National Library of Medicine)\nAlso in\nSpanish\nEstrogen Levels Test\n(National Library of Medicine)\nAlso in\nSpanish\nFollicle-Stimulating Hormone (FSH) Levels Test\n(National Library of Medicine)\nAlso..."}
{"chunk_id": "sexual_problems_in_women_dyspareunia_medlineplus__0000", "doc_id": "sexual_problems_in_women_dyspareunia_medlineplus", "title": "Sexual Problems in Women | Dyspareunia | MedlinePlus", "url_or_doi": "https://medlineplus.gov/sexualproblemsinwomen.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:sexual_health", "sx:dyspareunia", "triage:see_gp_routine"], "text_path": "corpus/text/sexual_problems_in_women_dyspareunia_medlineplus.txt", "n_tokens_est": 995, "preview": "Sexual Problems in Women | Dyspareunia | MedlinePlus\nSkip navigation\nOfficial websites use .gov\n.gov\nwebsite belongs to an official government\norganization in the United States.\nSecure .gov websites use HTTPS\nlock\nLock\nLocked padlock icon\n) or\nhttps://\nmeans you’ve safely connected to\nthe .gov website. Share sensitive information only on official,\nsecure websites.\nYou Are Here:\nHome\nHealth Topics\n..."}
{"chunk_id": "sexual_problems_in_women_dyspareunia_medlineplus__0001", "doc_id": "sexual_problems_in_women_dyspareunia_medlineplus", "title": "Sexual Problems in Women | Dyspareunia | MedlinePlus", "url_or_doi": "https://medlineplus.gov/sexualproblemsinwomen.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:sexual_health", "sx:dyspareunia", "triage:see_gp_routine"], "text_path": "corpus/text/sexual_problems_in_women_dyspareunia_medlineplus.txt", "n_tokens_est": 286, "preview": "vic pain and dyspareunia in women after...\nArticle: Psychological and sexual impact of human papillomavirus screening in women in...\nArticle: Risk factors of genito-pelvic pain/penetration disorder among Black women in the...\nSexual Problems in Women -- see more articles\nReference Desk\nFemale Reproductive System\n(Nemours Foundation)\nAlso in\nSpanish\nFind an Expert\nDepartment of Health and Human Ser..."}
{"chunk_id": "vulvar_disorders_vulva_vulva_cancer_medlineplus__0000", "doc_id": "vulvar_disorders_vulva_vulva_cancer_medlineplus", "title": "Vulvar Disorders | Vulva | Vulva Cancer | MedlinePlus", "url_or_doi": "https://medlineplus.gov/vulvardisorders.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:gynecologic_cancers", "possible:vulvar_disorder", "possible:vulvar_cancer", "triage:see_gp_routine"], "text_path": "corpus/text/vulvar_disorders_vulva_vulva_cancer_medlineplus.txt", "n_tokens_est": 736, "preview": "Vulvar Disorders | Vulva | Vulva Cancer | MedlinePlus\nSkip navigation\nOfficial websites use .gov\n.gov\nwebsite belongs to an official government\norganization in the United States.\nSecure .gov websites use HTTPS\nlock\nLock\nLocked padlock icon\n) or\nhttps://\nmeans you’ve safely connected to\nthe .gov website. Share sensitive information only on official,\nsecure websites.\nYou Are Here:\nHome\nHealth Topics..."}
{"chunk_id": "sexually_transmitted_infections_stis_venereal_disease_medlineplus__0000", "doc_id": "sexually_transmitted_infections_stis_venereal_disease_medlineplus", "title": "Sexually Transmitted Infections | STIs | Venereal Disease | MedlinePlus", "url_or_doi": "https://medlineplus.gov/sexuallytransmittedinfections.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:sexual_health", "possible:sti", "triage:see_gp_routine"], "text_path": "corpus/text/sexually_transmitted_infections_stis_venereal_disease_medlineplus.txt", "n_tokens_est": 993, "preview": "Sexually Transmitted Infections | STIs | Venereal Disease | MedlinePlus\nSkip navigation\nOfficial websites use .gov\n.gov\nwebsite belongs to an official government\norganization in the United States.\nSecure .gov websites use HTTPS\nlock\nLock\nLocked padlock icon\n) or\nhttps://\nmeans you’ve safely connected to\nthe .gov website. Share sensitive information only on official,\nsecure websites.\nYou Are Here:\n..."}
{"chunk_id": "sexually_transmitted_infections_stis_venereal_disease_medlineplus__0001", "doc_id": "sexually_transmitted_infections_stis_venereal_disease_medlineplus", "title": "Sexually Transmitted Infections | STIs | Venereal Disease | MedlinePlus", "url_or_doi": "https://medlineplus.gov/sexuallytransmittedinfections.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:sexual_health", "possible:sti", "triage:see_gp_routine"], "text_path": "corpus/text/sexually_transmitted_infections_stis_venereal_disease_medlineplus.txt", "n_tokens_est": 1142, "preview": "tics\ncan treat STIs that are caused by bacteria or parasites. There is no cure for STIs caused by viruses, but antiviral medicines can often help with the symptoms and lower your risk of spreading the infection.\nIt's important to get treatment if you have an STI. Some types of STIs can cause serious health problems if they are not treated. Talk to your provider about how long to not have sex after..."}
{"chunk_id": "sexually_transmitted_infections_stis_venereal_disease_medlineplus__0002", "doc_id": "sexually_transmitted_infections_stis_venereal_disease_medlineplus", "title": "Sexually Transmitted Infections | STIs | Venereal Disease | MedlinePlus", "url_or_doi": "https://medlineplus.gov/sexuallytransmittedinfections.html", "tags": ["tier:A_patient_info", "source:MedlinePlus", "type:patient_page", "topic:sexual_health", "possible:sti", "triage:see_gp_routine"], "text_path": "corpus/text/sexually_transmitted_infections_stis_venereal_disease_medlineplus.txt", "n_tokens_est": 523, "preview": "more articles\nFind an Expert\nCenters for Disease Control and Prevention\nAlso in\nSpanish\nNational Institute of Allergy and Infectious Diseases\nTeenagers\nCan I Get Checked for STDs Without My Parents Knowing?\n(Nemours Foundation)\nAlso in\nSpanish\nDo You Have to See a Doctor to Find Out if You Have an STD?\n(Nemours Foundation)\nAlso in\nSpanish\nGetting Tested for STDs\n(Nemours Foundation)\nAlso in\nSpanis..."}
{"chunk_id": "evidence_based_outcomes_after_oocyte_cryopreservation_for_donor_oocyte_in_vitro___0000", "doc_id": "evidence_based_outcomes_after_oocyte_cryopreservation_for_donor_oocyte_in_vitro_", "title": "Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline", "url_or_doi": "https://doi.org/10.1016/j.fertnstert.2021.02.024", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "status:paywalled_or_unresolved"], "text_path": "corpus/text/evidence_based_outcomes_after_oocyte_cryopreservation_for_donor_oocyte_in_vitro_.txt", "n_tokens_est": 2, "preview": "Redirecting"}
{"chunk_id": "fertility_evaluation_of_infertile_women_a_committee_opinion__0000", "doc_id": "fertility_evaluation_of_infertile_women_a_committee_opinion", "title": "Fertility evaluation of infertile women: a committee opinion", "url_or_doi": "https://doi.org/10.1016/J.FERTNSTERT.2021.08.038", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "status:paywalled_or_unresolved"], "text_path": "corpus/text/fertility_evaluation_of_infertile_women_a_committee_opinion.txt", "n_tokens_est": 2, "preview": "Redirecting"}
{"chunk_id": "clinical_practice_guideline_for_the_management_of_asymptomatic_bacteriuria_2019___0000", "doc_id": "clinical_practice_guideline_for_the_management_of_asymptomatic_bacteriuria_2019_", "title": "Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America", "url_or_doi": "https://pure.amc.nl/en/publications/clinical-practice-guideline-for-the-management-of-asymptomatic-bacteriuria-2019-update-by-the-infectious-diseases-society-of-america(b4c677e7-1bd4-4936-b574-f4a9bc507ada).html", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/clinical_practice_guideline_for_the_management_of_asymptomatic_bacteriuria_2019_.txt", "n_tokens_est": 49, "preview": "Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America › Research Explorer\nPortal disabled\nThe portal is not activated."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0000", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 61, "preview": "Morbidity and Mortality Weekly Report\nRecommendations and Reports / Vol. 70 / No. 4 July 23, 2021 \nSexually Transmitted Infections Treatment \nGuidelines, 2021\nU.S. Department of Health and Human Services\nCenters for Disease Control and Prevention"}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0001", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1041, "preview": "Morbidity and Mortality Weekly Report\nRecommendations and Reports / Vol. 70 / No. 4 July 23, 2021 \nSexually Transmitted Infections Treatment \nGuidelines, 2021\nU.S. Department of Health and Human Services\nCenters for Disease Control and Prevention\nThe MMWR series of publications is published by the Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Preve..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0002", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 288, "preview": "m .................................................................................... 80\nDiseases Characterized by Vulvovaginal Itching, Burning, Irritation, \nOdor, or Discharge ........................................................................................... 82\nPelvic Inflammatory Disease .......................................................................... 94\nEpididymitis .........."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0003", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1125, "preview": "Viral Hepatitis .....................................................................................................113\nProctitis, Proctocolitis, and Enteritis ..........................................................124\nEctoparasitic Infections ..................................................................................126\nSexual Assault and Abuse and STIs ..................................."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0004", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 449, "preview": "lescent care, and other primary care facilities. These \nguidelines are focused on treatment and counseling and do \nnot address other community services and interventions that \nare essential to STI and HIV prevention efforts.\nThese STI treatment guidelines complement Recommendations \nfor Providing Quality Sexually Transmitted Diseases Clinical \nServices, 2020 (2) regarding quality clinical services..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0005", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "d the subject \nmatter experts that they were being consulted to exchange \ninformation and observations and to obtain their individual \ninput. All subject matter experts disclosed potential conflicts \nof interest. STI T reatment Guidelines, 2021, Work Group \nmembers are listed at the end of this report.\nIn 2018, CDC staff identified key questions about treatment \nand clinical management to guide an..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0006", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 557, "preview": "ions. The peer review comments, webinar, \nquestions, and responses were considered by CDC staff in \ndeveloping the final recommendations for the updated STI \ntreatment guidelines. Recommendations for HIV , hepatitis C, \ncervical cancer screening, STI screening in pregnancy, human \npapillomavirus (HPV) testing, and hepatitis A virus (HAV) and \nhepatitis B virus (HBV) vaccination were developed afte..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0007", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1140, "preview": "on the following \nfive major strategies (3):\n1. Accurate risk assessment and education and counseling \nof persons at risk regarding ways to avoid STIs through \nchanges in sexual behaviors and use of recommended \nprevention services\n2. Pre-exposure vaccination for vaccine-preventable STIs\n3. Identification of persons with an asymptomatic \ninfection and persons with symptoms associated with \nan STI\n..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0008", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 360, "preview": "of any kind?”\n• “What is the gender(s) of your partner(s)?”\n2. Practices\n• “T o understand any risks for sexually transmitted \ninfections (STIs), I need to ask more specific questions \nabout the kind of sex you have had recently.”\n• “What kind of sexual contact do you have or have you had?”\n ű “Do you have vaginal sex, meaning ‘penis in vagina’ sex?”\n ű “Do you have anal sex, meaning ‘penis in rec..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0009", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "en diagnosed with an STI in the past?”\n• “Have any of your partners had an STI?”\nAdditional questions for identifying HIV and viral \nhepatitis risk:\n• “Have you or any of your partner(s) ever injected drugs?”\n• “Is there anything about your sexual health that you \nhave questions about?”\n5. Pregnancy intention\n• “Do you think you would like to have (more) children \nin the future?”\n• “How important ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0010", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 580, "preview": "es have been effective in reducing the occurrence \nof STIs among persons at risk, including those attending STD \nclinics (9). Brief, online, electronic-learning modules for young \nMSM have been reported to be effective in reducing incident \nSTIs and offer a convenient client platform for effective \ninterventions ( 10). Because the incidence of certain STIs, \nmost notably syphilis, is higher among ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0011", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "ost effective methods \nfor preventing transmission of HPV , HAV , and HBV , all \nof which can be sexually transmitted. HPV vaccination is \nrecommended routinely for males and females aged 11 or \n12 years and can be administered beginning at age 9 years. \nHPV vaccination is recommended through age 26 years for \nthose not previously vaccinated (11). Sharing clinical decision-\nmaking about HPV vaccin..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0012", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 593, "preview": "V and pregnancy comparable to that of latex \ncondoms (20,31). These can be substituted for latex condoms \nby persons with latex sensitivity, are typically more resistant to \ndeterioration, and are compatible with use of both oil-based \nand water-based lubricants. The effectiveness of other synthetic \nexternal condoms to prevent STIs has not been extensively \nstudied, and FDA labeling restricts the..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0013", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "elly, Astroglide, AquaLube, or glycerin) with latex \ncondoms. Oil-based lubricants (e.g., petroleum jelly, \nshortening, mineral oil, massage oils, body lotions, or \ncooking oil) can weaken latex and should not be used; \nhowever, oil-based lubricants typically can be used with \npolyurethane or other synthetic condoms.\n• Ensure adequate lubrication during vaginal and anal sex, \nwhich might require u..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0014", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 493, "preview": "ontaining nonoxynol-9 (N-9) might \ndisrupt genital or rectal epithelium and have been associated \nwith an increased risk for HIV infection. Condoms with N-9 \nare no more effective than condoms without N-9; therefore, \nN-9 alone or in a condom is not recommended for STI and \nHIV prevention (40). N-9 use also has been associated with \nan increased risk for bacterial urinary tract infections among \nw..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0015", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "traception\nUnprotected intercourse exposes women to risks for STIs \nand unplanned pregnancy. Providers should offer counseling \nabout the option of emergency contraception if pregnancy \nis not desired. Options for emergency contraception in the \nUnited States include copper-containing IUDs and emergency \ncontraceptive pills (ECPs) (58,59). More information is available \nat https://www.acog.org/cli..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0016", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 607, "preview": "policy statement. In light \nof these benefits, the American Urological Association states \nthat male circumcision should be considered an option for risk \nreduction, among other strategies (72). Additional information \nfor providers counseling male patients and parents regarding \nmale circumcision for preventing HIV , STIs, and other adverse \nhealth outcomes is available at https://www.cdc.gov/hiv..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0017", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1144, "preview": "V; however, less experience exits with this regimen, it is \nnot FDA cleared, and it has not been studied among other \npopulations (79).\nComprehensive clinical practice guidelines are available \nfor providers in prescribing PrEP to reduce the risk for HIV \ninfection ( 80). Among HIV-negative sexually active men \nand women, bacterial STIs are key indicators of risk for \nHIV acquisition. Studies have..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0018", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 577, "preview": "Antiretroviral \nTreatment of Persons with HIV to Prevent HIV \nAmong Partners\nIn 2011, the randomized controlled trial HPTN 052 \ndemonstrated that, among HIV mixed-status heterosexual \ncouples, HIV antiretroviral therapy (ART) for the infected \npartner decreased the risk for transmission to the uninfected \npartner by 96% (94). Therefore, ART not only is beneficial to \nthe health of persons with HIV..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0019", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "istent condom use but has lower risk compared with anal \nintercourse without a condom and without serosorting ( 99–\n101). Serosorting practices have been associated with increased \nrisk for STIs, including chlamydia and gonorrhea (102,103\n).\nSerosorting is not recommended for the following reasons: \nmany MSM who have HIV infection do not know they \nhave HIV because they have not been tested recent..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0020", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 639, "preview": "should familiarize themselves with public health \npractices in their area; however, in most instances, providers \nshould understand that responsibility for discussing the \ntreatment of partners of persons with STIs rests with the \ndiagnosing provider and the patient. State laws require a good \nfaith effort by the provider to inform partners, and providers \nshould familiarize themselves with public..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0021", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "oach \nfor additional sex partners. Evidence indicates that providing \npatients with written information to share with sex partners \ncan increase rates of partner treatment (110).\nCertain health departments now use technology (e.g., \nemail, texting, mobile applications, and social media outlets) \nto facilitate partner services for locating and notifying the \nsex partners of persons with STIs, inclu..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0022", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 629, "preview": "and the sex of the index patient \n(110,125–127). However, across trials, reductions in chlamydia \nprevalence at follow-up were approximately 20%, and \nreductions in gonorrhea were approximately 50% at follow-up.\nExisting data indicate that EPT also might have a role in \npartner management for trichomoniasis; however, no partner \nmanagement intervention has been reported to be more \neffective than ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0023", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "irements. Syphilis (including congenital syphilis), \ngonorrhea, chlamydia, chancroid, and HIV are reportable \ndiseases in every state. Because the requirements for reporting \nother STIs differ by state, clinicians should be familiar with the \nreporting requirements applicable within their jurisdictions.\nReporting can be provider based, laboratory based, or \nboth. Clinicians who are unsure of state..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0024", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 481, "preview": "infection (e.g., fever, lymphadenopathy, skin \nrash, myalgia, arthralgia, headache, oral ulcers, leukopenia, \nthrombocytopenia, or transaminase elevation) (140).\nRapid HIV testing should be performed for any woman in labor \nwho has not been tested for HIV during pregnancy or whose HIV \nstatus is unknown, unless she declines. If a rapid HIV test result \nis positive, ART should be administered witho..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0025", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1140, "preview": "card test and treatment, if that test is \nreactive, should be administered at the time that a pregnancy \nis confirmed or when the pregnancy test is performed, if \nfollow-up is uncertain. Pregnant women should be retested \nfor syphilis at 28 weeks’ gestation and at delivery if the mother \nlives in a community with high syphilis rates or is at risk for \nsyphilis acquisition during pregnancy (e.g., m..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0026", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 558, "preview": "xchanging sex for money \nor drugs) should be screened for Neisseria gonorrhoeae at the \nfirst prenatal visit (149). Pregnant women who remain at high \nrisk for gonococcal infection also should be retested during the \nthird trimester to prevent maternal postnatal complications and \ngonococcal infection in the neonate. Clinicians should consider \nthe communities they serve and might choose to consul..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0027", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1137, "preview": "ld receive counseling, supportive care, and \nlinkage to care (https://www.hcvguidelines.org). No vaccine \nis available for preventing HCV transmission.\nCervical Cancer\nPregnant women should undergo cervical cancer screening \nand at the same frequency as nonpregnant women; however, \nmanagement differs slightly during pregnancy ( 158 ). \nColposcopy is recommended for the same indications during \npre..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0028", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 641, "preview": "ntributing to increased vulnerability to STIs during \nadolescence include having multiple sex partners, having \nsequential sex partnerships of limited duration or concurrent \npartnerships, failing to use barrier protection consistently \nand correctly, having lower socioeconomic status, and facing \nmultiple obstacles to accessing health care (141,165).\nAll 50 states and the District of Columbia exp..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0029", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1135, "preview": "electronic health records, although technology \ncontinues to evolve to assist with ensuring confidential care. \nAAP and the Society for Adolescent Health and Medicine \n(SAHM) have published guidance on strategies to address \nemerging risks for confidentiality breaches associated with \nhealth information technology (169).\nAAP and the SAHM recommend that providers have \ntime alone with their adolesc..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0030", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 542, "preview": "Men).\nProviders might consider opt-out chlamydia and gonorrhea \nscreening (i.e., the patient is notified that testing will be \nperformed unless the patient declines, regardless of reported \nsexual activity) for adolescent and young adult females during \nclinical encounters. Cost-effectiveness analyses indicate that \nopt-out chlamydia screening among adolescent and young \nadult females might substa..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0031", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "fo.hiv.gov/en/\nguidelines/adult-and-adolescent-opportunistic-infection/\nhuman-papillomavirus-disease?view=full).\nOther Sexually Transmitted Infections\nYMSM and pregnant females should be routinely screened \nfor syphilis (see Pregnant Women; Men Who Have Sex with \nMen). Local disease prevalence can help guide decision-\nmaking regarding screening for T . vaginalis, especially among \nadolescent femal..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0032", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 525, "preview": "Abuse and STIs).\nMen Who Have Sex with Men\nMSM comprise a diverse group in terms of behaviors, \nidentities, and health care needs (179). The term “MSM” often \nis used clinically to refer to sexual behavior alone, regardless of \nsexual orientation (e.g., a person might identify as heterosexual \nbut still be classified as MSM). Sexual orientation is \nindependent of gender identity. Classification of..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0033", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1137, "preview": "mmon and \nmight be associated with HIV infection, substance use (e.g., \nmethamphetamines), Black race, and multiple sex partners \n(187). Similarly, gonorrhea incidence has increased among MSM \nand might be more likely to display antimicrobial resistance \ncompared with other groups (188,189). Gonococcal infection \namong MSM has been associated with similar risk factors to \nsyphilis, including havin..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0034", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 606, "preview": "ing is warranted (204–206).\nImportance of Rectal and Pharyngeal Testing\nRectal and pharyngeal testing by NAAT for gonorrhea \nand chlamydia is recognized as an important sexual health \nconsideration for MSM. Rectal gonorrhea and chlamydia are \nassociated with HIV infection (82,207), and men with repeat \nrectal infections can be at substantially higher risk for HIV \nacquisition ( 208). Pharyngeal in..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0035", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "h HIV infection and engaged in care also experience \nsuboptimal rates of STI testing (222,223). Limited data exist \nregarding the optimal frequency of screening for gonorrhea, \nchlamydia, and syphilis among MSM, with the majority of \nevidence derived from mathematical modeling. Models from \nAustralia have demonstrated that increasing syphilis screening \nfrequency from two times a year to four time..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0036", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 440, "preview": "r all MSM who \nreport exposure at these sites. T esting can be offered to MSM \nwho do not report exposure at these sites after a detailed \nexplanation, due to known underreporting of risk behaviors. \nAll MSM with HIV infection entering care should be screened \nfor gonorrhea and chlamydia at appropriate anatomic sites of \nexposure as well as for syphilis.\nMore frequent STI screening (i.e., for syph..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0037", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "y is unknown; however, vaccination should not be \ndelayed. Vaccinating persons who have had previous infection \nor vaccination does not increase the risk for vaccine-related \nadverse events (see Hepatitis A Virus; Hepatitis B Virus).\nHepatitis C Virus\nCDC recommends HCV screening at least once for all \nadults aged ≥18 years, except in settings where the prevalence \nof HCV infection (HCV RNA positi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0038", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 501, "preview": "outreach effort to consider. Hookup sites are Internet sites \nand mobile telephone applications that men might use for \nmeeting other men for sex. Internet use might facilitate sexual \nencounters and STI transmission among MSM, and many \nmen report using hookup sites to meet partners ( 242–245). \nThe ease and accessibility of meeting partners online might \nreduce stigma and barriers of meeting par..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0039", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "y \nboth biologic or host and behavioral factors. HIV without \nviral suppression can be an independent risk factor that \ncan contribute to transmission by increasing shedding of \nthe enteric pathogen, increasing susceptibility of the host, \nor both ( 255,263). Surveillance data in England during \n2004–2015 demonstrated that 21% of nontravel-associated \nShigella diagnoses among MSM were among person..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0040", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 609, "preview": "dolescent WSWM and WSW than among adolescent \nWSM (280). WSW report reduced knowledge of STI risks \n(288), and both WSW and WSWM experience barriers to care, \nespecially Black WSW and WSWM (289,290). In addition, a \ncontinuum of sexual behaviors reported by WSW and WSWM \nindicates the need for providers to not assume lower risk for \nWSW , highlighting the importance of an open discussion \nabout se..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0041", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1141, "preview": "and \nlow-grade squamous intraepithelial lesions (LSIL) have been \ndetected on Papanicolaou smears (Pap tests) among WSW \nwho reported no previous sex with men ( 301,302). WSWM \nare at risk for acquiring HPV from both their female partners \nand male partners and thus are at risk for cervical cancer. \nTherefore, routine cervical cancer screening should be offered \nto all women, regardless of sexual ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0042", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 649, "preview": "nal \nmicrobiota (e.g., oral bacterial communities) between partners \nmight be involved in the pathogenesis of BV among WSW .\nAlthough BV is common among WSW , routine screening \nfor asymptomatic BV is not recommended. Results of one \nrandomized trial used a behavioral intervention to reduce \npersistent BV among WSW through reduced sharing of vaginal \nfluid on hands or sex toys. Women randomly assi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0043", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "–332). Persons who are transgender have a gender \nidentity that differs from the sex that they were assigned at birth \n(333,334). T ransgender women (also known as trans women, \ntransfeminine persons, or women of transgender experience) \nare women who were assigned male sex at birth (born with \nmale anatomy). T ransgender men (also known as trans men, \ntransmasculine persons, or men of transgender..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0044", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 593, "preview": "lence of gonorrhea and chlamydia among transgender \nwomen similar to rates among cisgender MSM (346–348). A \nrecent study using data from the STD Surveillance Network \nrevealed that the proportions of transgender women with \nextragenital chlamydial or gonococcal infections were similar \nto those of cisgender MSM (349).\nProviders caring for transgender women should have \nknowledge of their patients..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0045", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "eritoneal lining ( 353), and N. gonorrhoeae in \nboth penile-inversion and colovaginoplasty ( 354–359). If \nthe vaginoplasty used an intestinal graft, a risk also exists for \nbowel-related disease (e.g., adenocarcinoma, inflammatory \nbowel disease, diversion colitis, and polyps) (360–362).\nTransgender Men\nThe few studies of HIV prevalence among transgender men \nindicated that they have a lower prev..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0046", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 535, "preview": "or vaginal). No data are available regarding \nthe optimal screening method (urine or vaginal swab) for \nbacterial STIs of the neovagina. The usual techniques for \ncreating a neovagina do not result in a cervix; therefore, \nno rationale exists for cervical cancer screening (368).\n• If transgender men have undergone metoidioplasty surgery \nwith urethral lengthening and have not had a vaginectomy, \na..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0047", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "usefulness of expanded \nSTI screening and treatment services in correctional settings, \nincluding short-term facilities (jails), long-term institutions \n(prisons), and juvenile detention centers. For example, in \njurisdictions with comprehensive, targeted jail screening, more \nchlamydial infections among females (and males if screened) \nare detected and subsequently treated in the correctional set..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0048", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 355, "preview": "tion status. Vaccination for HAV and HBV \nshould be offered if the person is susceptible.\nCervical Cancer\nWomen and transgender men who are housed in correctional \nfacilities should be screened for cervical cancer as for women \nwho are not incarcerated (393,394) (see Cervical Cancer).\nHIV Infection\nAll persons being housed in juvenile and adult correctional \nfacilities should be screened at entry ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0049", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1141, "preview": "immediately after \nrelease from incarceration ( 397). For those identified with \nHIV infection, treatment should be initiated. Those persons \nreceiving PrEP or HIV treatment should have linkage to \ncare established before release. Correctional settings should \nconsider implementing other STI prevention approaches, \nboth during incarceration and upon release, which might \ninclude educational and be..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0050", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 516, "preview": "and is recommended for women who are at high risk for \nacquiring HIV infection, women who receive health care \nin jurisdictions with high rates of HIV , and women \nexamined in clinical settings in which HIV incidence is \n≥1 per 1,000 women screened per year (138,140). \n• HIV screening should be voluntary and free from coercion. \nPatients should not be tested without their knowledge.\n• Opt-out HIV ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0051", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "ht be more likely to \nthink about HIV and consider their risk-related behavior \nwhen undergoing an HIV test. HIV testing gives providers \nan opportunity to conduct STI and HIV prevention \ncounseling and communicate risk-reduction messages.\n• Acute HIV infection can occur among persons who report \nrecent sexual or needle-sharing behavior or who have had \nan STI diagnosis.\n• Providers should test fo..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0052", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 566, "preview": "mmended because it substantially reduces infection \ntransmission to others, improves laboratory markers of \ndisease, might decrease severity of acute disease, lowers viral \nsetpoint, reduces the size of the viral reservoir, decreases \nthe rate of viral mutation by suppressing replication, and \npreserves immune function ( https://clinicalinfo.hiv.gov/en/\nguidelines/adult-and-adolescent-arv/acute-an..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0053", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "t testing in a few weeks is recommended \nto rule out very early acute infection when HIV RNA might \nnot be detectable. A more detailed discussion of testing in \nthe context of acute HIV infection is available at https://\nclinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv/\ninitiation-antiretroviral-therapy?view=full.\nTreatment\nART should be initiated as soon as possible for all persons wit..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0054", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 514, "preview": "ect \npersons with HIV against other STIs.\n• Provide additional counseling, either on-site or through \nreferral, about the psychosocial and medical implications \nof having HIV infection.\n• Assess the need for immediate medical care and \npsychosocial support.\n• Link persons with diagnosed HIV infection to services \nprovided by health care personnel experienced in managing \nHIV infection. Additional ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0055", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1136, "preview": "98).\nMore frequent screening for syphilis, gonorrhea, and \nchlamydia (e.g., every 3 or 6 months) should be tailored \nto individual risk and the local prevalence of specific STIs. \nCertain STIs can be asymptomatic; their diagnosis might \nprompt referral for partner services, might identify sexual and \nneedle-sharing partners who can benefit from early diagnosis \nand treatment of HIV , and might pro..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0056", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 558, "preview": "on status can help maintain the woman’s health, and \nit enables receipt of interventions (i.e., ART or specialized \nobstetrical care) that can substantially reduce the risk for \nperinatal transmission of HIV . Pregnant women with \ndiagnosed HIV infection should be educated about the benefits \nof ART for their own health and for reducing the risk for HIV \ntransmission to their infant. In the absenc..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0057", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1141, "preview": "V \ninfection should be referred to physicians with expertise in \nneonatal and pediatric HIV management.\nDiseases Characterized by Genital, \nAnal, or Perianal Ulcers\nIn the United States, the majority of young, sexually active \npatients who have genital, anal, or perianal ulcers have either \ngenital herpes or syphilis. The frequency of each condition \ndiffers by geographic area and population; howe..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0058", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 546, "preview": "syphilis at the initial visit after syphilis \nand HSV tests are performed. After a complete diagnostic \nevaluation, >25% of patients who have genital ulcers might \nnot have a laboratory-confirmed diagnosis (426).\nChancroid\nChancroid prevalence has declined in the United States \n(141). When infection does occur, it is usually associated \nwith sporadic outbreaks. Worldwide, chancroid appears to \nhav..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0059", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1144, "preview": ") the \npatient has no evidence of T . pallidum infection by darkfield \nexamination or NAAT (i.e., ulcer exudate or serous fluid) or \nby serologic tests for syphilis performed at least 7–14 days \nafter onset of ulcers; and 4) HSV-1 or HSV-2 NAAT or HSV \nculture performed on the ulcer exudate or fluid are negative.\nTreatment\nSuccessful antimicrobial treatment for chancroid cures \nthe infection, reso..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0060", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 388, "preview": "ansmission route \namong U.S. patients, diagnosis of chancroid ulcers among infants \nand children, especially in the genital or perineal region, is highly \nsuspicious of sexual abuse. However, H. ducreyi is recognized as a \nmajor cause of nonsexually transmitted cutaneous ulcers among \nchildren in tropical regions and, specifically, countries where \nyaws is endemic (433–435). Acquisition of a lower..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0061", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "n attributed to \nHSV-1, which is especially prominent among young women \nand MSM (186,437,438).\nThe majority of persons infected with HSV-2 have not \nhad the condition diagnosed, many of whom have mild or \nunrecognized infections but shed virus intermittently in the \nanogenital area. Consequently, most genital herpes infections \nare transmitted by persons unaware that they have the \ninfection or w..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0062", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 673, "preview": "te type-\nspecific HSV serologic assays are based on the HSV-specific \nglycoprotein G2 (gG2) (HSV-2) and glycoprotein G1 (gG1) \n(HSV-1). Type-common antibody tests do not distinguish \nbetween HSV-1 and HSV-2 infection; therefore, type-specific \nserologic assays should be requested (450–452).\nBoth laboratory-based assays and POC tests that provide \nresults for HSV-2 antibodies from capillary blood o..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0063", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "acquired, presence of type-specific HSV-2 antibody implies \nanogenital infection. In this instance, education and counseling \nfor persons with genital HSV infections should be provided. \nThe presence of HSV-1 antibody alone is more difficult \nto interpret. HSV-1 serologic testing does not distinguish \nbetween oral and genital infection and typically should not \nbe performed for diagnosing genital ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0064", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 528, "preview": "7–10 days\n* Treatment can be extended if healing is incomplete after 10 days of therapy.\n† Acyclovir 200 mg orally 5 times/day is also effective but is not \nrecommended because of the frequency of dosing.\nRecurrent HSV-2 Genital Herpes\nAlmost all persons with symptomatic first-episode HSV-2 \ngenital herpes subsequently experience recurrent episodes of \ngenital lesions. Intermittent asymptomatic sh..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0065", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1140, "preview": "ng daily acyclovir, \nvalacyclovir, and famciclovir (474). Quality of life is improved \nfor many patients with frequent recurrences who receive \nsuppressive therapy rather than episodic treatment ( 475). \nProviders should discuss with patients on an annual basis \nwhether they want to continue suppressive therapy because \nfrequency of genital HSV-2 recurrence diminishes over time \nfor many persons. ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0066", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 464, "preview": "Famciclovir 125 mg orally 2 times/day for 5 days\nor\nValacyclovir 500 mg orally 2 times/day for 3 days\nor\nValacyclovir 1 g orally once daily for 5 days\n* Acyclovir 400 mg orally 3 times/day for 5 days is also effective but is not \nrecommended because of frequency of dosing.\nSevere Disease\nIntravenous (IV) acyclovir therapy (5–10 mg/kg body weight \nIV every 8 hours) should be provided for patients w..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0067", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "until clinical improvement is observed, followed by high-dose \noral antiviral therapy (valacyclovir 1 g 3 times/day) to complete \na 10- to 14-day course of total therapy, is recommended. \nFor patients with previous episodes of documented HSV-2 \nmeningitis, oral valacyclovir may be used for the entire \ncourse during episodes of recurrent HSV-2 meningitis. A \nrandomized clinical trial indicated that..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0068", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 506, "preview": "disease after the acute \nillness subsides. Multiple resources, including Internet sites and \nprinted materials, are available to assist patients, their partners, \nand clinicians who provide counseling (496,497) (https://www.\nashasexualhealth.org and https://www.cdc.gov/std/herpes).\nAlthough the psychological effect of a serologic diagnosis of \nHSV-2 infection in a person with asymptomatic or unrec..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0069", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "nting symptomatic recurrent episodes of genital \nherpes for persons experiencing a first episode or recurrent \ngenital herpes.\n• The effectiveness of daily use of valacyclovir in reducing \nrisk for transmission of HSV-2 among persons without \nHIV (473) and use of episodic therapy to shorten the \nduration of recurrent episodes.\n• The importance of informing current sex partners about \ngenital herpe..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0070", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 403, "preview": "c \ngenital herpes can benefit from evaluation and counseling. \nSymptomatic sex partners should be evaluated and treated in \nthe same manner as patients who have symptomatic genital \nherpes. Asymptomatic sex partners of patients who have \nsymptomatic genital herpes should be asked about a history \nof genital symptoms and offered type-specific serologic testing \nfor HSV-2. For partners without genit..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0071", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "th HIV infection and \nmight be severe, painful, and atypical (501). HSV shedding is \nincreased among persons with HIV infection (502). Whereas \nART reduces the severity and frequency of symptomatic genital \nherpes, frequent subclinical shedding still occurs ( 503,504). \nClinical manifestations of genital herpes might worsen during \nimmune reconstitution early after initiation of ART . HSV-2 \ntype-..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0072", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 558, "preview": "for outbreaks (513).\nGenital Herpes During Pregnancy\nPrevention of neonatal herpes depends both on preventing \nacquisition of genital herpes during late pregnancy and \navoiding exposure of the neonate to herpetic lesions and viral \nshedding during delivery. Mothers of newborns who acquire \nneonatal herpes often lack histories of clinically evident genital \nherpes (514,515). The risk for transmissi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0073", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "omen without known genital herpes should \nbe counseled to abstain from vaginal intercourse during the \nthird trimester with partners known to have or suspected of \nhaving genital herpes. In addition, to prevent HSV-1 genital \nherpes, pregnant women without known orolabial herpes \nshould be advised to abstain from receptive oral sex during the \nthird trimester with partners known to have or suspect..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0074", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 480, "preview": "es, or for 21 days for disseminated disease \nand disease involving the CNS.\nGranuloma Inguinale (Donovanosis)\nGranuloma inguinale (donovanosis) is a genital ulcerative \ndisease caused by the intracellular gram-negative bacterium \nKlebsiella granulomatis (formerly known as Calymmatobacterium \ngranulomatis). The disease occurs rarely in the United States; \nhowever, sporadic cases have been described..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0075", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "y. \nAlthough no FDA-cleared molecular tests for the detection of \nK. granulomatis DNA exist, molecular assays might be useful \nfor identifying the causative agent.\nTreatment\nMultiple antimicrobial regimens have been effective; \nhowever, only a limited number of controlled trials have \nbeen published ( 538). T reatment has been reported to halt \nprogression of lesions, and healing typically proceed..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0076", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 399, "preview": "e persons seek care, the lesions have often \ndisappeared. LGV-associated lymphadenopathy can be severe, \nwith bubo formation from fluctuant or suppurative inguinal or \nfemoral lymphadenopathy. Oral ulceration can occur and might \nbe associated with cervical adenopathy (549–551). Persons with \ngenital or colorectal LGV lesions can also experience secondary \nbacterial infection or can be infected wi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0077", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1140, "preview": "r etiologies for proctocolitis, inguinal \nlymphadenopathy, or genital, oral, or rectal ulcers (551,552). \nGenital or oral lesions, rectal specimens, and lymph node \nspecimens (i.e., lesion swab or bubo aspirate) can be tested \nfor C. trachomatis by NAAT or culture. NAAT is the preferred \napproach for testing because it can detect both LGV strains and \nnon–LGV C. trachomatis strains (553). Therefor..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0078", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 390, "preview": "ve an LGV diagnosis \nshould be tested for other STIs, especially HIV , gonorrhea, and \nsyphilis. Those whose HIV test results are negative should be \noffered HIV PrEP .\nFollow-Up\nAll persons who have been treated for LGV should be retested \nfor chlamydia approximately 3 months after treatment. If \nretesting at 3 months is not possible, providers should retest \nat the patient’s next visit for medic..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0079", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "teeth; however, the risk is not well defined \n(563). Doxycycline is compatible with breastfeeding ( 431). \nAzithromycin might prove useful for LGV treatment during \npregnancy, at a presumptive dose of 1 g weekly for 3 weeks; \nno published data are available regarding an effective dose and \nduration of treatment. Pregnant and lactating women with \nLGV can be treated with erythromycin, although this..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0080", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 525, "preview": "s) (566–568). At least 18 treponemal-specific tests are \ncleared for use in the United States. Use of only one type of \nserologic test (nontreponemal or treponemal) is insufficient \nfor diagnosis and can result in false-negative results among \npersons tested during primary syphilis and false-positive results \namong persons without syphilis or previously treated syphilis.\nNontreponemal Tests and Tr..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0081", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1141, "preview": "ting method (VDRL or RPR), preferably by the same \nlaboratory. VDRL and RPR are equally valid assays; however, \nquantitative results from the two tests cannot be compared \ndirectly with each other because the methods are different, \nand RPR titers frequently are slightly higher than VDRL titers.\nNontreponemal test titers usually decrease after treatment \nand might become nonreactive with time. How..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0082", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 608, "preview": "ys, and the values that correspond to \nhigh levels of reactivity with confirmatory testing might differ \nby immunoassay (567,575–582).\nCerebrospinal Fluid Evaluation\nFurther testing with CSF evaluation is warranted for \npersons with clinical signs of neurosyphilis (e.g., cranial nerve \ndysfunction, meningitis, stroke, acute or chronic altered mental \nstatus, or loss of vibration sense). All patien..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0083", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "ogic signs or symptoms, a \nreactive CSF-VDRL (in the absence of blood contamination) \nis considered diagnostic of neurosyphilis.\nWhen CSF-VDRL is negative despite clinical signs of \nneurosyphilis, reactive serologic tests results, lymphocytic \npleocytosis, or protein, neurosyphilis should be considered. \nIn that instance, additional evaluation by using fluorescent \ntreponemal-antibody absorption (..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0084", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 465, "preview": "rse reaction and how to manage it if it occurs. The \nJarisch-Herxheimer reaction occurs most frequently among \npersons who have early syphilis, presumably because bacterial \nloads are higher during these stages. Antipyretics can be used \nto manage symptoms; however, they have not been proven to \nprevent this reaction. The Jarisch-Herxheimer reaction might \ninduce early labor or cause fetal distres..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0085", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "diagnosis of primary, secondary, or early latent \nsyphilis >90 days before the diagnosis should be treated \npresumptively for early syphilis if serologic test results are \nnot immediately available and the opportunity for \nfollow-up is uncertain. If serologic tests are negative, no \ntreatment is needed. If serologic tests are positive, \ntreatment should be based on clinical and serologic \nevaluati..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0086", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 520, "preview": "ocular syphilis (e.g., uveitis, iritis, \nneuroretinitis, or optic neuritis) should have a thorough cranial \nnerve examination and ocular slit-lamp and ophthalmologic \nexaminations. CSF evaluation is not always needed for persons \nwith ocular syphilis if no evidence of cranial nerves 2, 3, 4, \n5, and 6 dysfunction or other evidence of neurologic disease \nexists. If symptoms and signs of otic syphil..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0087", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "udent if opportunity for follow-up is uncertain \nor if repeat infection is a clinical concern. Serologic response \n(i.e., titer) should be compared with the titer at the time of \ntreatment. However, assessing serologic response to treatment \ncan be difficult, and definitive criteria for cure or failure by \nserologic criteria have not been well established. In addition, \nnontreponemal test titers m..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0088", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 512, "preview": "for 14 days) (600,601) \nand tetracycline (500 mg orally 4 times/day for 14 days) have \nbeen used for years and can be effective. Compliance is likely to \nbe better with doxycycline than tetracycline because tetracycline \ncan cause more gastrointestinal side effects and requires more \nfrequent dosing. Limited clinical studies, along with biologic \nand pharmacologic evidence, indicate that ceftriaxo..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0089", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1136, "preview": "Who Have a History \nof Penicillin Allergy).\nPregnancy\nPregnant women with primary or secondary syphilis who \nare allergic to penicillin should be desensitized and treated \nwith penicillin G. Skin testing or oral graded penicillin dose \nchallenge might be helpful in identifying women at risk for \nacute allergic reactions (see Management of Persons Who Have \na History of Penicillin Allergy; Syphilis..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0090", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 638, "preview": "ongenital or acquired \nsyphilis. For those with congenital syphilis, treatment should \nbe undertaken as described (see Congenital Syphilis). Those \nwith acquired syphilis should be evaluated for sexual abuse \n(e.g., through consultation with child protection services) (see \nSexual Assault or Abuse of Children). These regimens are for \nchildren who are not allergic to penicillin who have acquired \n..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0091", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1135, "preview": "erred (610–612). Delayed doses are not optimal \nfor pregnant women receiving therapy for latent syphilis (613). \nPregnant women who have delays in any therapy dose >9 days \nbetween doses should repeat the full course of therapy.\nFollow-Up\nQuantitative nontreponemal serologic tests should be \nrepeated at 6, 12, and 24 months. These serologic titers should \nbe compared with the titer at the time of ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0092", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 489, "preview": "ined; treatment \ndecisions should be discussed in consultation with a specialist. \nPersons with a penicillin allergy whose compliance with \ntherapy or follow-up cannot be ensured should be desensitized \nand treated with benzathine penicillin G. Skin testing for \npenicillin allergy might be useful in circumstances in which \nthe reagents and expertise are available for performing the test \nadequatel..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0093", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1150, "preview": "nd Otosyphilis). Persons with gummas \nand cardiovascular syphilis who are not allergic to penicillin \nand have no evidence of neurosyphilis by clinical and CSF \nexamination should be treated with the following regimen.\nRecommended Regimen for Tertiary Syphilis Among Adults \nTertiary syphilis with normal CSF examination: Benzathine \npenicillin G 7.2 million units total, administered as 3 doses of 2..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0094", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 335, "preview": "normal and is not recommended \nbefore treatment. Otosyphilis should be managed in \ncollaboration with an otolaryngologist and treated by using \nthe same regimen as for neurosyphilis.\nRecommended Regimen for Neurosyphilis, Ocular Syphilis, or \nOtosyphilis Among Adults \nAqueous crystalline penicillin G 18–24 million units per day, \nadministered as 3–4 million units IV every 4 hours or continuous \nin..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0095", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "orter than the duration of the regimen \nused for latent syphilis. Therefore, benzathine penicillin, \n2.4 million units IM once per week for 1–3 weeks, can be \nconsidered after completion of these neurosyphilis treatment \nregimens to provide a comparable total duration of therapy.\nOther Management Considerations\nThe following are other considerations in the management \nof persons who have neurosyph..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0096", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 398, "preview": "is \nnot defined precisely but is likely small. Although long-term \n(>1 year) comparative data are lacking, no treatment regimens \nfor syphilis have been demonstrated to be more effective in \npreventing neurosyphilis among persons with HIV infection \nthan the syphilis regimens recommended for persons without \nHIV (609). Careful follow-up after therapy is essential. Using \nART per current HIV guidel..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0097", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1140, "preview": "philis among persons with HIV \ninfection do not result in enhanced efficacy (592,593,609).\nOther Management Considerations\nThe majority of persons with HIV infection respond \nappropriately to the recommended benzathine penicillin G \ntreatment regimen for primary and secondary syphilis (626). \nCSF abnormalities (e.g., mononuclear pleocytosis and elevated \nprotein levels) can be common among persons..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0098", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 488, "preview": "HIV Infection\nRecommended Regimen for Early Latent Syphilis Among \nPersons with HIV Infection\nBenzathine penicillin G 2.4 million units IM in a single dose\nRecommended Regimen for Late Latent Syphilis or Latent \nSyphilis of Unknown Duration Among Persons with HIV \nInfection\nBenzathine penicillin G 7.2 million units total, administered as 3 doses \nof 2.4 million units IM at 1-week intervals\nOther M..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0099", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "sons \nwithout HIV (i.e., depending on history of sexual activity and \non findings of neurologic examination, either repeat treatment \nwith weekly injections of benzathine penicillin G 2.4 million \nunits IM for 3 weeks or CSF examination and repeat treatment \nguided by CSF findings) (see Latent Syphilis).\nIn addition, CSF examination and retreatment can be \nconsidered for persons whose nontreponema..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0100", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 450, "preview": "or syphilis \nat the first prenatal care visit ( 174), which is mandated by \nthe majority of states (142). Among populations for whom \nreceipt of prenatal care is not optimal, serologic screening and \ntreatment (if serologic test is reactive) should be performed at \nthe time of pregnancy testing (632). Antepartum screening can \nbe performed by manual nontreponemal antibody testing (e.g., \nRPR) by u..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0101", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "e., first \nvisit during the second trimester or later) or no prenatal \ncare, methamphetamine or heroin use, incarceration of the \nwoman or her partner, and unstable housing or homelessness \n(174,633–636). Moreover, as part of the management of \npregnant women who have syphilis, providers should obtain \ninformation concerning ongoing risk behaviors and treatment \nof sex partners to assess the risk ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0102", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 580, "preview": "G is the only known effective antimicrobial for \ntreating fetal infection and preventing congenital syphilis \n(639). Evidence is insufficient to determine the optimal \npenicillin regimen during pregnancy (640).\nRecommended Regimen for Syphilis During Pregnancy\nPregnant women should be treated with the recommended penicillin \nregimen for their stage of infection\nOther Management Considerations\nThe ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0103", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "ever, \ncontractions, or decrease in fetal movements. Stillbirth is \na rare complication of treatment; however, concern for \nthis complication should not delay necessary treatment. \nNo data are available to support that corticosteroid \ntreatment alters the risk for treatment-related complications \nduring pregnancy.\n• Missed doses >9 days between doses are not acceptable for \npregnant women receivin..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0104", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 499, "preview": "tal of \n1,870 cases of congenital syphilis were reported, including 94 \nstillbirths and 34 infant deaths (141). The 2019 national rate \nof 48.5 cases per 100,000 live births represents a 41% increase \nrelative to 2018 (34.3 cases per 100,000 live births) and a 477% \nincrease relative to 2012 (8.4 cases per 100,000 live births). \nDuring 2015–2019, the rate of congenital syphilis increased \n291.1% (..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0105", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "no prenatal \ncare, methamphetamine or heroin use, incarceration of the \nwoman or her partner, and unstable housing or homelessness \n(174,633–636). Moreover, as part of the management of \npregnant women who have syphilis, providers should obtain \ninformation concerning ongoing risk behaviors and treatment \nof sex partners to assess the risk for reinfection.\nRoutine screening of neonatal sera or umb..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0106", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 755, "preview": "nfants, \nskeletal survey demonstrating typical osseous lesions might aid \nin the diagnosis of congenital syphilis because these \nabnormalities are not detected on fetal ultrasound.\nThe following scenarios describe the recommended \ncongenital syphilis evaluation and treatment of neonates born \nto women who had reactive nontreponemal and treponemal \nserologic tests for syphilis during pregnancy (e.g..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0107", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": ", Zorc JJ, Hodinka \nRL, Shah SS. Defining cerebrospinal fluid white blood cell count reference \nvalues in neonates and young infants. Pediatrics 2010;125:257–64; Shah SS, \nEbberson J, Kestenbaum LA, Hodinka RL, Zorc JJ. Age-specific reference \nvalues for cerebrospinal fluid protein concentration in neonates and young \ninfants. J Hosp Med 2011;6:22–7; Thomson J, Sucharew H, Cruz AT , et al.; \nPedia..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0108", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 417, "preview": ".\nIf the neonate’s nontreponemal test is nonreactive and \nthe provider determines that the mother’s risk for untreated \nsyphilis is low, treatment of the neonate with a single IM \ndose of benzathine penicillin G 50,000 units/kg body weight \nfor possible incubating syphilis can be considered without \nan evaluation. Neonates born to mothers with untreated \nearly syphilis at the time of delivery are ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0109", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1137, "preview": "s before delivery.\n• The mother has no evidence of reinfection or relapse.\nRecommended Evaluation\nNo evaluation is recommended.\nRecommended Regimen, Congenital Syphilis Less Likely\nBenzathine penicillin G 50,000 units/kg body weight/dose IM in a \nsingle dose*\n* Another approach involves not treating the newborn if follow-up is \ncertain but providing close serologic follow-up every 2–3 months for \n..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0110", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 540, "preview": "ed testing should be performed; \nhowever, results should not delay evaluation and treatment \nof the neonate. These neonates should be evaluated and \ntreated with a 10-day course of penicillin as recommended in \nScenario 1, and consultation with a specialist is recommended.\nFollow-Up\nAll neonates with reactive nontreponemal tests should receive \nthorough follow-up examinations and serologic testing..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0111", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "e qualitative, and passive transfer of maternal IgG treponemal \nantibody might persist for >15 months.\nNeonates whose initial CSF evaluations are abnormal do \nnot need repeat lumbar puncture unless they exhibit persistent \nnontreponemal serologic test titers at age 6–12 months. \nPersistent nontreponemal titers and CSF abnormalities should \nbe managed in consultation with an expert.\nSpecial Conside..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0112", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 426, "preview": "ldren). In the case of extremely \nearly or incubating syphilis at the time of delivery, all maternal \nserologic tests might have been negative; thus, infection might \nbe undetected until a diagnosis is made later in the infant or \nchild. Any infant or child at risk for congenital syphilis should \nreceive a full evaluation and testing for HIV infection.\nInternational adoptee, immigrant, or refugee ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0113", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1144, "preview": "uditory brain-stem response)\nRecommended Regimen for Congenital Syphilis Among Infants \nand Children\nAqueous crystalline penicillin G 200,000–300,000 units/kg body \nweight/day IV, administered as 50,000 units/kg body weight every \n4–6 hours for 10 days\nIf the infant or child has no clinical manifestations of \ncongenital syphilis and the evaluation (including the CSF \nexamination) is normal, treatm..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0114", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 470, "preview": "nt to support use of ceftriaxone \nfor treatment of congenital syphilis among infants or children. \nFor infants aged ≥30 days, use ceftriaxone 75 mg/kg body \nweight/day IV or IM in a single daily dose for 10–14 days \n(dose adjustment might be necessary on the basis of current \nweight). For children, ceftriaxone 100 mg/kg body weight/\nday in a single daily dose is recommended.\n• For infants and chil..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0115", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1141, "preview": "fants and children with congenital syphilis \nshould be managed similarly, regardless of HIV status.\nManagement of Persons Who Have a \nHistory of Penicillin Allergy\nPenicillin and other ß-lactam antibiotics have a crucial \nrole in treating STIs. Penicillin is recommended for all \nclinical stages of syphilis, and no proven alternatives exist for \ntreating neurosyphilis, congenital syphilis, or syphi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0116", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 654, "preview": "bidities, the typical rates of \nvalidated penicillin allergy among patients who report a history \nof penicillin allergy are 2.5%–9.0% (670–673).\nCross-Reactivity with Cephalosporins\nPenicillin and cephalosporins both contain a ß-lactam ring. \nThis structural similarity has led to considerable confusion \nregarding cross-reactivity of these drugs and the risks for \nallergic reactions from cephalospo..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0117", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "-lactam therapy (667,675).\nFor persons who have a positive skin test reactive to penicillin \n(either to the major or minor determinants), treatment with a \nß-lactam antibiotic is not usually advised, and other effective \nantimicrobials should be used (656,658). For persons among \nwhom the only therapy option is a penicillin antibiotic (e.g., a \npatient with neurosyphilis or a pregnant woman with s..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0118", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 452, "preview": "d not be administered \npenicillin or a ß-lactam antibiotic in an ambulatory setting. \nFurthermore, these persons with high-risk symptoms should \nnot receive penicillin skin testing or amoxicillin oral challenge \nin an ambulatory STI setting and should be referred to an \nallergist for further evaluation.\nHigh-risk symptom histories include development of \nthe following after penicillin or ß-lactam ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0119", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1141, "preview": "che, fatigue, or nonurticarial rash) (Box 2). In addition, \na family history of penicillin or ß-lactam allergy alone is not a \ncontraindication for treatment with ß-lactam antibiotics. This \npractice is increasingly being used in ambulatory settings and \nfor preoperative prophylaxis (658,663,680,682–684).\nBOX 2. Low-risk history in patients who report penicillin allergy\nGastrointestinal symptoms\nH..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0120", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 417, "preview": "who have a positive skin test should not receive \nß-lactam drugs in the ambulatory setting and should be \nreferred to an allergist or penicillin allergy expert for further \nevaluation. The allergy testing results should be documented \nin the medical record. Patients who test negative should be \ninformed that their risk for anaphylaxis is extremely low and is \nequivalent to a person who does not re..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0121", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "illin G (10-2M, 3.3 mg/mL, 10,000 units/mL)\n• Benzylpenicilloate (10-2M, 3.3 mg/mL)\n• Benzylpenicilloate (or penicilloyl propylamine) \n(10\n-2M, 3.3 mg/mL)\nAged penicillin is not an adequate source of minor \ndeterminants. Penicillin G should either be freshly \nprepared or come from a fresh-frozen source.\nPositive control\n• Commercial histamine for scratch testing (1.0 mg/mL)\nNegative control\n• Dilu..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0122", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 514, "preview": "2% in Japan (706), and \n28.7% in the United States (range: 20.4%–38.8%) (697). Data \nare inconsistent regarding other Mycoplasma and Ureaplasma \nspecies as etiologic agents of urethritis (707). The majority \nof men with Ureaplasma infections do not have overt disease \nunless a high organism load is present.\nT . vaginalis can cause urethritis among heterosexual \nmen; however, the prevalence varies ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0123", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "meningitidis as the etiologic agent with \npresumed gonococcal urethritis on the basis of Gram stain \nbut negative NAAT for gonorrhea requires a confirmation \nby culture. Meningococcal urethritis is treated with the same \nantimicrobial regimens as gonococcal urethritis. Although \nevidence is limited regarding the risk for sexual transmission or \nrecurrent infections with meningococcal urethritis, t..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0124", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 708, "preview": "ritis and the presence or absence \nof gonococcal infection; MB or GV stain of urethral \nsecretions is an alternative POC diagnostic test with \nperformance characteristics similar to Gram stain; thus, \nthe cutoff number for WBCs per oil immersion field \nshould be the same (737).\n ű Presumed gonococcal infection is established by \ndocumenting the presence of WBCs containing GNID \nin Gram stain or in..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0125", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "rce: Leipertz G, Chambers L, Lowens S, et al. P796 \nReassessing the Gram stain smear [GSS] polymorphonuclear leukocyte [PMN] \ncutoff for diagnosing non-gonococcal urethritis [NGU]. Sex T ransm Infect \n2019;95[Suppl 1]:A339). Another study discussed that the WBC/HPF cutoff \nvalue should discriminate on the basis of the prevalence of chlamydia, \nmycoplasma, and gonorrhea among a clinic population ( ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0126", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 455, "preview": "wn to be infected, \nor for men who have persistent or recurrent symptoms after \ninitial empiric treatment.\nTreatment\nIdeally, treatment should be pathogen based; however, \ndiagnostic information might not be immediately available. \nPresumptive treatment should be initiated at NGU diagnosis. \nDoxycycline is highly effective for chlamydial urethral \ninfections and is also effective for chlamydial in..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0127", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "medications should be dispensed on-site at the clinic, and, \nregardless of the number of doses involved in the regimen, \nthe first dose should be directly observed. Erythromycin is no \nlonger recommended for NGU because of its gastrointestinal \nside effects and dosing frequency. Levofloxacin is no longer \nrecommended for NGU because of its inferior efficacy, \nespecially for M. genitalium.\nManageme..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0128", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 523, "preview": "men with recurrent \nor persistent symptoms, including those with gonorrhea, \nchlamydia, M. genitalium, and trichomoniasis, can be used to \nguide further management decisions.\nT . vaginalis is also known to cause urethritis among men who \nhave sex with women. In areas where T . vaginalis is prevalent, \nmen who have sex with women with persistent or recurrent \nurethritis should be tested for T . vag..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0129", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "ailures. Men with persistent or recurrent NGU after \ntreatment for M. genitalium or T . vaginalis should be referred \nto an infectious disease or urology specialist.\nSpecial Considerations\nHIV Infection\nNGU might facilitate HIV transmission (760). Persons with \nNGU and HIV infection should receive the same treatment \nregimen as those who do not have HIV .\nCervicitis\nT wo major diagnostic signs cha..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0130", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 527, "preview": "U. urealyticum, Mycoplasma hominis , or genital \nculture for group B streptococcus is not recommended.\nTreatment\nMultiple factors should affect the decision to provide \npresumptive therapy for cervicitis. Presumptive treatment with \nantimicrobials for C. trachomatis and N. gonorrhoeae should \nbe provided for women at increased risk (e.g., those aged \n<25 years and women with a new sex partner, a s..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0131", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "f a 7-day regimen or for 7 days after \nsingle-dose therapy) and symptoms have resolved. Women \nwho receive a cervicitis diagnosis should be tested for syphilis \nand HIV in addition to other recommended diagnostic tests.\nFollow-Up\nWomen receiving treatment should return to their provider \nfor a follow-up visit to determine whether cervicitis has \nresolved. For women who are untreated, a follow-up v..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0132", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 473, "preview": "n Among \nAdolescents and Adults\nChlamydial infection is the most frequently reported \nbacterial infectious disease in the United States, and prevalence \nis highest among persons aged ≤24 years (141,784). Multiple \nsequelae can result from C. trachomatis infection among \nwomen, the most serious of which include PID, ectopic \npregnancy, and infertility. Certain women who receive a \ndiagnosis of unco..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0133", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "ydia screening programs have been demonstrated \nto reduce PID rates among women ( 786,787). Although \nevidence is insufficient to recommend routine screening for \nC. trachomatis among sexually active young men because of \ncertain factors (i.e., feasibility, efficacy, and cost-effectiveness), \nscreening of sexually active young men should be considered \nin clinical settings with a high prevalence o..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0134", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 554, "preview": "can be considered for females on the basis of reported sexual \nbehaviors and exposure through shared clinical decision-\nmaking by the patient and the provider. The majority of \npersons with C. trachomatis detected at oropharyngeal sites do \nnot have oropharyngeal symptoms. The clinical significance of \noropharyngeal C. trachomatis infection is unclear, and prevalence \nis low, even among population..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0135", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1137, "preview": "mplications (e.g., \nPID) in a limited proportion of women (810).\nRecommended Regimen for Chlamydial Infection Among \nAdolescents and Adults\nDoxycycline 100 mg orally 2 times/day for 7 days\nAlternative Regimens\nAzithromycin 1 g orally in a single dose\nor\nLevofloxacin 500 mg orally once daily for 7 days\nA meta-analysis and a Cochrane systematic review evaluated \ndata from randomized clinical trials ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0136", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 597, "preview": "e disease transmission to sex partners, persons \ntreated for chlamydia should be instructed to abstain from \nsexual intercourse for 7 days after single-dose therapy or until \ncompletion of a 7-day regimen and resolution of symptoms if \npresent. T o minimize risk for reinfection, patients also should \nbe instructed to abstain from sexual intercourse until all of their \nsex partners have been treate..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0137", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1140, "preview": "er \nthey believe their sex partners were treated; scheduling the \nfollow-up visit at the time of treatment is encouraged (753). \nIf retesting at 3 months is not possible, clinicians should retest \nwhenever persons next seek medical care <12 months after \ninitial treatment.\nManagement of Sex Partners\nSex partners should be referred for evaluation, testing, and \npresumptive treatment if they had sex..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0138", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 492, "preview": "gnant women who have chlamydial infection \ndiagnosed should be retested 3 months after treatment. \nDetection of C. trachomatis infection during the third semester \nis not uncommon among adolescent and young adult women, \nincluding those without C. trachomatis detected at the time of \ninitial prenatal screening ( 827). Women aged <25 years and \nthose at increased risk for chlamydia (i.e., those who..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0139", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "ide \nantimicrobials, especially erythromycin, during pregnancy and \nadverse child outcomes, indicating cautious use in pregnancy \n(830–831).\nHIV Infection\nPersons who have chlamydia and HIV infection should \nreceive the same treatment regimen as those who do not \nhave HIV .\nChlamydial Infection Among Neonates\nPrenatal screening and treatment of pregnant women is \nthe best method for preventing chl..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0140", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 493, "preview": "lamydia \nscreening has been confirmed and the results are negative are \nnot at high risk for infection.\nDiagnostic Considerations\nSensitive and specific methods for diagnosing chlamydial \nophthalmia in the neonate include both tissue culture and \nnonculture tests (e.g., DFA tests and NAATs). DFA is the \nonly nonculture FDA-cleared test for detecting chlamydia \nfrom conjunctival swabs. NAATs are no..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0141", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1135, "preview": "of these antimicrobials should \nbe followed for IHPS signs and symptoms.\nAlthough data regarding use of azithromycin for treating \nneonatal chlamydial infection are limited, available data \ndemonstrate that a short therapy course might be effective \n(834). T opical antibiotic therapy alone is inadequate for \ntreating ophthalmia neonatorum caused by chlamydia and is \nunnecessary when systemic treat..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0142", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 409, "preview": "dose \ndaily for 3 days\nFollow-Up\nBecause erythromycin effectiveness in treating pneumonia \ncaused by C. trachomatis is approximately 80%, a second \ncourse of therapy might be required ( 836). Data regarding \neffectiveness of azithromycin in treating chlamydial pneumonia \nare limited. Follow-up of infants is recommended to determine \nwhether the pneumonia has resolved, although certain infants \nwit..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0143", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1150, "preview": "see \nSexual Assault or Abuse of Children).\nDiagnostic Considerations\nNAATs can be used to test vaginal and urine specimens \nfrom girls and urine in boys (see Sexual Assault or Abuse \nof Children). Data are lacking regarding use of NAATs for \nspecimens from extragenital sites (rectum and pharynx) among \nboys and girls ( 553); other nonculture tests (e.g., DFA) are \nnot recommended because of specif..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0144", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 445, "preview": "microbiologic diagnosis of N. gonorrhoeae infection \nshould be performed for all persons at risk for or suspected of \nhaving gonorrhea; a specific diagnosis can potentially reduce \ncomplications, reinfections, and transmission. Culture, NAAT , \nand POC NAAT , such as GeneXpert (Cepheid), are available \nfor detecting genitourinary infection with N. gonorrhoeae \n(149); culture requires endocervical ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0145", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "detecting N. gonorrhoeae from urogenital and nongenital \nanatomic sites is superior to culture but varies by NAAT type \n(553,800–803). For urogenital infections, optimal specimen \ntypes for gonorrhea screening using NAATs include first-void \nurine for men and vaginal swab specimens for women (553). \nPatient-collected samples can be used in place of provider-\ncollected samples in clinical settings ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0146", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 642, "preview": "nt failures \nfor pharyngeal infections reported in Australia ( 864,865), \nJapan ( 866 ), and Europe were concerning ( 856 ,867 ). \nConsequently, CDC no longer recommends cefixime as a \nfirst-line regimen for gonorrhea treatment in the United \nStates ( 868). Since 2013, the proportion of GISP isolates \nthat demonstrate reduced susceptibility (minimal inhibitory \nconcentration [MIC] ≥2.0 µg/mL) to a..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0147", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1136, "preview": "ome and the effect on other pathogens diminishes \nthe benefits of maintaining dual therapy. Consequently, only \nceftriaxone is recommended for treating gonorrhea in the \nUnited States (872). Clinicians remaining vigilant for treatment \nfailures is paramount, and CDC plans to continue to monitor \nfor changing ceftriaxone MICs until additional antimicrobials \nor a vaccine is available. In cases in w..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0148", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 593, "preview": "or Uncomplicated Gonococcal \nInfection of the Cervix, Urethra, or Rectum Among Adults and \nAdolescents\nCeftriaxone 500 mg* IM in a single dose for persons weighing <150 kg\nIf chlamydial infection has not been excluded, treat for chlamydia with \ndoxycycline 100 mg orally 2 times/day for 7 days.\n* For persons weighing ≥150 kg, 1 g ceftriaxone should be administered.\nAlthough clinical data confirm th..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0149", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "orins have not been evaluated, these dosing \nregimens might be at a disadvantage over ceftriaxone 500 mg. \nAlternative Regimens if Ceftriaxone Is Not Available\nGentamicin 240 mg IM in a single dose\nplus\nAzithromycin 2 g orally in a single dose\nor\nCefixime* 800 mg orally in a single dose\n* If chlamydial infection has not been excluded, providers should treat for \nchlamydia with doxycycline 100 mg o..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0150", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 564, "preview": "nomycin, if a cephalosporin \nallergy exists, in the United States.\nUncomplicated Gonococcal Infection of \nthe Pharynx\nThe majority of gonococcal infections of the pharynx are \nasymptomatic and can be relatively common among certain \npopulations ( 800,801,888–890). Although these infections \nrarely cause complications, they have been reported to be a \nmajor source of community transmission and migh..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0151", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1150, "preview": "onococcal infection should be provided on-site and \ndirectly observed. If medications are unavailable when \ntreatment is indicated, linkage to an STI treatment facility \nshould be provided for same-day treatment. T o minimize \ndisease transmission, persons treated for gonorrhea should \nbe instructed to abstain from sexual activity for 7 days after \ntreatment and until all sex partners are treated ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0152", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 600, "preview": "for educating partners about gonorrhea, their exposure to \ngonorrhea, and the importance of therapy. These materials \nshould also educate partners about seeking clinical evaluation \nfor adverse reactions or complications and general follow-up \nwhen able. Educational materials for female partners should \ninclude information about the importance of seeking medical \nevaluation for PID, especially if ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0153", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1137, "preview": "xual contact during the posttreatment follow-up \nperiod and persons with a positive test of cure (i.e., positive \nculture >72 hours or positive NAAT >7 days after receiving \nrecommended treatment) when no sexual contact is reported \nduring the posttreatment follow-up period ( 874). T reatment \nfailure should also be considered for persons who have a \npositive culture on test of cure, if obtained, ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0154", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 497, "preview": "ion cephalosporins but is rare (<1%) with \nthird-generation cephalosporins (e.g., ceftriaxone and \ncefixime) (631,680,896). Clinicians should first thoroughly \nassess a patient’s allergy history, including type of reaction, \nassociated medications, and previous prescription records. \nIf IgE-mediated penicillin allergy is strongly suspected, dual \ntreatment with single doses of IM gentamicin 240 mg..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0155", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "ty (897) \n(https://www.stdccn.org/render/Public).\nHIV Infection\nPersons who have gonorrhea and HIV infection should \nreceive the same treatment regimen as those who do not \nhave HIV .\nGonococcal Conjunctivitis\nIn the only published study of the treatment regarding \ngonococcal conjunctivitis among adults, all 12 study \nparticipants responded to a single 1-g IM injection of \nceftriaxone (898). Becau..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0156", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 362, "preview": "ally studied and should be determined in consultation \nwith an infectious disease specialist. T reatment for DGI should \nbe guided by the results of antimicrobial susceptibility testing. \nLength of treatment should be determined based on clinical \npresentation. Therapy for meningitis should be continued with \nrecommended parenteral therapy for 10–14 days. Parenteral \nantimicrobial therapy for endo..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0157", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "sumptive treatment (see Gonococcal Infections, \nManagement of Sex Partners).\nGonococcal Infection Among Neonates\nPrenatal screening and treatment of pregnant women for \ngonorrhea is the best method for preventing N. gonorrhoeae \ninfection among neonates. Gonococcal infection among \nneonates results from perinatal exposure to the mother’s infected \ncervix. It is usually an acute illness that manife..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0158", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 526, "preview": "e iodine \nhas not been studied adequately ( 905,906). Gentamicin \nophthalmic ointment has been associated with severe ocular \nreactions (907,908). If erythromycin ointment is unavailable, \ninfants at risk for exposure to N. gonorrhoeae, especially those \nborn to a mother at risk for gonococcal infection or with no \nprenatal care, can be administered ceftriaxone 25–50 mg/kg \nbody weight IV or IM, n..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0159", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "ng presumptive treatment \nfor gonorrhea after appropriate cultures and antimicrobial \nsusceptibility testing for N. gonorrhoeae are performed. \nPresumptive treatment for N. gonorrhoeae might be indicated \nfor newborns at increased risk for gonococcal ophthalmia who \nhave increased WBCs (no GNID) in a Gram-stained smear \nof conjunctival exudate. Nongonococcal causes of neonatal \nophthalmia include ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0160", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 272, "preview": "p abscesses caused \nby N. gonorrhoeae should be evaluated, tested, and presumptively \ntreated for gonorrhea, along with their sex partners (see \nGonococcal Infection Among Adolescents and Adults).\nNeonates Born to Mothers Who Have Gonococcal \nInfection\nNeonates born to mothers who have untreated gonorrhea \nare at high risk for infection. Neonates should be tested for \ngonorrhea at exposed sites (e..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0161", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1113, "preview": "Gonococcal Infection\nCeftriaxone 20–50 mg/kg body weight IV or IM in a single dose, not to \nexceed 250 mg\nOther Management Considerations\nCeftriaxone should be administered cautiously to neonates \nwith hyperbilirubinemia, especially those born prematurely. \nCefotaxime 100 mg/kg body weight IV or IM as a single \ndose can be administered for those neonates unable to \nreceive ceftriaxone because of s..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0162", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 377, "preview": "gonococcal \ninfections should be tested for C. trachomatis, syphilis, and \nHIV (see Sexual Assault or Abuse of Children).\nMycoplasma genitalium\nM. genitalium causes symptomatic and asymptomatic \nurethritis among men and is the etiology of approximately \n15%–20% of NGU, 20%–25% of nonchlamydial NGU, \nand 40% of persistent or recurrent urethritis (697,909,910). \nInfection with C. trachomatis is comm..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0163", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "for these outcomes among women infected with M. genitalium \n(766). M. genitalium infections among women are also \nfrequently asymptomatic, and the consequences associated \nwith asymptomatic M. genitalium infection are unknown.\nM. genitalium can be detected among 10%–30% of women \nwith clinical cervicitis ( 767,770,772,914–916). The existing \nevidence between M. genitalium and cervicitis is mostly ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0164", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 571, "preview": "in the United States, Canada, Western Europe, and Australia \n(697,702,945–953). T reatment with azithromycin alone \nhas been reported to select for resistance ( 705,954,955), \nwith treatment of macrolide-susceptible infections with a \n1-g dose of azithromycin resulting in selection of resistant-\nstrain populations in 10%–12% of cases. The prevalence of \nquinolone resistance markers is much lower (..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0165", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1150, "preview": "If resistance testing is available, \nit should be performed and the results used to guide therapy. \nWomen with recurrent cervicitis should be tested for \nM. genitalium, and testing should be considered among women \nwith PID. T esting should be accompanied with resistance \ntesting, if available. Screening of asymptomatic M. genitalium \ninfection among women and men or extragenital testing \nfor M. g..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0166", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 425, "preview": "ommended regimen. In \nsettings in which M. genitalium testing is available, persons \nwith persistent urethritis, cervicitis, or PID accompanied by \ndetection of M. genitalium should be treated with moxifloxacin.\nManagement of Sex Partners\nRecent studies report a high concordance of M. genitalium \namong partners of males, females, and MSM; however, no \nstudies have determined whether reinfection is..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0167", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "during \ntheir lifetime. With the availability of complementary and \nalternative therapies and over-the-counter medications for \ncandidiasis, symptomatic women often seek these products \nbefore or in addition to an evaluation by a medical provider.\nObtaining a medical history alone has been reported to \nbe insufficient for accurate diagnosis of vaginitis and can \nlead to inappropriate administratio..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0168", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 624, "preview": "the vagina with high concentrations of anaerobic \nbacteria, including G. vaginalis, Prevotella species, Mobiluncus \nspecies, A. vaginae, and other BV-associated bacteria. A notable \nfeature is the appearance of a polymicrobial biofilm on vaginal \nepithelial cells ( 970). Certain women experience transient \nvaginal microbial changes, whereas others experience them for \nlonger intervals (971). BV is..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0169", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "to HIV \n(993, 994) and the risk for HIV transmission to male \nsex partners ( 187). Evaluation of short-term valacyclovir \nsuppression among women with HSV-2 did not decrease the \nrisk for BV , despite effective suppression of HSV-2 (995).\nAlthough BV-associated bacteria can be identified on male \ngenitalia (996,997), treatment of male sex partners has not been \nbeneficial in preventing the recurre..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0170", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 584, "preview": "acillus Profiling by qPCR \n(Medical Diagnostic Laboratories) (1009), and SureSwab BV \n(Quest Diagnostics). T wo of these assays are FDA cleared (BD \nMax Vaginal Panel and Aptima BV), and the other three are \nlaboratory-developed tests.\nThe Max Vaginal Panel provides results by an algorithmic \nanalysis of molecular DNA detection of Lactobacillus species \n(L. crispatus and L. jensenii ) in addition ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0171", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1140, "preview": "c. Cervical Pap tests have no clinical utility for \ndiagnosing BV because of their low sensitivity and specificity.\nTreatment\nT reatment for BV is recommended for women with \nsymptoms. Established benefits of therapy among nonpregnant \nwomen are to relieve vaginal symptoms and signs of infection. \nOther potential benefits of treatment include reduction \nin the risk for acquiring C. trachomatis, N...."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0172", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 515, "preview": "6.6% in the placebo arm (p = 0.01) (1018). A patient savings \ncard for metronidazole 1.3% vaginal gel is available at https://\nnuvessa.com/nuvessa_files/19_Nuvessa_WEB_Card_032819.\npdf. In a multicenter, randomized, single-blind, parallel-\ngroup study of Clindesse 2% vaginal cream single dose versus \nclindamycin 2% vaginal cream at bedtime for 7 days among \n540 women with BV , no statistically sig..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0173", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "egarding optimal management strategies for women \nwith persistent or recurrent BV . Using a different recommended \ntreatment regimen can be considered for women who have a \nrecurrence; however, retreatment with the same recommended \nregimen is an acceptable approach for treating persistent or \nrecurrent BV after the first occurrence ( 1026). For women \nwith multiple recurrences after completion of..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0174", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 533, "preview": "ion, and \npostpartum endometritis (989,991,1036). Studies have been \nundertaken to determine the efficacy of BV treatment among \nthis population, including two trials demonstrating that oral \nmetronidazole was efficacious during pregnancy by using \nthe 250 mg 3 times/day regimen (1037,1038); however, oral \nmetronidazole administered as a 500 mg 2 times/day regimen \ncan also be used. One trial invo..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0175", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "d during pregnancy ( 431). Data are insufficient \nregarding efficacy and adverse effects of secnidazole, Clindesse \n2% vaginal cream, metronidazole 1.3% vaginal gel, and \n750-mg vaginal metronidazole tablets during pregnancy; thus, \ntheir use should be avoided.\nOral therapy has not been reported to be superior to topical \ntherapy for treating symptomatic BV in effecting cure or \npreventing adverse..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0176", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 571, "preview": "arcerated men (388). Women with a history of \nincarceration are two to five times more likely to have T . vaginalis \n(387,388,1063,1064). Other risk factors for T . vaginalis include \nhaving two or more sex partners during the previous year, having \nless than a high school education, and living below the national\n \npoverty level (1065). Women with BV are at higher risk for \nT . v\naginalis (1066). ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0177", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "increase the risk for vaginal \ninfections, including trichomoniasis (1074).\nT . vaginalis causes reproductive morbidity and has been \nreported to be associated with a 1.4-times greater likelihood \nof preterm birth, premature rupture of membranes, and \ninfants who are small for gestational age ( 1075). T . vaginalis \nwas also determined to be associated with a 2.1-fold increased \nrisk for cervical ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0178", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 637, "preview": "imens have <100% concordance (1084). This assay \nhas not been FDA cleared for use among men and should be \ninternally validated in accordance with CLIA regulations before \nuse with urine or urethral swabs from men. The Probe T ec TV \nQ\nx Amplified DNA Assay (Becton Dickinson) is FDA cleared \nfor detection of T . vaginalis from vaginal (patient-collected \nor clinician-collected) swabs, endocervical..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0179", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "of 97%–100%, compared with wet mount, culture, and \ntranscription-mediated amplification ( 1089,1093,1094). A \nstudy of 209 women aged 14–22 years reported that >99% \ncould correctly perform and interpret a vaginal self-test by \nusing the Osom assay, with a high correlation with clinician \ninterpretation (96% agreement; κ = 0.87) (1094). The Osom \ntest should not be used with men because of low se..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0180", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 479, "preview": "proximately 92%–100% (1108–1112). Randomized \ncontrolled trials comparing single 2-g doses of metronidazole \nand tinidazole indicated that tinidazole is equivalent or superior \nto metronidazole in achieving parasitologic cure and symptom \nresolution (1110,1113,1114).\nMetronidazole gel does not reach therapeutic levels in the \nurethra and perivaginal glands. Because it is less efficacious \nthan ora..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0181", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "rs\nConcurrent treatment of all sex partners is vital for \npreventing reinfections. Current partners should be referred \nfor presumptive therapy. Partners also should be advised to \nabstain from intercourse until they and their sex partners \nhave been treated and any symptoms have resolved. EPT \nmight have a role in partner management for trichomoniasis \n(129,1116) and can be used in states where p..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0182", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 580, "preview": "e 500 mg 2 times/day for \n14 days (1121). If this regimen fails, high-dose oral tinidazole \n(1 g 3 times/day) plus intravaginal paromomycin (4 g of 6.25% \nintravaginal paromomycin cream nightly) for 14 days should \nbe considered (1122).\nAlternative regimens might be effective but have not been \nsystemically evaluated; therefore, consultation with an infectious \ndisease specialist is recommended. C..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0183", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1137, "preview": "of pregnant women with asymptomatic trichomoniasis \nreported no substantial difference in preterm birth after \ntreatment with 2 g of metronidazole 48 hours apart during \n16–23 and 24–29 weeks’ gestation, compared with placebo \n(1130). However, that trial had multiple limitations, including \nuse of an atypical metronidazole regimen. Another multicenter \nobservational study of asymptomatic pregnant ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0184", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 547, "preview": "h HIV \nand T . vaginalis infection demonstrated that a single dose \nof metronidazole 2 g orally was less effective than 500 mg \n2 times/day for 7 days ( 1105). Factors that might interfere \nwith standard single-dose treatment for trichomoniasis among \nwomen with HIV include high rates of asymptomatic BV \ninfection, ART use, changes in vaginal ecology, and impaired \nimmunity (1141). Thus, to improv..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0185", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1150, "preview": "ter treatment; \nNAAT is encouraged because of higher sensitivity of these \ntests. Data are insufficient to support retesting of men with \ntrichomonas and HIV infection.\nVulvovaginal Candidiasis\nVVC usually is caused by Candida albicans but can \noccasionally be caused by other Candida species or yeasts. \nTypical symptoms of VVC include pruritus, vaginal soreness, \ndyspareunia, external dysuria, and..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0186", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 298, "preview": "s\nor\nMiconazole 4% cream 5 g intravaginally daily for 3 days\nor\nMiconazole 100 mg vaginal suppository one suppository daily for 7 days\nor\nMiconazole 200 mg vaginal suppository one suppository for 3 days\nor\nMiconazole 1,200 mg vaginal suppository one suppository for 1 day\nor\nTioconazole 6.5% ointment 5 g intravaginally in a single application\nPrescription Intravaginal Agents\nButoconazole 2% cream (..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0187", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1141, "preview": "or\nTerconazole 80 mg vaginal suppository one suppository daily for 3 days\nOral Agent\nFluconazole 150 mg orally in a single dose\nThe creams and suppositories in these regimens are oil \nbased and might weaken latex condoms and diaphragms. \nPatients should refer to condom product labeling for further \ninformation. Even women who have previously received a \ndiagnosis of VVC by a clinician are not nece..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0188", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 428, "preview": "icated maintenance regimen. \nIf this regimen is not feasible, topical treatments used \nintermittently can also be considered. Suppressive maintenance \ntherapies are effective at controlling recurrent VVC but are \nrarely curative long-term (1147). Because C. albicans azole \nresistance is becoming more common, susceptibility tests, if \navailable, should be obtained among symptomatic patients who \nre..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0189", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "t is often \ndifficult, clinicians should make every effort to exclude other \ncauses of vaginal symptoms for women with non– albicans \nyeast (1148). The optimal treatment of non–albicans VVC \nremains unknown; however, a longer duration of therapy \n(7–14 days) with a nonfluconazole azole regimen (oral or \ntopical) is recommended. If recurrence occurs, 600 mg of boric \nacid in a gelatin capsule admin..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0190", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 439, "preview": "ptoms (919,923,928), although one study failed \nto demonstrate a substantial increase in PID after detection of \nM. genitalium in the lower genital tract (925).\nScreening and treating sexually active women for chlamydia \nand gonorrhea reduces their risk for PID (1162,1163\n). Although \nBV is associated with PID, whether PID incidence can be \nreduced by identifying and treating women with BV is uncl..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0191", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "dometritis and \nmight not detect subtle inflammation of the fallopian tubes. \nConsequently, a PID diagnosis usually is based on imprecise \nclinical findings (1164–1166).\nData indicate that a clinical diagnosis of symptomatic PID \nhas a positive predictive value for salpingitis of 65%–90%, \ncompared with laparoscopy (1167 –1170 ). The positive \npredictive value of a clinical diagnosis of acute PID ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0192", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 601, "preview": "on (predominance of leukocytes in vaginal \nsecretions, cervical discharge, or cervical friability), in addition \nto one of the three minimum criteria, increases the specificity of \nthe diagnosis. One or more of the following additional criteria \ncan be used to enhance the specificity of the minimum clinical \ncriteria and support a PID diagnosis:\n• Oral temperature >38.3°C (>101°F)\n• Abnormal cervi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0193", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "egimen and long-term outcome of \nearly treatment of women with subclinical PID are unknown. \nAll regimens used to treat PID should also be effective against \nN. gonorrhoeae and C. trachomatis because negative endocervical \nscreening for these organisms does not rule out upper genital \ntract infection. Anaerobic bacteria have been isolated from the \nupper genital tract of women who have PID, and da..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0194", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 377, "preview": "een investigated \nin at least one clinical trial and has broad-spectrum coverage \n(1177). Ampicillin-sulbactam plus doxycycline is effective \nagainst C. trachomatis , N. gonorrhoeae , and anaerobes for \nwomen with tubo-ovarian abscess. Another trial demonstrated \nshort-term clinical cure rates with azithromycin monotherapy \nor combined with metronidazole (1178).\nWhen using the clindamycin and gent..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0195", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "Ampicillin-sulbactam 3 g IV every 6 hours\nplus\nDoxycycline 100 mg orally or IV every 12 hours\nor\nClindamycin 900 mg IV every 8 hours\nplus\nGentamicin loading dose IV or IM (2 mg/kg body weight), followed by a \nmaintenance dose (1.5 mg/kg body weight) every 8 hours; single daily \ndosing (3–5 mg/kg body weight) can be substituted\nIntramuscular or Oral Treatment\nIM or oral therapy can be considered fo..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0196", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 457, "preview": "and syphilis. The value of \ntesting women with PID for M. genitalium is unknown (see \nMycoplasma genitalium) . All contraceptive methods can be \ncontinued during treatment. \nFollow-Up\nWomen should demonstrate clinical improvement (e.g., \ndefervescence; reduction in direct or rebound abdominal \ntenderness; and reduction in uterine, adnexal, and cervical \nmotion tenderness) <3 days after therapy ini..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0197", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "egardless of the PID etiology or pathogens \nisolated. If the last sexual intercourse was >60 days before \nsymptom onset or diagnosis, the most recent sex partner should \nbe treated. Sex partners of persons who have PID caused by \nC. trachomatis or N. gonorrhoeae frequently are asymptomatic. \nArrangements should be made to link sex partners to care. If \nlinkage is delayed or unlikely, EPT is an alt..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0198", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 448, "preview": "trachomatis, \nN. gonorrhoeae, or M. genitalium) or enteric organisms (i.e., \nEscherichia coli ) (1192). Acute epididymitis caused by an \nSTI is usually accompanied by urethritis, which is frequently \nasymptomatic. Acute epididymitis caused by sexually \ntransmitted enteric organisms might also occur among men \nwho are the insertive partner during anal sex. Nonsexually \ntransmitted acute epididymiti..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0199", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "most common \ngranulomatous disease affecting the epididymis and should be \nsuspected, especially among men with a known history of or recent \nexposure to TB. The differential diagnosis of chronic noninfectious \nepididymitis, sometimes termed orchialgia or epididymalgia, is \nbroad (e.g., trauma, cancer, autoimmune conditions, or idiopathic \nconditions). Men with this diagnosis should be referred to..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0200", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 533, "preview": "py for all sexually active men is indicated \nat the time of the visit before all laboratory test results are \navailable. Selection of presumptive therapy is based on risk for \nchlamydial and gonococcal infections or enteric organisms. \nT reatment goals for acute epididymitis are 1) microbiologic \ninfection cure, 2) improvement of signs and symptoms, \n3) prevention of transmission of chlamydia and ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0201", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1140, "preview": "loxacin 500 mg orally once daily for 10 days\n* For persons weighing ≥150 kg, 1 g of ceftriaxone should be administered.\nLevofloxacin monotherapy should be considered if the \ninfection is most likely caused by enteric organisms only, and \ngonorrhea has been ruled out by Gram, MB, or GV stain. This \nincludes men who have undergone prostate biopsy, vasectomy, \nand other urinary tract instrumentation ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0202", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 352, "preview": "ers (1197), whereas other HPV infection \n(e.g., HPV types 6 and 11) causes genital warts and recurrent \nrespiratory papillomatosis. Persistent oncogenic HPV infection \nis the strongest risk factor for development of HPV-attributable \nprecancers and cancers. A substantial proportion of cancers and \nanogenital warts are attributable to HPV in the United States. \nAn estimated 34,800 new HPV-attributa..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0203", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1144, "preview": "d Gardasil 9, a 9-valent \nvaccine (9vHPV) that targets HPV types 6, 11, 16, 18, 31, \n33, 45, 52, and 58. Types 16 and 18 account for 66% of all \ncervical cancers, whereas the five additional types targeted by \nthe 9-valent vaccine account for 15%. Types 6 and 11 cause \n>90% of genital warts. Only 9vHPV vaccine is available in \nthe United States.\nACIP recommendations for HPV vaccination (https://ww..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0204", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 460, "preview": "detect genital mucosa infected with HPV . The routine use \nof this procedure to detect mucosal changes attributed to \nHPV infection is not recommended because the results do \nnot influence clinical management.\nTreatment\nT reatment is directed to the macroscopic (e.g., genital warts) \nor pathologic precancerous lesions caused by HPV . Subclinical \ngenital HPV infection typically clears spontaneousl..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0205", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "r \nhis or her partner is having sex outside the relationship.\n• Persons who acquire HPV usually clear the infection \nspontaneously, meaning that HPV becomes undetectable \nwith no associated health problems.\n• If HPV infection persists, genital warts, precancers, and \ncancers of the cervix, anus, penis, vulva, vagina, head, or \nneck might develop.\n• Discussion of tobacco use, and provision of cessa..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0206", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 486, "preview": "ly at certain anatomic sites, including around \nthe vaginal introitus, under the foreskin of the uncircumcised \npenis, and on the shaft of the circumcised penis. Warts can \nalso occur at multiple sites in the anogenital epithelium or \nwithin the anogenital tract (e.g., cervix, vagina, urethra, \nperineum, perianal skin, anus, or scrotum). Intra-anal warts \nare observed predominantly in persons who ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0207", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "sults are not confirmatory and do not \nguide genital wart management. Some anogenital lesions can \nresemble anogenital warts (condyloma accuminata), but do \nnot respond to anogenital wart treatment. Condyloma lata, \na manifestation of secondary syphilis, can be diagnosed by \nserologic tests or through direct detection from serous fluid \nfrom the lesions (see Syphilis, Diagnostic Considerations).\nT..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0208", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 685, "preview": "washed with soap and water 6–10 hours \nafter the application. Local inflammatory reactions, including \nredness, irritation, induration, ulceration or erosion, and vesicles \nmight occur with using imiquimod, and hypopigmentation has \nalso been described (1219). Limited case reports demonstrate \nan association between treatment with imiquimod cream and \nworsened inflammatory or autoimmune skin disea..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0209", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1144, "preview": "on, edema, induration, and vesicular \nrash. This medication is not recommended for persons with HIV \ninfection, other immunocompromised conditions, or genital herpes \nbecause the safety and efficacy of therapy has not been evaluated. \nThe safety of sinecatechins during pregnancy is unknown.\nCryotherapy is a provider-administered therapy that destroys \nwarts by thermal-induced cytolysis. Health car..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0210", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 495, "preview": "as of friable tissue and was not washed \noff within 4 hours (1227–1229). Podophyllin resin 10%–25% \nin a compound tincture of benzoin might be considered for \nprovider-administered treatment under conditions of strict \nadherence to recommendations. Podophyllin should be applied \nto each wart and then allowed to air dry before the treated area \ncomes into contact with clothing. Overapplication or f..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0211", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "en\nThe use of a cryoprobe in the vagina is not recommended because of \nthe risk for vaginal perforation and fistula formation.\nor\nSurgical removal\nor\nTrichloracetic acid (TCA) or bichloroacetic acid (BCA) 80%–90% \nsolution\nRecommended Regimens for Cervical Warts\nCryotherapy with liquid nitrogen\nor\nSurgical removal\nor\nTrichloracetic acid (TCA) or bichloroacetic acid (BCA) 80%–90% \nsolution\nManageme..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0212", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 415, "preview": "ut having genital \nwarts because the types of HPV that cause warts can be passed \non to partners. Partners should be counseled that they might \nalready have HPV despite no visible signs of warts; therefore, \nHPV testing of sex partners of persons with genital warts is \nnot recommended. Partners might benefit from a physical \nexamination to detect genital warts and tests for other STIs. No \nrecomme..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0213", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "s and children, although the route \nof transmission (i.e., transplacental, perinatal, or postnatal) is \nnot completely understood. Whether cesarean delivery prevents \nrespiratory papillomatosis among infants and children also \nis unclear (1230); therefore, cesarean delivery should not be \nperformed solely to prevent transmission of HPV infection to \nthe newborn. Cesarean delivery is indicated for ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0214", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 566, "preview": "pes of HPV . \nFor cytopathologic testing, clinics should use CLIA-certified \nlaboratories using acceptable terminology (Bethesda 2001 or \nLAST terminology) (1239).\nAnnual cervical cancer screening is not recommended for \npersons at average risk. Instead, cytology testing is recommended \nevery 3 years for persons aged 21–29 years. For persons aged \n30–65 years, a cytology test every 3 years, an HPV..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0215", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1126, "preview": "menting cervical cancer screening in clinics (1246).\nPatients should be provided a copy of their test results; \nthose with normal results should be provided information \non follow-up visits and the importance of continued cervical \ncancer screening, if applicable. Those with abnormal screening \ntests should be managed per published guidelines. National \nconsensus guidelines are available for the m..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0216", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 304, "preview": "tology alone annually \nContinue for ≥25 yrs from the initial CIN diagnosis, even if extends past age 65 yrs \nRoutine screening can resume after the posttreatment surveillance period\nPrevious hysterectomy \nwith removal of cervix\nHPV testing alone or cytology plus HPV testing every 3 yrs \nor \nCytology alone annually \nContinue for ≥25 yrs from the initial CIN diagnosis, even if extends past age 65 yr..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0217", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "= American Cancer Society; ACOG = American College of Obstetricians and Gynecologists; AIS = adenocarcinoma in situ; ASCCP = American \nSociety for Colposcopy and Cervical Pathology; CIN = cervical intraepithelial neoplasia; HPV = human papillomavirus; HSIL = high-grade squamous intraepithelial \nlesion; USPSTF = U.S. Preventive Services Task Force.\n* Considered an alternative screening strategy by ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0218", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 523, "preview": "d colposcopy) to assist with \nmanagement; effort should be made to obtain copies of \nrecent results. The importance and frequency of screening \nshould be reinforced.\nCounseling\nPersons might believe the cytology (Pap test) or HPV test \nscreens for conditions other than cervical cancer, or they \nmight be confused by abnormal results (1252–1254). Health \ncare providers, as trusted sources of informa..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0219", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "and female partners. Having an HPV infection \nshould not raise concerns about a male partner’s health (1262). \nProviders should communicate the meaning of both the \ncytology and HPV test results to patients at screening.\nProviders also should screen for tobacco use and perform \ncessation counseling (www.acog.org/clinical/clinical-guidance/\ncommittee-opinion/articles/2011/09/tobacco-use-and-\nwomens..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0220", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 466, "preview": "risk. No data are available \nto suggest that more frequent screening is of benefit.\n• When used correctly and consistently, condoms might \nlower the risk for HPV infection and might decrease the \ntime to clear in those with HPV infection. However, HPV \ncan infect areas not covered by the condom, and condoms \nmight not fully protect against HPV (24,25).\nAdditional messages for partners include the ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0221", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "t) can be done in individuals aged ≥30 years with \nHIV . Annual screening is recommended for persons with HIV \ninfection; after 3 years of consecutive normal cytology results \nor normal cotest (normal cytology and negative HPV test), the \nscreening interval can be increased to every 3 years. Lifelong \nscreening is recommended among persons with HIV infection.\nProviders should defer to existing Gui..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0222", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 531, "preview": "p \ncare should be provided according to the 2019 ASCCP Risk-\nBased Management Consensus Guidelines for Abnormal Cervical \nCancer Screening T ests and Cancer Precursors (158). Clinics that \nserve clients who might have difficulty adhering to follow-up \nrecommendations and for whom linkage to care is unlikely should \nconsider offering in-house colposcopy and biopsy services.\nConsensus guidelines for..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0223", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1116, "preview": "a negative screening HPV test or \ncotest within the past 5 years, follow-up in 1 year instead \nof colposcopy is recommended (a negative HPV test or \ncotest performed during follow-up of abnormal results \nwould not similarly reduce risk).\n ű Referral to colposcopy is recommended if cytology test \nresults are abnormal or the HPV test is positive at the \n1-year follow-up visit.\n• T reatment can be ex..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0224", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 569, "preview": "olaou.\n* Colposcopy may be warranted for patients with a history of high-grade lesions (CIN 2 or CIN 3, histologic or cytologic HSIL, ASC-H, AGC, or AIS).\n† Previous Pap test results do not modify the recommendation; colposcopy is always recommended for two consecutive HPV-positive tests.\n§ Negative HPV test or cotest (HPV plus Pap test) results only reduce risk sufficiently to defer colposcopy if..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0225", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "the \nlaboratory as a reflex test from the same specimen so the \npatient does not need to return to the clinic. Colposcopy \nis recommended if HPV genotyping is positive for types \n16 or 18, and it can be considered if it is infeasible for \nthe patient to return for cytology alone (1274).\n ű HPV 16 is the highest-risk HPV type. Expedited \ntreatment should be considered for HSIL cytology \nresults, an..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0226", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 533, "preview": "ould be \nperformed to detect early anal cancer in persons with HIV \ninfection and MSM without HIV with a history of receptive \nanal intercourse (98,1283). DARE is acceptable to patients and \nhas a low risk for adverse outcomes (1284,1285).\nData are insufficient to guide initiation of DARE at a defined \nage or optimal intervals for examination. Whereas anal HSIL \nis observed among young adults, can..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0227", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "DARE. However, data are \ninsufficient to conclude whether use of HRA leads to reductions \nin anal cancer incidence or improves anal cancer morbidity and \nmortality. An ongoing clinical trial is investigating whether \ntreatment of HSIL is effective in reducing the incidence of anal \ncancer among persons with HIV infection (NCT02135419).\nHuman Papillomavirus Testing\nHPV tests (using high-risk HPV ty..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0228", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 502, "preview": "ve enough to detect the \nlow level of protective antibody after vaccination, anti-HAV \ntests also might be positive after hepatitis A vaccination.\nTreatment\nPatients with acute HAV infection usually require only \nsupportive care, with no restrictions in diet or activity. \nHospitalization might be necessary for patients who become \ndehydrated because of nausea and vomiting and is crucial \nfor patie..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0229", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1137, "preview": "otective antibody levels, and after a second \ndose, 100% achieve protective levels ( 1297,1300,1301). \nKinetic models of antibody decrease among adults indicate that \nprotective levels persist for >40 years (1302–1304). A study of \nAlaska Natives demonstrated that seropositivity for hepatitis \nA persists for >20 years after completing 2-dose vaccination at \nage 12–21 months (1302). Anti-HAV persis..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0230", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 206, "preview": "ere \noutcome from HAV infection\n• Any persons who requests a vaccine\nVaccination during outbreaks\n• Unvaccinated persons in outbreak settings who are at \nrisk for HAV infection or at risk for severe disease from \nHAV\nImplementation strategies for settings providing \nservices to adults\n• Persons in settings that provide services to adults where \na high proportion of those persons have risk factors ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0231", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1045, "preview": "Source: Nelson NP , Weng MK, Hofmeister MG, et al. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee \non Immunization Practices, 2020. MMWR Recomm Rep 2020;69(No. RR-5).\nRecommendations and Reports\nMMWR / July 23, 2021 / Vol. 70 / No. 4 115\nUS Department of Health and Human Services/Centers for Disease Control and Prevention\nPersons for whom ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0232", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 609, "preview": "1 dose† 0.1 mL/kg body weight§\n≥12 mos Immunocompromised or chronic liver disease 1 dose† 0.1 mL/kg body weight¶\n≥12 mos Vaccine contraindicated** No 0.1 mL/kg body weight\nPre-exposure protection (e.g., travel)††\n<6 mos Healthy No 0.1–0.2 mL/kg body weight§§\n6–11 mos Healthy 1 dose¶¶ None\n12 mos to 40 yrs Healthy 1 dose*** None\n>40 yrs Healthy 1 dose*** 0.1–0.2 mL/kg body weight§§,†††\n>6 mos Immun..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0233", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "infection or severe disease from HAV infection.\n §§ 0.1 mL/kg body weight for travel ≤1 month; 0.2 mL/kg body weight for travel ≤2 months; 0.2 mL/kg every 2 months for travel of ≥2 months’ duration.\n ¶¶ This dose should not be counted toward the routine 2-dose series, which should be initiated at age 12 months.\n *** For persons not previously vaccinated with hepatitis A vaccine, administer dose as..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0234", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 533, "preview": "mothers whose HBsAg status is unknown, routine infant \nvaccination, vaccination of previously unvaccinated children \nand adolescents through age 18 years, and vaccination of \npreviously unvaccinated adults at increased risk for infection \n(12). High vaccination coverage rates with subsequent \ndecreases in acute HBV infection incidence have been achieved \namong infants and adolescents ( 1318). The ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0235", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "-HBc, with a negative test for IgM \nanti-HBc, indicates chronic HBV infection. The presence of \ntotal anti-HBc alone might indicate acute, resolved, or chronic \ninfection or a false-positive result.\nTreatment\nNo specific therapy is available for persons with acute HBV \ninfection; treatment is supportive. Persons with chronic \nHBV infection should be referred for evaluation to a provider \nexperienc..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0236", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 506, "preview": "s \naged 11–15 years, with a 4-month minimal interval between \ndoses. When scheduled to receive the second dose, adolescents \naged 16–19 years should be switched to a 3-dose series, with \ndoses 2 and 3 consisting of the pediatric formulation (5 µg) \nadministered on a recommended schedule. Heplisav-B is a \nnew single-antigen recombinant hepatitis B vaccine with a \nnovel cytosine-phosphate-guanine 10..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0237", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "en the vaccine from \nthe same manufacturer is unavailable (1324).\nAmong adolescents and healthy adults aged <40 years, \napproximately 30%–55% achieve a protective antibody response \n(i.e., anti-HBs ≥10 mIU/mL) after the first single-antigen \nvaccine dose, 75% after the second, and >90% after the third. \nRecent clinical trials reported a protective antibody response \nachieved among approximately 90..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0238", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 431, "preview": "with diabetes and all adults seeking protection \nfrom HBV infection (1318). For adults, acknowledgment of \na specific risk factor is not a requirement for vaccination.\nHepatitis B vaccine should be routinely offered to all \nunvaccinated persons attending STD clinics and to all \nunvaccinated persons seeking evaluation or treatment for STIs \nin other settings, especially correctional facilities, fac..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0239", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "ccine series exist.\nPrevaccination Serologic Testing\nConducting prevaccination serologic testing for susceptibility \njust before the initial vaccine dose is administered can \nbe considered for identifying persons with chronic HBV \ninfection and, potentially, reducing the cost of completing the \nvaccination series for adult populations that have an expected \nhigh prevalence (20%–30%) of HBV infecti..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0240", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 575, "preview": "is B vaccination alone) have been demonstrated to be \nhighly effective in preventing transmission after exposure to \nHBV (12). HBIG alone also has been demonstrated to be \neffective in preventing HBV transmission; however, with the \navailability of hepatitis B vaccine, HBIG typically is used as \nan adjunct to vaccination.\nExposure to a Source Who Is HBsAg Positive\nUnvaccinated persons or persons k..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0241", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "e a discrete, identifiable \nexposure to blood or body fluids containing blood from \na person with unknown HBsAg status should receive the \nhepatitis B vaccine series, with the first dose initiated as soon \nas possible after exposure (preferably <24 hours) and the series \ncompleted according to the age-appropriate dose and schedule. \nExposed persons who are not fully vaccinated but started the \nser..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0242", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 393, "preview": "l, and needle-sharing contacts of persons \nwith chronic infection should be evaluated. Unvaccinated \nsex partners and household and needle-sharing contacts \nshould be tested for susceptibility to HBV infection and \nreceive the first dose of hepatitis B vaccine immediately \nafter collection of the blood sample for serologic testing \n(see Prevaccination Serologic T esting). Susceptible persons \nshou..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0243", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1137, "preview": "condoms) to protect nonimmune sex \npartners from acquiring HBV infection from sexual \nactivity until the partner can be vaccinated and \nimmunity documented;\n ű cover cuts and skin lesions to prevent spread by \ninfectious secretions or blood;\n ű refrain from donating blood, plasma, body organs, other \ntissue, or semen; and\n ű refrain from sharing household articles (e.g., \ntoothbrushes, razors, or ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0244", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 452, "preview": "r 1,000 person years among MSM with HIV infection \n(1343). An association exists with high-risk and traumatic \nsexual practices (e.g., condomless receptive anal intercourse \nor receptive fisting) and concurrent genital ulcerative disease \nor STI-related proctitis (237,1342). HCV transmission among \nMSM with HIV infection has also been associated with group \nsex and chemsex (i.e., using recreationa..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0245", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1140, "preview": "n blood within 1–3 weeks after exposure. The \naverage time from exposure to antibody to HCV (anti-HCV) \nseroconversion is 4−10 weeks, and anti-HCV can be detected \namong approximately 97% of persons by 6 months after \nexposure ( 1361–1364) ( https://www.cdc.gov/hepatitis/hcv/\nhcvfaq.htm#section3).\nChronic HCV infection develops among 75%–85% of \npersons with HCV infection (1365,1366), and 10%–20% ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0246", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 492, "preview": "over time \n(1334,1371–1373), condom use might not be necessary in \nsuch circumstances. Persons with HCV infection with one \nlong-term, steady sex partner do not need to change their \nsexual practices. However, they should discuss the risk for \ntransmission with their partner and discuss the need for \ntesting (234) (https://www.cdc.gov/hepatitis/hcv/index.htm). \nHeterosexual persons and MSM with HC..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0247", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "other chronic \ndiseases and HCV transmission. No vaccine for hepatitis C is \navailable, and prophylaxis with IG is not effective in preventing \nHCV infection after exposure. PEP using direct-acting \nantivirals is not recommended.\nPersons with HCV infection should be provided information \nabout how to protect their liver from further harm (i.e., \nhepatotoxic agents); for instance, persons with HCV ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0248", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 524, "preview": "nths because anti-HCV \nfrom the mother might last until that age. If diagnosis is desired \nbefore the child reaches age 18 months, testing for HCV \nRNA can be performed at or after the infant’s first well-child \nvisit at age 1–2 months. HCV RNA testing can be repeated \nat a subsequent visit, independent of the initial HCV RNA \ntest result (1376) (https://www.cdc.gov/hepatitis/hcv/hcvfaq.\nhtm#secti..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0249", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "d be limited to HCV RNA testing only. Indirect testing \n(e.g., alanine aminotransferase [ALT]) is not recommended \nfor detecting incident HCV infections because such testing, \nespecially if performed once a year, can miss persons who have \nreverted after acute HCV infection to a normal ALT level at \nthe time of testing ( 239) ( https://www.hcvguidelines.org ). \nConversely, ALT can be elevated by a..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0250", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 517, "preview": "ion of enteric pathogens include oral-anal contact or, \nin certain instances, direct genital-anal contact. G. lamblia is the \nmost frequently implicated parasite, and bacterial pathogens \ninclude Shigella species, Salmonella, E. coli, Campylobacter \nspecies, and Cryptosporidium. Outbreaks of Shigella species, \nCampylobacter, Cryptosporidium, and microsporidiosis have \nbeen reported among MSM (259,..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0251", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "ailable in time for clinical decision-making. However, if \navailable, molecular PCR testing for C. trachomatis serovars \nL1, L2, or L3 can be considered for confirming LGV (553).\nThe pathogenic role of M. genitalium in proctitis is unclear. \nFor persons with persistent symptoms after standard treatment, \nproviders should consider testing for M. genitalium with NAAT \nand treat if positive (see Myco..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0252", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 398, "preview": "riers, and washing hands after \nhanding materials that have been in contact with the anal \narea (i.e., barriers and sex toys) and after touching the anus \nor rectal area.\nFollow-Up\nFollow-up should be based on specific etiology and severity \nof clinical symptoms. For proctitis associated with gonorrhea \nor chlamydia, retesting for the respective pathogen should be \nperformed 3 months after treatme..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0253", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1141, "preview": "thogens; however, partners should seek \ncare if symptomatic.\nSpecial Considerations\nDrug Allergy, Intolerance, and Adverse Reactions\nAllergic reactions with third-generation cephalosporins (e.g., \nceftriaxone) are uncommon among persons with a history of \npenicillin allergy (620,631,658,896).\nHIV Infection \nPersons with HIV infection and acute proctitis might present \nwith bloody discharge, painfu..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0254", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 329, "preview": "d clothing decontaminated, and \nreevaluation performed to rule out persistent infection.\nSpecial Considerations\nPregnancy\nExisting data from human participants demonstrate that \npregnant and lactating women should be treated with either \npermethrin or pyrethrin with piperonyl butoxide. Because no \nteratogenicity or toxicity attributable to ivermectin has been \nobserved during human pregnancy exper..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0255", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "d by the mite Sarcoptes \nscabiei, which causes pruritus. Sensitization to S. scabiei occurs \nbefore pruritus begins. The first time a person is infested with \nS. scabiei , sensitization takes weeks to develop. However, \npruritus might occur <24 hours after a subsequent reinfestation. \nScabies among adults frequently is sexually acquired, although \nscabies among children usually is not (1400–1402)...."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0256", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 539, "preview": "opical \nglucocorticoids, organ transplant recipients, persons with \nHIV infection or human T-lymphotropic virus-1 infection, \nand persons with hematologic malignancies. Crusted scabies \nis transmitted more easily than scabies (1418). No controlled \ntherapeutic studies for crusted scabies have been conducted, \nand a recommended treatment remains unclear. Substantial \ntreatment failure might occur w..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0257", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "to reinfection by family \nmembers or fomites. Finally, other household mites can cause \nsymptoms to persist as a result of cross-reactivity between \nantigens. Even when treatment is successful, reinfection is \navoided, and cross-reactivity does not occur, symptoms can \npersist or worsen as a result of allergic dermatitis.\nRetreatment 2 weeks after the initial treatment regimen can \nbe considered f..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0258", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 445, "preview": "this \nreason. Although collection of specimens at initial examination \nfor laboratory STI diagnosis gives the survivor and clinician \nthe option of deferring empiric prophylactic antimicrobial \ntreatment, compliance with follow-up visits is typically poor \n(1423–1425). Among sexually active adults, identification \nof an STI might represent an infection acquired before the \nassault, and therefore m..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0259", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "ly assaulted \nalso are at risk for acquiring HPV infection, and the efficacy \nof the HPV vaccine is high (1426,1427), HPV vaccination is \nalso recommended for females and males through age 26 years \n(https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/\nhpv.html) (11). Reproductive-aged female survivors should be \nevaluated for pregnancy and offered emergency contraception.\nEvaluating Adolesce..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0260", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 399, "preview": "IM in a single dose\nplus\nDoxycycline 100 mg 2 times/day orally for 7 days\n* For persons weighing ≥150 kg, 1 g of ceftriaxone should be administered.\nClinicians should counsel persons regarding the possible \nbenefits and toxicities associated with these treatment regimens; \ngastrointestinal side effects can occur with this combination. \nThe efficacy of these regimens in preventing infections after ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0261", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "pportunity to detect new infections \nacquired during or after the assault, complete hepatitis B \nand HPV vaccinations, if indicated, complete counseling \nand treatment for other STIs, and monitor side effects and \nadherence to PEP , if prescribed. If initial testing was performed, \nfollow-up evaluation should be conducted in <1 week to ensure \nthat results of positive tests can be discussed prompt..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0262", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 650, "preview": "ivor should be based on whether vaginal \nor anal penetration occurred; whether ejaculation occurred on \nmucous membranes; whether multiple assailants were involved; \nwhether mucosal lesions were present in the assailant or \nsurvivor; and any other characteristics of the assault, survivor, \nor assailant that might increase risk for HIV transmission.\nIf PEP is offered, the following information shou..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0263", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 861, "preview": "itional counseling and \nsupport, provide indicated vaccines not administered at the \ninitial evaluation, assess medication side effects and adherence, \nor provide an altered PEP medication regimen if indicated by \nside effects or laboratory test results.\nRecommendations for Postexposure HIV Risk \nAssessment of Adolescents and Adults <72 Hours \nAfter Sexual Assault\nHealth care providers should do t..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0264", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1125, "preview": "EP , and provide referrals to \na PrEP provider.\nAssistance with PEP-related decisions can be obtained by \ncalling the National Clinician’s Post Exposure Prophylaxis \nHotline (PEP Line) (telephone: 888-448-4911).\nSexual Assault or Abuse of Children\nThese guidelines are limited to the identification and \ntreatment of STIs in prepubertal children. Management of \nthe psychosocial or legal aspects of t..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0265", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 542, "preview": "ildren who received \na diagnosis of one STI should be screened for other STIs. \nHistory and reported type of sexual contact might not be a \nreliable indicator, and urogenital, pharyngeal, and rectal testing \nshould be considered for preverbal children and children who \ncannot verbalize details of the assault (1438,1449). Factors that \nshould lead the physician to consider testing for STIs include ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0266", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "5–31.\n * If unlikely to have been perinatally acquired and vertical transmission, which is rare, is excluded.\n † Reports should be made to the local or state agency mandated to receive reports of suspected child abuse or neglect.\n § If unlikely to have been acquired perinatally or through transfusion.\n ¶ Unless a clear history of aut oinoculation exists.\n ** Report if evidence exists to suspect ab..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0267", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 592, "preview": "a \nmeatal specimen discharge is an adequate substitute for \nan intraurethral swab specimen. Culture or NAAT can be \nused to test for N. gonorrhoeae and C. trachomatis. \nAlthough data regarding NAAT for children are more \nlimited and performance is test dependent ( 553), no \nevidence demonstrates that performance of NAAT for \ndetection of N. gonorrhoeae or C. trachomatis among \nchildren differs fro..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0268", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "ing the original specimen or \nobtaining another. Because of the overall low prevalence \nof N. gonorrhoeae and C. trachomatis among children, \nfalse-positive results can occur, and all specimens that are \ninitially positive should be confirmed.\n• T esting for T . vaginalis should not be limited to girls with \nvaginal discharge if other indications for vaginal testing \nexist because evidence indicat..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0269", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 486, "preview": "nfections were identified at the initial examination \nafter the last suspected sexual exposure, and if this exposure \nwas recent, a follow-up evaluation approximately 2 weeks \nafter the last exposure can be considered. Likewise, if no \nphysical examination or diagnostic testing was performed \nat the initial visit, a complete examination can be scheduled \napproximately 2 weeks after the last exposu..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0270", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "case-by-case basis depending on the likelihood \nof infection in the assailant ( 1448,1454). Although data are \ninsufficient concerning the efficacy of PEP among children, \ntreatment is well tolerated by infants and children with and \nwithout HIV , and children have a minimal risk for serious \nadverse reactions because of the short period recommended \nfor prophylaxis (1455).\nRecommendations for Pos..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0271", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 812, "preview": "ject RESPECT Study \nGroup. Efficacy of risk-reduction counseling to prevent human \nimmunodeficiency virus and sexually transmitted diseases: a randomized \ncontrolled trial. JAMA 1998;280:1161–7. PMID:9777816 https://doi.\norg/10.1001/jama.280.13.1161\n 6. Metsch LR, Feaster DJ, Gooden L, et al. Effect of risk-reduction \ncounseling with rapid HIV testing on risk of acquiring sexually \ntransmitted inf..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0272", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "002/14651858.CD003255\n 15. Giannou FK, Tsiara CG, Nikolopoulos GK, et al. Condom effectiveness \nin reducing heterosexual HIV transmission: a systematic review and \nmeta-analysis of studies on HIV serodiscordant couples. Expert Rev \nPharmacoecon Outcomes Res 2016;16:489–99. PMID:26488070 \nhttps://doi.org/10.1586/14737167.2016.1102635\n 16. Smith DK, Herbst JH, Zhang X, Rose CE. Condom effectiveness ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0273", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1087, "preview": "2012.668285\n 30. Steiner MJ, Cates W Jr, Warner L. The real problem with male condoms \nis nonuse. Sex T ransm Dis 1999;26:459–62. PMID:10494937 https://\ndoi.org/10.1097/00007435-199909000-00007\n 31. Kowal D, Hatcher RA, Nelson AL, et al., eds. Contraceptive technology. \n21st ed. Atlanta, GA: Managing Contraception; 2017.\n 32. Gallo MF, Kilbourne-Brook M, Coffey PS. A review of the effectiveness \na..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0274", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1136, "preview": "gel (C31G) for \nprevention of HIV infection: a randomized controlled trial in Nigeria. \nPLoS One 2008;3:e1474. PMID:18213382 https://doi.org/10.1371/\njournal.pone.0001474\n 45. Cottrell ML, Kashuba AD. T opical microbicides and HIV prevention \nin the female genital tract. J Clin Pharmacol 2014 ;54:603–15. \nPMID:24664786 https://doi.org/10.1002/jcph.292\n 46. Abdool Karim SS, Abdool Karim Q, Kharsany..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0275", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "4). PMID:27467319 https://doi.org/10.15585/mmwr.\nrr6504a1\n 60. Cleland K, Zhu H, Goldstuck N, Cheng L, T russell J. The efficacy of\nintrauterine devices for emergency contraception: a systematic review\nof 35 years of experience. Hum Reprod 2012 ;27:1994 –2000 .\nPMID:22570193 https://doi.org/10.1093/humrep/des140\n 61. Shen J, Che Y, Showell E, Chen K, Cheng L. Interventions for emergency\ncontracept..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0276", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1135, "preview": "V prevention in men who have sex with men.\nN Engl J Med 2010;363:2587–99. PMID:21091279 https://doi.\norg/10.1056/NEJMoa1011205\n 76. Baeten JM, Donnell D, Ndase P, et al. ; Partners PrEP Study T eam.\nAntiretroviral prophylaxis for HIV prevention in heterosexual men and \nwomen. N Engl J Med 2012;367:399–410. PMID:22784037 https://\ndoi.org/10.1056/NEJMoa1108524\n 77. Thigpen MC, Kebaabetswe PM, Paxton..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0277", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "ect \nof aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive \nwomen and men who have sex with men: a randomised, double-blind, \nplacebo-controlled trial. Lancet 2008;371:2109–19. PMID:18572080 \nhttps://doi.org/10.1016/S0140-6736(08)60920-4\n 90. Bolan RK, Beymer MR, Weiss RE, Flynn RP, Leibowitz AA, Klausner \nJD. Doxycycline prophylaxis to reduce incident syphilis among HIV-\ninfect..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0278", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 199, "preview": ";39:191–4. \nPMID:22337105 https://doi.org/10.1097/OLQ.0b013e3182401a2f\n 103. Hotton AL, Gratzer B, Mehta SD. Association between serosorting \nand bacterial sexually transmitted infection among HIV-negative men \nwho have sex with men at an urban lesbian, gay, bisexual, and \ntransgender health center. Sex T ransm Dis 2012 ;39:959 –64. \nPMID:23191950 https://doi.org/10.1097/OLQ.0b013e31826e870d\n 104...."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0279", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1043, "preview": "and reproductive tract infection treatment among female sexually \ntransmitted infection clinic patients. Sex T ransm Dis 2013;40:105–10. \nPMID:23321990 https://doi.org/10.1097/OLQ.0b013e31827938a1\nRecommendations and Reports\nMMWR / July 23, 2021 / Vol. 70 / No. 4 139\nUS Department of Health and Human Services/Centers for Disease Control and Prevention\n 105. Golden MR, Hogben M, Handsfield HH, St L..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0280", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1122, "preview": "partner therapy program in an urban \nclinic. Sex T ransm Dis 2012;39:923–9. PMID:23169171 https://doi.\norg/10.1097/OLQ.0b013e3182756f20\n 118. Kachur R, Strona FV, Kinsey J, Collins D. Introducing technology \ninto partner services: a toolkit for programs. Atlanta, GA: US \nDepartment of Health and Human Services, CDC; 2015. https://www.\ncdc.gov/std/program/ips/ips-toolkit-12-28-2015.pdf\n 119. Kachur..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0281", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1150, "preview": "th \nmen. Sex T ransm Dis 2011;38:941–6. PMID:21934569 https://doi.\norg/10.1097/OLQ.0b013e318223fcbc\n 133. Stekler J, Bachmann L, Brotman RM, et al. Concurrent sexually \ntransmitted infections (STIs) in sex partners of patients with selected \nSTIs: implications for patient-delivered partner therapy. Clin Infect \nDis 2005 ; 40 : 787 – 93 . PMID:15736009 https://doi.\norg/10.1086/428043\n 134. McNulty ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0282", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1114, "preview": "da, 2013–2014. Sex T ransm Dis 2017;44:498–502. \nPMID:28703731 https://doi.org/10.1097/OLQ.0000000000000638\n 147. Albright CM, Emerson JB, Werner EF, Hughes BL. Third-trimester \nprenatal syphilis screening: a cost-effectiveness analysis. Obstet Gynecol \n2015; 126:479–85. PMID:26244531 https://doi.org/10.1097/\nAOG.0000000000000997\n 148. Owens DK, Davidson KW, Krist AH, et al.; US Preventive Service..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0283", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1134, "preview": "Obstetrics and Gynecology; 2017.\n 161. Curry SJ, Krist AH, Owens DK, et al.; US Preventive Services Task \nForce. Screening for syphilis infection in pregnant women: US \nPreventive Services Task Force reaffirmation recommendation \nstatement. JAMA 2018;320:911–7. PMID:30193283 https://doi.\norg/10.1001/jama.2018.11785\n 162. Bibbins-Domingo K, Grossman DC, Curry SJ, et al.; US Preventive \nServices Tas..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0284", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1067, "preview": "27 :e1–20. PMID:26695583 https://doi.org/10.1097/\nAOG.0000000000001263\n 176. Benard VB, Watson M, Castle PE, Saraiya M. Cervical carcinoma rates \namong young females in the United States. Obstet Gynecol \n2012 ;120:1117 –23. PMID:23090530 https://doi.org/10.1097/\nAOG.0b013e31826e4609\n 177. Fontham ETH, Wolf AMD, Church TR, et al. Cervical cancer screening \nfor individuals at average risk: 2020 guid..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0285", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1139, "preview": "the Gonococcal Isolate Surveillance Project, 2005–2010. Ann \nIntern Med 2013 ;158 :321 –8. PMID:23460055 https://doi.\norg/10.7326/0003-4819-158-5-201303050-00004\n 190. Newman LM, Dowell D, Bernstein K, et al. A tale of two gonorrhea \nepidemics: results from the STD Surveillance Network. Public Health \nRep 2012; 127: 282– 92. PMID:22547859 https://doi.\norg/10.1177/003335491212700308\n 191. Hess KL, ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0286", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1083, "preview": "c review and meta-analysis. Clin Infect Dis 2018;67:676–86. \nPMID:29509889 https://doi.org/10.1093/cid/ciy182\n 205. Jenness SM, Weiss KM, Goodreau SM, et al. Incidence of gonorrhea \nand chlamydia following human immunodeficiency virus preexposure \nprophylaxis among men who have sex with men: a modeling study. \nClin Infect Dis 2017; 65:712– 8. PMID:28505240 https://doi.\norg/10.1093/cid/cix439\n 206...."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0287", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "e \nand acceptability of self-collected rectal swabs for diagnosis of \nChlamydia trachomatis and Neisseria gonorrhoeae in men who have sex \nwith men and women. Sex T ransm Dis 2009;36:493–7. PMID:19617869 \nhttps://doi.org/10.1097/OLQ.0b013e3181a44b8c\n 218. Alexander S, Ison C, Parry J, et al.; Brighton Home Sampling Kits \nSteering Group. Self-taken pharyngeal and rectal swabs are appropriate \nfor t..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0288", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "cMillan A, Young H, Moyes A. Rectal gonorrhoea in homosexual \nmen: source of infection. Int J STD AIDS 2000 ;11: 284 –7. \nPMID:10824935 https://doi.org/10.1177/095646240001100502\n 231. Chow EP, Cornelisse VJ, Read TR, Chen MY, Bradshaw CS, Fairley \nCK. Saliva use in sex: associations with use of smartphone dating \napplications in men who have sex with men. Int J STD AIDS \n2018 ; 29 : 362 – 6 . PMI..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0289", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 183, "preview": "y transmitted infections \namong a cross-sectional sample of men who have sex with men in Los \nAngeles County. Sex T ransm Infect 2014;90:567–72. PMID:24926041 \nhttps://doi.org/10.1136/sextrans-2013-051494\n 246. Medina MM, Crowley C, Montgomery MC, et al. Disclosure of HIV \nserostatus and pre-exposure prophylaxis use on internet hookup sites \namong men who have sex with men. AIDS Behav 2019;23:1681..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0290", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1022, "preview": "2013: a call for public health action. Public Health Rep 2016;131:264–71. \nPMID:26957661 https://doi.org/10.1177/003335491613100210\nRecommendations and Reports\n144 MMWR / July 23, 2021 / Vol. 70 / No. 4\nUS Department of Health and Human Services/Centers for Disease Control and Prevention\n 248. Lampkin D, Crawley A, Lopez TP, Mejia CM, Yuen W, Levy V. \nReaching suburban men who have sex with men fo..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0291", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1094, "preview": "o. Jpn J Infect Dis 2012;65:277–8. \nPMID:22627317 https://doi.org/10.7883/yoken.65.277\n 261. Wilmer A, Romney MG, Gustafson R, et al. Shigella flexneri serotype \n1 infections in men who have sex with men in Vancouver, Canada. \nHIV Med 2015;16:168–75. PMID:25656740 https://doi.org/10.1111/\nhiv.12191\n 262. CDC. Shigella sonnei outbreak among men who have sex with men—\nSan Francisco, California, 2000..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0292", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1134, "preview": "T ransm \nDis 2011;38:1118–25. PMID:22082722 https://doi.org/10.1097/\nOLQ.0b013e31822e6179\n 276. Eisenberg M. Differences in sexual risk behaviors between college \nstudents with same-sex and opposite-sex experience: results from a \nnational survey. Arch Sex Behav 2001;30:575–89. PMID:11725456 \nhttps://doi.org/10.1023/A:1011958816438\n 277. Koh AS, Gómez CA, Shade S, Rowley E. Sexual risk factors amo..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0293", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1080, "preview": "tps://doi.org/10.2105/AJPH.2013.301733\n 290. Brenick A, Romano K, Kegler C, Eaton LA. Understanding the \ninfluence of stigma and medical mistrust on engagement in routine \nhealthcare among Black women who have sex with women. LGBT \nHealth 2017;4:4–10. PMID:28113005 https://doi.org/10.1089/\nlgbt.2016.0083\n 291. Fethers K, Marks C, Mindel A, Estcourt CS. Sexually transmitted \ninfections and risk beh..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0294", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "5. PMID:14646636 https://doi.org/10.1097/01.\nOLQ.0000091151.52656.E5\n 306. Muzny CA, Schwebke JR. The clinical spectrum of Trichomonas \nvaginalis infection and challenges to management. Sex T ransm Infect \n2013 ;89 :423 –5. PMID:23543252 https://doi.org/10.1136/\nsextrans-2012-050893\n 307. Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR. Added \nbenefit of nucleic acid amplification testin..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0295", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "320. Bradshaw CS, Vodstrcil LA, Hocking JS, et al. Recurrence of bacterial \nvaginosis is significantly associated with posttreatment sexual activities \nand hormonal contraceptive use. Clin Infect Dis 2013;56:777–86. \nPMID:23243173 https://doi.org/10.1093/cid/cis1030\n 321. Marrazzo JM, Thomas KK, Fiedler TL, Ringwood K, Fredricks DN. \nRisks for acquisition of bacterial vaginosis among women who rep..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0296", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 158, "preview": "577 https://doi.\norg/10.1371/journal.pone.0107104\n 336. Cahill SR, Baker K, Deutsch MB, Keatley J, Makadon HJ. Inclusion \nof sexual orientation and gender identity in Stage 3 Meaningful Use \nGuidelines: a huge step forward for LGBT health . LGBT Health \n2016 ;3:100– 2. PMID:26698386 https://doi.org/10.1089/\nlgbt.2015.0136\n 337. T ordoff DM, Morgan J, Dombrowski JC, Golden MR, Barbee LA. \nIncreased..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0297", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1008, "preview": "org/10.1097/OLQ.0000000000000952\nRecommendations and Reports\nMMWR / July 23, 2021 / Vol. 70 / No. 4 147\nUS Department of Health and Human Services/Centers for Disease Control and Prevention\n 338. Grant JM, Mottet LA, Tanis J. National transgender discrimination \nsurvey report on health and health care. Washington, DC: National \nCenter for T ransgender Equality and the National Gay and Lesbian \nTas..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0298", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1116, "preview": "nd human \nimmunodeficiency virus infection among transgender women and \ntransgender men attending clinics that provide sexually transmitted \ndisease services in six US cities: results from the Sexually T ransmitted \nDisease Surveillance Network. Sex T ransm Dis 2019;46:112–7. \nPMID:30278030 https://doi.org/10.1097/OLQ.0000000000000917\n 350. James S, Herman JL, Rankin S, Keisling M, Mottet L, Anafi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0299", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "Wkly Rep 2017 ;66 :883 –7. \nPMID:28837547 https://doi.org/10.15585/mmwr.mm6633a3\n 366. Reisner SL, Perkovich B, Mimiaga MJ. A mixed methods study of the \nsexual health needs of New England transmen who have sex with \nnontransgender men. AIDS Patient Care STDS 2010;24:501–13. \nPMID:20666586 https://doi.org/10.1089/apc.2010.0059\n 367. Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine \ntreatm..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0300", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "summary \nof evidence reviewed for the 2010 Centers for Disease Control and \nPrevention Sexually T ransmitted Diseases T reatment Guidelines. Sex \nT ransm Dis 2013; 40: 679– 84. PMID:23945422 https://doi.\norg/10.1097/01.olq.0000431353.88464.ab\n 380. CDC. Male chlamydia screening consultation, March 28–29, 2006, \nmeeting report. Atlanta, GA: US Department of Health and Human \nServices, CDC; 2007. ht..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0301", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 164, "preview": "c Health 2005;95:1781–7. PMID:16186455 \nhttps://doi.org/10.2105/AJPH.2004.052498\n 395. Brinkley-Rubinstein L, Peterson M, Arnold T, et al. Knowledge, interest, \nand anticipated barriers of pre-exposure prophylaxis uptake and \nadherence among gay, bisexual, and men who have sex with men who \nare incarcerated. PLoS One 2018;13:e0205593. PMID:30532275 \nhttps://doi.org/10.1371/journal.pone.0205593\n 39..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0302", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1005, "preview": "PMID:29516265 https://doi.org/10.1007/s11904-018-0389-9\nRecommendations and Reports\nMMWR / July 23, 2021 / Vol. 70 / No. 4 149\nUS Department of Health and Human Services/Centers for Disease Control and Prevention\n 397. Morrow KM; Project START Study Group. HIV , STD, and hepatitis \nrisk behaviors of young men before and after incarceration. AIDS Care \n2009 ; 21: 235 – 43. PMID:19229694 https://doi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0303", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1137, "preview": "N, Camacho M, et al. Signs or symptoms of acute \nHIV infection in a cohort undergoing community-based screening. \nEmerg Infect Dis 2016;22:532–4. PMID:26890854 https://doi.\norg/10.3201/eid2203.151607\n 410. Legarth RA, Ahlström MG, Kronborg G, et al. Long-term mortality \nin HIV-infected individuals 50 years or older: a nationwide, population-\nbased cohort study. J Acquir Immune Defic Syndr 2016;71:..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0304", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "ica . Primary care guidelines \nfor the management of persons infected with HIV: 2013 update by \nthe HIV medicine association of the Infectious Diseases Society of \nAmerica. Clin Infect Dis 2014;58:e1–34. PMID:24235263 https://\ndoi.org/10.1093/cid/cit665\n 426. DiCarlo RP, Martin DH. The clinical diagnosis of genital ulcer disease \nin men. Clin Infect Dis 1997;25:292–8. PMID:9332527 https://doi.\norg..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0305", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "tps://doi.org/10.1097/QAD.0000000000000646\n 442. Sam SS, Caliendo AM, Ingersoll J, Abdul-Ali D, Kraft CS. Performance \nevaluation of the Aptima HSV-1 and 2 assay for the detection of HSV \nin cutaneous and mucocutaneous lesion specimens. J Clin Virol \n2018 ;99-100 :1–4. PMID:29253834 https://doi.org/10.1016/j.\njcv.2017.12.006\n 443. Wald A, Huang ML, Carrell D, Selke S, Corey L. Polymerase chain \nre..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0306", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "://doi.org/10.1097/01.olq.0000175377.88358.f3\n 456. Morrow RA, Friedrich D, Meier A, Corey L. Use of “biokit HSV-2 \nRapid Assay” to improve the positive predictive value of Focus \nHerpeSelect HSV-2 ELISA. BMC Infect Dis 2005 ;5:84. \nPMID:16225691 https://doi.org/10.1186/1471-2334-5-84\n 457. Ngo TD, Laeyendecker O, La H, Hogrefe W, Morrow RA, Quinn TC. \nUse of commercial enzyme immunoassays to dete..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0307", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "famciclovir for the suppression of recurrent genital herpes: a randomized \ncontrolled trial. JAMA 1998;280:887–92. PMID:9739972 https://doi.\norg/10.1001/jama.280.10.887\n 470. Mertz GJ, Loveless MO, Levin MJ, et al.; Collaborative Famciclovir \nGenital Herpes Research Group. Oral famciclovir for suppression \nof recurrent genital herpes simplex virus infection in women. A \nmulticenter, double-blind, ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0308", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 175, "preview": "956 https://doi.org/10.1080/147670\n58.2018.1527311\n 485. Masadeh M, Shen H, Lee Y, et al. A fatal case of herpes simplex virus \nhepatitis in a pregnant patient. Intractable Rare Dis Res 2017;6:124–7. \nPMID:28580213 https://doi.org/10.5582/irdr.2017.01013\n 486. Martin ET, Krantz E, Gottlieb SL, et al. A pooled analysis of the \neffect of condoms in preventing HSV-2 acquisition. Arch Intern \nMed 2009..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0309", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1012, "preview": "Intern Med 2005 ;143 :707 –13. PMID:16287791 https://doi.\norg/10.7326/0003-4819-143-10-200511150-00007\nRecommendations and Reports\n152 MMWR / July 23, 2021 / Vol. 70 / No. 4\nUS Department of Health and Human Services/Centers for Disease Control and Prevention\n 488. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing \nthe transmission of herpes simplex virus type 2 from men to women..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0310", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "et al. Clinical \ncharacteristics of hypertrophic herpes simplex genitalis and treatment \noutcomes of imiquimod: a retrospective observational study. Int J Infect \nDis 2015;33:165–70. PMID:25660091 https://doi.org/10.1016/j.\nijid.2015.02.002\n 502. Keller MJ, Huber A, Espinoza L, et al. Impact of herpes simplex virus \ntype 2 and human immunodeficiency virus dual infection on female \ngenital tract mu..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0311", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 165, "preview": "7–52. PMID:1849612 https://\ndoi.org/10.1056/NEJM199105023241804\n 517. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of \nserologic status and cesarean delivery on transmission rates of herpes \nsimplex virus from mother to infant. JAMA 2003; 289: 203– 9. \nPMID:12517231 https://doi.org/10.1001/jama.289.2.203\n 518. Ahrens KA, Anderka MT, Feldkamp ML, Canfield MA, Mitchell AA, \nWerler MM..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0312", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1014, "preview": "2013;27:340–5. PMID:23772935 https://doi.org/10.1111/ppe.12064\nRecommendations and Reports\nMMWR / July 23, 2021 / Vol. 70 / No. 4 153\nUS Department of Health and Human Services/Centers for Disease Control and Prevention\n 519. Stone KM, Reiff-Eldridge R, White AD, et al. Pregnancy outcomes \nfollowing systemic prenatal acyclovir exposure: conclusions from the \ninternational acyclovir pregnancy regis..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0313", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1041, "preview": "ttps://doi.org/10.1258/ijsa.2012.012096\n 533. Pilani A, Vora R, Anjaneyan G. Granuloma inguinale \nmimicking as squamous cell carcinoma of penis. Indian J Sex \nT ransm Dis AIDS 2014;35:56–8. PMID:24958990 https://doi.\norg/10.4103/0253-7184.132433\n 534. Ramdial PK, Sing Y, Ramburan A, et al. Infantile donovanosis \npresenting as external auditory canal polyps: a diagnostic trap. Am J \nDermatopathol 2..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0314", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "org/10.3201/eid1903.121028\n 549. Riera-Monroig J, Fuertes de Vega I. Lymphogranuloma venereum \npresenting as an ulcer on the tongue. Sex T ransm Infect 2019;95:169–70. \nPMID:30554142 https://doi.org/10.1136/sextrans-2018-053787\n 550. Andrada MT, Dhar JK, Wilde H. Oral lymphogranuloma venereum \nand cervical lymphadenopathy. Case report. Mil Med 1974;139:99–101. \nPMID:4204816 https://doi.org/10.1093..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0315", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1105, "preview": "s coinfection: a cross-sectional clinic-based study. Sex \nT ransm Infect 2016 ;92:110– 5. PMID:26378262 https://doi.\norg/10.1136/sextrans-2015-052219\n 565. Theel ES, Katz SS, Pillay A. Molecular and direct detection tests for \nTreponema pallidum subspecies pallidum: a review of the literature, \n1964–2017. Clin Infect Dis 2020;71(Suppl 1):S4–12. PMID:32578865 \nhttps://doi.org/10.1093/cid/ciaa176\n 5..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0316", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "78 https://doi.org/10.1097/\nOLQ.0000000000000066\n 581. Li Z, Feng Z, Liu P, Yan C. Screening for antibodies against Treponema \npallidum with chemiluminescent microparticle immunoassay: analysis \nof discordant serology results and clinical characterization. Ann Clin \nBiochem 2016 ;53 :588 –92 . PMID:26680646 https://doi.\norg/10.1177/0004563215623806\n 582. Yen-Lieberman B, Daniel J, Means C, Waletzk..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0317", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1084, "preview": "s://\ndoi.org/10.1093/cid/cir671\n 596. Zhang RL, Wang QQ, Zhang JP, Yang LJ. Molecular subtyping of \nTreponema pallidum and associated factors of serofast status in early \nsyphilis patients: identified novel genotype and cytokine marker. PLoS \nOne 2017;12:e0175477. PMID:28410389 https://doi.org/10.1371/\njournal.pone.0175477\n 597. Seña AC, Zhang XH, Li T, et al. A systematic review of syphilis \nsero..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0318", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "and old people. Br J Vener Dis \n1980 ;56: 355 –62 . PMID:7448577 https://doi.org/10.1136/\nsti.56.6.355\n 611. Hagdrup HK, Lange Wantzin G, Secher L, Rosdahl VT. Penicillin \nconcentrations in serum following weekly injections of benzathine \npenicillin G. Chemotherapy 1986;32:99–101. PMID:3698728 https://\ndoi.org/10.1159/000238397\n 612. Frentz G, Nielsen PB, Espersen F, Czartoryski A, Aastrup H. Peni..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0319", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1119, "preview": "creening for asymptomatic neurosyphilis in HIV patients after \ntreatment of early syphilis: an observational study. Sex T ransm \nInfect 2018;94:337–9. PMID:28196838 https://doi.org/10.1136/\nsextrans-2016-052938\n 627. Yang CJ, Chang SY, Hung CC. Sensitivity and specificity of lumbar \npuncture in HIV-infected patients with syphilis and no neurologic \nsymptoms. Clin Infect Dis 2009;49:162–3, author r..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0320", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "Maternal and \ncongenital syphilis in Shanghai, China, 2002 to 2006. Int J Infect Dis \n2010;14(Suppl 3):e45–8. PMID:20137991 https://doi.org/10.1016/j.\nijid.2009.09.009\n 643. Hawkes S, Matin N, Broutet N, Low N. Effectiveness of interventions \nto improve screening for syphilis in pregnancy: a systematic review and \nmeta-analysis. Lancet Infect Dis 2011;11:684–91. PMID:21683653 \nhttps://doi.org/10.1..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0321", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1089, "preview": "3 https://doi.org/10.1001/\njama.1993.03510200062033\n 660. Macy E, Ngor EW. Safely diagnosing clinically significant penicillin \nallergy using only penicilloyl-poly-lysine, penicillin, and oral \namoxicillin. J Allergy Clin Immunol Pract 2013 ;1:258– 63. \nPMID:24565482 https://doi.org/10.1016/j.jaip.2013.02.002\n 661. Jares EJ, Sánchez-Borges M, Cardona-Villa R, et al.; Latin America \nDrug Allergy In..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0322", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "675. Pham MN, Ho HE, Desai M. Penicillin desensitization: treatment of \nsyphilis in pregnancy in penicillin-allergic patients. Ann Allergy Asthma \nImmunol 2017 ;118 :537 –41 . PMID:28477786 https://doi.\norg/10.1016/j.anai.2017.03.013\n 676. Sogn DD, Evans R 3rd, Shepherd GM, et al. Results of the National \nInstitute of Allergy and Infectious Diseases Collaborative Clinical T rial \nto test the predi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0323", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1059, "preview": "persensitivity. J Cyst Fibros 2009 ;8:418–24. \nPMID:19740711 https://doi.org/10.1016/j.jcf.2009.08.002\n 691. Manhart LE, Holmes KK, Hughes JP, Houston LS, T otten PA. \nMycoplasma genitalium among young adults in the United States: an \nemerging sexually transmitted infection. Am J Public Health \n2007; 97:1118– 25. PMID:17463380 https://doi.org/10.2105/\nAJPH.2005.074062\n 692. Ross JDC, Jensen JS. My..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0324", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "y-confirmed urethritis in a routine genitourinary medicine \nsetting. Int J STD AIDS 2016;27:861–7. PMID:26378187 https://\ndoi.org/10.1177/0956462415597620\n 705. Li Y, Su X, Le W, et al. Mycoplasma genitalium in symptomatic male \nurethritis: macrolide use is associated with increased resistance. \nClin Infect Dis 2020;70:805–10. PMID:30972419 https://doi.\norg/10.1093/cid/ciz294\n 706. Ito S, Hanaoka ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0325", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1124, "preview": "ted? T wo case \nreports. New Microbiol 2014;37:109–12. PMID:24531179\n 719. You C, Hamasuna R, Ogawa M, et al. The first report: an analysis of \nbacterial flora of the first voided urine specimens of patients with male \nurethritis using the 16S ribosomal RNA gene-based clone library \nmethod. Microb Pathog 2016;95:95–100. PMID:27013259 https://\ndoi.org/10.1016/j.micpath.2016.02.022\n 720. Deguchi T, ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0326", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1133, "preview": "89–94. \nPMID:26658669 https://doi.org/10.2340/00015555-2314\n 734. Chambers LC, Morgan JL, Lowens MS, et al. Cross-sectional study of \nurethral exposures at last sexual episode associated with non-gonococcal \nurethritis among STD clinic patients. Sex T ransm Infect 2019;95:212–8. \nPMID:30181326 https://doi.org/10.1136/sextrans-2018-053634\n 735. Manhart LE, Khosropour CM, Liu C, et al. Bacterial vag..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0327", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1114, "preview": "zi SN, Law M, et al. Azithromycin versus doxycycline \nfor the treatment of genital chlamydia infection: a meta-analysis of \nrandomized controlled trials. Clin Infect Dis 2014;59:193–205. \nPMID:24729507 https://doi.org/10.1093/cid/ciu220\n 749. Páez-Canro C, Alzate JP, González LM, Rubio-Romero JA, Lethaby \nA, Gaitán HG. Antibiotics for treating urogenital Chlamydia trachomatis \ninfection in men and..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0328", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1150, "preview": "nagement of women with cervicitis. \nClin Infect Dis 2007;44(Suppl 3):S102–10. PMID:17342663 https://\ndoi.org/10.1086/511423\n 764. Manavi K, Young H, Clutterbuck D. Sensitivity of microscopy for the \nrapid diagnosis of gonorrhoea in men and women and the role of \ngonorrhoea serovars. Int J STD AIDS 2003;14:390–4. PMID:12816666 \nhttps://doi.org/10.1258/095646203765371277\n 765. Lillis RA, Martin DH, ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0329", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "shedding in the female upper and lower genital tracts. AIDS \n2007 ;21 :755 –9. PMID:17413697 https://doi.org/10.1097/\nQAD.0b013e328012b838\n 780. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 \nshedding in the genital tract: a systematic review and meta-analysis. \nSex T ransm Dis 2008;35:946–59. PMID:18685546 https://doi.\norg/10.1097/OLQ.0b013e3181812d15\n 781. McClelland RS, ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0330", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "PMID:12438900 https://doi.\norg/10.1097/00007435-200211000-00006\n 794. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are \nthe specimens of choice when screening for Chlamydia trachomatis \nand Neisseria gonorrhoeae: results from a multicenter evaluation \nof the APTIMA assays for both infections. Sex T ransm Dis \n2005 ;32:725– 8. PMID:16314767 https://doi.org/10.1097/01.\nolq.0000190092.5..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0331", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1104, "preview": "Bristow CC, Joseph Davey D, Klausner JD. A \nsystematic review of point of care testing for Chlamydia trachomatis, \nNeisseria gonorrhoeae , and Trichomonas vaginalis. Infect Dis Obstet \nGynecol 2016;2016:4386127. Epub May 26, 2016. PMID:27313440 \nhttps://doi.org/10.1155/2016/4386127\n 808. Rivard KR, Dumkow LE, Draper HM, Brandt KL, Whalen DW, \nEgwuatu NE. Impact of rapid diagnostic testing for chla..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0332", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1144, "preview": ".1097/\nOLQ.0b013e31817247b2\n 821. Kjaer HO, Dimcevski G, Hoff G, Olesen F, Ostergaard L. Recurrence of \nurogenital Chlamydia trachomatis infection evaluated by mailed samples \nobtained at home: 24 weeks’ prospective follow up study. Sex T ransm \nInfect 2000;76:169–72. PMID:10961191 https://doi.org/10.1136/\nsti.76.3.169\n 822. Whittington WL, Kent C, Kissinger P, et al. Determinants \nof persistent a..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0333", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1098, "preview": "395–401. PMID:7163029 https://doi.\norg/10.1097/00006454-198211000-00007\n 836. Beem MO, Saxon E, Tipple MA. T reatment of chlamydial pneumonia \nof infancy. Pediatrics 1979;63:198–203. PMID:440807\n 837. Brownell AD, Shapiro RA, Hammerschlag MR. Caution is required \nwhen using non-Food and Drug Administration-cleared assays to \ndiagnose sexually transmitted infections in children. J Pediatr \n2019 ;20..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0334", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1141, "preview": "ID:17431378\n 851. CDC. Sexually transmitted disease surveillance 2013. Atlanta, GA: US \nDepartment of Health and Human Services, CDC; 2014. https://www.\ncdc.gov/std/stats/archive/Surv2013-Print.pdf\n 852. Muratani T, Akasaka S, Kobayashi T, et al. Outbreak of \ncefozopran (penicillin, oral cephems, and aztreonam)-resistant \nNeisseria gonorrhoeae in Japan. Antimicrob Agents Chemother \n2001 ;45:3603 –..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0335", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1093, "preview": "xone-resistant Neisseria gonorrhoeae \nin France: novel penA mosaic allele in a successful international clone \ncauses treatment failure. Antimicrob Agents Chemother 2012;56:1273–\n80. PMID:22155830 https://doi.org/10.1128/AAC.05760-11\n 868. CDC. Update to CDC’s sexually transmitted diseases treatment \nguidelines, 2010: oral cephalosporins no longer a recommended \ntreatment for gonococcal infections..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0336", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "in the gonorrhea mouse model. Antimicrob Agents Chemother \n2019;63:e01644-18 . PMID:30642924 https://doi.org/10.1128/\nAAC.01644-18\n 882. Blondeau JM, Hansen G, Metzler K, Hedlin P. The role of PK/PD \nparameters to avoid selection and increase of resistance: mutant \nprevention concentration. J Chemother 2004;16(Suppl 3 ):1–19. \nPMID:15334827 https://doi.org/10.1080/1120009X.2004.11782371\n 883. Mora..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0337", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1053, "preview": "á B, Nyčová E, Hercogová J, Unemo M. Gentamicin \n240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus \nazithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a \nrandomized controlled trial. Clin Microbiol Infect 2020;26:207–12. \nPMID:31419483 https://doi.org/10.1016/j.cmi.2019.08.004\n 896. Romano A, Gaeta F, Valluzzi RL, Caruso C, Rumi G, Bousquet PJ. \nIgE-mediated hypersensitivit..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0338", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1140, "preview": "R.00006-11\n 910. Seña AC, Lensing S, Rompalo A, et al. Chlamydia trachomatis, \nMycoplasma genitalium , and Trichomonas vaginalis infections in \nmen with nongonococcal urethritis: predictors and persistence after \ntherapy. J Infect Dis 2012;206:357–65. PMID:22615318 https://doi.\norg/10.1093/infdis/jis356\n 911. Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, Hobbs MM. \nMycoplasma genitalium det..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0339", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1069, "preview": "ti.79.2.154\n 925. Oakeshott P, Aghaizu A, Hay P, et al. Is Mycoplasma genitalium in \nwomen the “New Chlamydia?” A community-based prospective cohort \nstudy. Clin Infect Dis 2010;51:1160–6. PMID:20942656 https://doi.\norg/10.1086/656739\n 926. Wiesenfeld HC, Hillier SL, Meyn L, et al. Mycoplasma genitalium—is \nit a pathogen in acute pelvic inflammatory disease (PID)? Sex T ransm \nInfect 2013 ;89( Sup..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0340", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "rg Infect Dis 2019;25:719–27. PMID:30882306 https://doi.\norg/10.3201/eid2504.181258\n 940. Cina M, Baumann L, Egli-Gany D, et al. Mycoplasma genitalium \nincidence, persistence, concordance between partners and progression: \nsystematic review and meta-analysis. Sex T ransm Infect 2019;95:328–35. \nPMID:31055469 https://doi.org/10.1136/sextrans-2018-053823\n 941. Baumann L, Cina M, Egli-Gany D, et al. ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0341", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1105, "preview": "sistance and \nazithromycin failure in a Mycoplasma genitalium-infected cohort and \nresponse of azithromycin failures to alternative antibiotic regimens. \nClin Infect Dis 2015;60:1228–36. PMID:25537875 https://doi.\norg/10.1093/cid/ciu1162\n 955. Piñeiro L, Idigoras P, de la Caba I, López-Olaizola M, Cilla G. Guided \nantibiotic therapy for Mycoplasma genitalium infections: analysis of \nmutations asso..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0342", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1149, "preview": "roquinolone resistance-associated mutations in heterosexual African \nAmerican couples in Alabama. Sex T ransm Dis 2019;46:18–24. \nPMID:29979336 https://doi.org/10.1097/OLQ.0000000000000891\n 968. Slifirski JB, Vodstrcil LA, Fairley CK, et al. Mycoplasma genitalium \ninfection in adults reporting sexual contact with infected partners, \nAustralia, 2008–2016. Emerg Infect Dis 2017 ;23:1826 –33. \nPMID:2..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0343", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1021, "preview": "Combined oral \ncontraceptive pill-exposure alone does not reduce the risk of bacterial \nvaginosis recurrence in a pilot randomised controlled trial. Sci Rep \n2019; 9:3555. PMID:30837554 https://doi.org/10.1038/\ns41598-019-39879-8\n 984. Brooks JP, Edwards DJ, Blithe DL, et al. Effects of combined oral \ncontraceptives, depot medroxyprogesterone acetate and the \nlevonorgestrel-releasing intrauterine ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0344", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": ", male urethra, and vaginas of heterosexual couples with and \nwithout bacterial vaginosis. Microbiome 2016;4:16. PMID:27090518 \nhttps://doi.org/10.1186/s40168-016-0161-6\n 997. Liu CM, Hungate BA, T obian AA, et al. Penile microbiota and female \npartner bacterial vaginosis in Rakai, Uganda. MBio 2015;6:e00589. \nPMID:26081632 https://doi.org/10.1128/mBio.00589-15\n 998. Mehta SD. Systematic review of..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0345", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1079, "preview": "nt \nof bacterial vaginosis: a randomized controlled trial. Obstet Gynecol \n2017 ;130: 379– 86. PMID:28697102 https://doi.org/10.1097/\nAOG.0000000000002135\n1013. Schwebke JR, Morgan FG Jr, Koltun W, Nyirjesy P. A phase-3, \ndouble-blind, placebo-controlled study of the effectiveness and safety \nof single oral doses of secnidazole 2 g for the treatment of women \nwith bacterial vaginosis. Am J Obstet ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0346", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1138, "preview": "-05 in women with bacterial vaginosis. \nSex T ransm Dis 2010;37:745–50. PMID:20644497 https://doi.\norg/10.1097/OLQ.0b013e3181e50026\n1026\n. Bunge KE, Beigi RH, Meyn LA, Hillier SL. The efficacy of retreatment \nwith the same medication for early treatment failure of bacterial \nvaginosis. Sex T ransm Dis 2009;36:711–3. PMID:19652628 https://\ndoi.org/10.1097/OLQ.0b013e3181af6cfd\n1027\n. Aguin T, Akins ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0347", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1066, "preview": "adu A, Reid F, Hay P, Manyonda I. Natural history of bacterial \nvaginosis and intermediate flora in pregnancy and effect of oral \nclindamycin. Obstet Gynecol 2004;104:114–9. PMID:15229009 \nhttps://doi.org/10.1097/01.AOG.0000130068.21566.4e\n1041\n. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. \nSafety of metronidazole in pregnancy: a meta-analysis. Am \nJ O bstet Gynecol 1995;172:525–9. PMID:..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0348", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1131, "preview": "study. Obstet Gynecol 2001;98:656–63. PMID:11576584 https://\ndoi.org/10.1097/00006250-200110000-00023\n1055\n. Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, \ngonorrhoea, trichomoniasis and syphilis: global prevalence \nand incidence estimates, 2016. Bull World Health Organ \n2019;97:548–562P. PMID:31384073 https://doi.org/10.2471/\nBLT .18.228486\n1056\n. Hoots BE, Peterman TA, T orrone EA, We..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0349", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1144, "preview": "en. Sex T ransm Dis 2012;39:739. \nPMID:22902674 https://doi.org/10.1097/OLQ.0b013e318264248b\n1069. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, \nMarkowitz L. The prevalence of Trichomonas vaginalis infection \namong reproductive-age women in the United States, 2001–2004. \nClin Infect Dis 2007;45:1319–26. PMID:17968828 https://doi.\norg/10.1086/522532\n1070\n. Peterman TA, Tian LH, Metcalf..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0350", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 158, "preview": "ey SM, Fox AS, Herold BC. Screening for \nTrichomonas vaginalis in high-risk adolescent females with a new \ntranscription-mediated nucleic acid amplification test (NAAT): \nassociations with ethnicity, symptoms, and prior and current STIs. \nJ Pediatr Adolesc Gynecol 2010;23:312–6. PMID:20493735 https://\ndoi.org/10.1016/j.jpag.2010.03.004\n1085\n. Roth AM, Williams JA, Ly R, et al. Changing sexually tr..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0351", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1007, "preview": "org/10.1097/OLQ.0b013e318203e3ce\nRecommendations and Reports\n172 MMWR / July 23, 2021 / Vol. 70 / No. 4\nUS Department of Health and Human Services/Centers for Disease Control and Prevention\n1086. Hobbs MM, Seña AC. Modern diagnosis of Trichomonas vaginalis \ninfection. Sex T ransm Infect 2013;89:434–8. PMID:23633669 \nhttps://doi.org/10.1136/sextrans-2013-051057\n1087. Kingston MA, Bansal D, Carlin E..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0352", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1019, "preview": ", and PCR. J Glob Infect Dis 2012;4:22–5. \nPMID:22529623 https://doi.org/10.4103/0974-777X.93756\n1099\n. Lawing LF, Hedges SR, Schwebke JR. Detection of trichomonosis \nin vaginal and urine specimens from women by culture and PCR. \nJ Clin Microbiol 2000;38:3585–8. PMID:11015368 https://doi.\norg/10.1128/JCM.38.10.3585-3588.2000\n1100\n. Mohamed OA, Cohen CR, Kungu D, et al. Urine proves a poor \nspecime..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0353", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "D:12804391\n1115. Cu-Uvin S, Ko H, Jamieson DJ, et al.; HIV Epidemiology Research \nStudy (HERS) Group . Prevalence, incidence, and persistence or \nrecurrence of trichomoniasis among human immunodeficiency \nvirus (HIV)-positive women and among HIV-negative women at \nhigh risk for HIV infection. Clin Infect Dis 2002;34:1406–11. \nPMID:11981738 https://doi.org/10.1086/340264\n1116\n. Schwebke JR, Barrien..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0354", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1073, "preview": "pregnant women with asymptomatic Trichomonas vaginalis \ninfection. N Engl J Med 2001;345:487–93. PMID:11519502 https://\ndoi.org/10.1056/NEJMoa003329\n1131\n. Stringer E, Read JS, Hoffman I, Valentine M, Aboud S, Goldenberg \nRL. T reatment of trichomoniasis in pregnancy in sub-Saharan Africa \ndoes not appear to be associated with low birth weight or preterm \nbirth. S Afr Med J 2010;100:58–64. PMID:20..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0355", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1148, "preview": "tis. Obstet Gynecol \n2012;120:1407–14. PMID:23168767 https://doi.org/10.1097/\nAOG.0b013e31827307b2\n1146. Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global \nburden of recurrent vulvovaginal candidiasis: a systematic review. \nLancet Infect Dis 2018;18:e339–47. PMID:30078662 https://doi.\norg/10.1016/S1473-3099(18)30103-8\n1147. Crouss T, Sobel JD, Smith K, Nyirjesy P. Long-term outcomes \no..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0356", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1036, "preview": "ervicitis. Am J Emerg Med 2012;30:1114–7. \nPMID:22030186 https://doi.org/10.1016/j.ajem.2011.07.014\n1160\n. Wiesenfeld HC, Meyn LA, Darville T, Macio IS, Hillier SL. A \nrandomized controlled trial of ceftriaxone and doxycycline, with or \nwithout metronidazole, for the treatment of acute pelvic inflammatory \ndisease. Clin Infect Dis 2021;72:1181–9. PMID:32052831 https://\ndoi.org/10.1093/cid/ciaa101\n..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0357", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "r histological endometritis to \nantimicrobial agents. Anaerobe 2019;56:61–5. PMID:30753898 \nhttps://doi.org/10.1016/j.anaerobe.2019.02.005\n1174\n. Haggerty CL, Ness RB, Amortegui A, et al. Endometritis does not \npredict reproductive morbidity after pelvic inflammatory disease. \nAm J Obstet Gynecol 2003;188:141–8. PMID:12548208 https://\ndoi.org/10.1067/mob.2003.87\n1175. Haggerty CL, T otten PA, Tang..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0358", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1051, "preview": "tis KM. The safety of intrauterine \ndevices among young women: a systematic review. Contraception \n2017 ;95:17–39. PMID:27771475 https://doi.org/10.1016/j.\ncontraception.2016.10.006\n1189. Chen MJ, Kim CR, Whitehouse KC, Berry-Bibee E, Gaffield ME. \nDevelopment, updates, and future directions of the World Health \nOrganization Selected Practice Recommendations for Contraceptive \nUse. Int J Gynaecol ..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0359", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1147, "preview": "gano JW, Querec T, Unger ER, \nMarkowitz LE. Declines in vaccine-type human papillomavirus \nprevalence in females across racial/ethnic groups: data from a national \nsurvey. J Adolesc Health 2019;65:715–22. PMID:31515134 https://\ndoi.org/10.1016/j.jadohealth.2019.07.003\n1203\n. Drolet M, Bénard É, Pérez N, et al.; HPV Vaccination Impact \nStudy Group . Population-level impact and herd effects \nfollowi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0360", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1051, "preview": "s://doi.org/10.1136/\nsextrans-2014-051813\n1216. Petrosky EY, Liu G, Hariri S, Markowitz LE. Human papillomavirus \nvaccination and age at first sexual activity, National Health and \nNutrition Examination Survey. Clin Pediatr (Phila) 2017;56:363–70. \nPMID:27609513 https://doi.org/10.1177/0009922816660541\n1217\n. Gotovtseva EP, Kapadia AS, Smolensky MH, Lairson DR. Optimal \nfrequency of imiquimod (ald..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0361", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1143, "preview": "Shah KV. \nCondyloma in pregnancy is strongly predictive of juvenile-\nonset recurrent respiratory papillomatosis. Obstet Gynecol \n2003;101:645–52. PMID:12681865\n1231\n. Dolev JC, Maurer T, Springer G, et al. Incidence and risk factors \nfor verrucae in women. AIDS 2008;22:1213–9. PMID:18525267 \nhttps://doi.org/10.1097/QAD.0b013e3283021aa3\n1232. Silverberg MJ, Ahdieh L, Munoz A, et al. The impact of H..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0362", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1031, "preview": "Guideline Committee . American Cancer Society, \nAmerican Society for Colposcopy and Cervical Pathology, and \nAmerican Society for Clinical Pathology screening guidelines for \nthe prevention and early detection of cervical cancer. CA Cancer \nJ Clin 2012;62:147–72. PMID:22422631 https://doi.org/10.3322/\ncaac.21139\n1245\n. Committee on Practice Bulletins—Gynecology . ACOG Practice \nBulletin No. 131: S..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0363", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1135, "preview": "ingness to participate in cervical cancer \nscreening. J Epidemiol Community Health 2003 ;57:589–93. \nPMID:12883063 https://doi.org/10.1136/jech.57.8.589\n1258\n. Drolet M, Brisson M, Maunsell E, et al. The psychosocial impact of \nan abnormal cervical smear result. Psychooncology 2012;21:1071–81. \nPMID:21695747 https://doi.org/10.1002/pon.2003\n1259. McCaffery KJ, Irwig L, T urner R, et al. Psychosoci..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0364", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1022, "preview": "ps://doi.\norg/10.1177/0956462418792653\n1273\n. Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have \nhigher risk of human papilloma virus infection, precancerous lesions, \nand cervical cancer. AIDS 2018;32:795–808. PMID:29369827 \nhttps://doi.org/10.1097/QAD.0000000000001765\n1274\n. Sawaya GF, Lamar R, Perkins RB. Managing minimally abnormal \ncervical cancer screening test results. JAMA 2020;..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0365", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1145, "preview": "002/cncy.21702\n1287\n. Silva M, Peixoto A, Sarmento JA, Coelho R, Macedo G. Anal cytology, \nhistopathology and anoscopy in an anal dysplasia screening program: \nis anal cytology enough? Rev Esp Enferm Dig 2018;110:109–14. \nPMID:29168646 https://doi.org/10.17235/reed.2018.5678/2018\n1288\n. Iribarren Díaz M, Ocampo Hermida A, González-Carreró Fojón \nJ, et al. Preliminary results of a screening program..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0366", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1081, "preview": "71(Suppl 1):S44–9. PMID:7876648 https://doi.org/10.1093/\ninfdis/171.Supplement_1.S44\n1301. Sharapov UM, Bulkow LR, Negus SE, et al. Persistence of hepatitis \nA vaccine induced seropositivity in infants and young children \nby maternal antibody status: 10-year follow-up. Hepatology \n2012 ;56:516–22. PMID:22371069 https://doi.org/10.1002/\nhep.25687\n1302\n. Mosites E, Gounder P, Snowball M, et al. Hepa..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0367", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1146, "preview": "535 https://doi.org/10.1093/oxfordjournals.aje.a009474\n1317. CDC. Healthcare-associated hepatitis B and C outbreaks (≥2 cases) \nreported to the CDC 2008–2019. Atlanta, GA: US Department of \nHealth and Human Services, CDC; 2019. https://www.cdc.gov/\nhepatitis/outbreaks/pdfs/HealthcareInvestigationTable.pdf\n1318\n. Schillie S, Harris A, Link-Gelles R, Romero J, Ward J, Nelson N. \nRecommendations of t..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0368", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1020, "preview": "al. Efficacy of commercial \ncondoms in the prevention of hepatitis B virus infection. \nGastroenterology 1987;93:710–4. PMID:3040512 https://doi.\norg/10.1016/0016-5085(87)90431-8\n1332. Hofmeister MG, Rosenthal EM, Barker LK, et al. Estimating \nprevalence of hepatitis C virus infection in the United States, 2013–\n2016. Hepatology 2019;69:1020–31. PMID:30398671 https://doi.\norg/10.1002/hep.30297\n1333..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0369", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1137, "preview": ";16:189– 92. PMID:27037392 https://doi.org/10.7861/\nclinmedicine.16-2-189\n1346. Apers L, Vanden Berghe W, De Wit S, et al. Risk factors for HCV \nacquisition among HIV-positive MSM in Belgium. J Acquir \nImmune Defic Syndr 2015;68:585–93. PMID:25763786 https://\ndoi.org/10.1097/QAI.0000000000000528\n1347. Daskalopoulou M, Rodger AJ, Phillips AN, et al.; ASTRA Study \nGroup. Condomless sex in HIV-diagno..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0370", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1085, "preview": "b N, Charreau I, et al.; IPERGAY Study Group. Early \ndiagnosis and risk factors of acute hepatitis C in high-risk MSM on \npreexposure prophylaxis. AIDS 2020;34:47–52. PMID:31789889 \nhttps://doi.org/10.1097/QAD.0000000000002364\n1361\n. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. \nHepatology 1997;26(Suppl 1 ):15S–20S. PMID:9305658 https://\ndoi.org/10.1002/hep.510260703\n1362. Orland J..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0371", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1142, "preview": "7701\n1377\n. Barbosa C, Fraser H, Hoerger TJ, et al. Cost-effectiveness of scaling-up \nHCV prevention and treatment in the United States for people who \ninject drugs. Addiction 2019;114:2267–78. PMID:31307116 https://\ndoi.org/10.1111/add.14731\n1378\n. Lambers FA, Prins M, Thomas X, et al. ; MOSAIC (MSM \nObservational Study of Acute Infection with hepatitis C) study \ngroup. Alarming incidence of hepa..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0372", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 991, "preview": ". Galiczynski EM Jr, Elston DM. What’s eating you? Pubic lice (Pthirus \npubis). Cutis 2008;81:109–14. PMID:18441761\n1394. Meinking TL, Serrano L, Hard B, et al. Comparative in vitro \npediculicidal efficacy of treatments in a resistant head lice \npopulation in the United States. Arch Dermatol 2002;138:220–4. \nPMID:11843643 https://doi.org/10.1001/archderm.138.2.220\n1395\n. Yoon KS, Gao JR, Lee SH, C..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0373", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1135, "preview": "of topical versus oral ivermectin in treatment of uncomplicated \nscabies. Dermatol Ther (Heidelb) 2016;29:58–63. PMID:26555785 \nhttps://doi.org/10.1111/dth.12310\n1411\n. Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. \nN Engl J Med 2010;362:717–25. PMID:20181973 https://doi.\norg/10.1056/NEJMct0910329\n1412. Chiu S, Argaez C. Ivermectin for parasitic skin infections of scabies: \na revi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0374", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 993, "preview": "doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst \n2011;103:1444–51. PMID:21908768 https://doi.org/10.1093/jnci/\ndjr319\n1428. Claydon E, Murphy S, Osborne EM, Kitchen V, Smith JR, Harris \nJR. Rape and HIV . Int J STD AIDS 1991;2:200–1. PMID:1863649 \nhttps://doi.org/10.1177/095646249100200310\n1429. Murphy S, Kitchen V, Harris JR, Forster SM. Rape and subsequent \nseroconversion to HIV . BMJ 1..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0375", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 970, "preview": "/10.1097/INF .0b013e31819b592e\n1441\n. T rotman GE, Young-Anderson C, Deye KP. Acute sexual assault in \nthe pediatric and adolescent population. J Pediatr Adolesc Gynecol \n2016;29:518–26. PMID:26702774 https://doi.org/10.1016/j.\njpag.2015.05.001\n1442. Schwandt A, Williams C, Beigi RH. Perinatal transmission of \nTrichomonas vaginalis: a case report. J Reprod Med 2008;53:59–61. \nPMID:18251366\n1443. B..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0376", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1125, "preview": "454\n. Girardet RG, Lemme S, Biason TA, Bolton K, Lahoti S. HIV \npost-exposure prophylaxis in children and adolescents presenting \nfor reported sexual assault. Child Abuse Negl 2009;33:173–8. \nPMID:19324415 https://doi.org/10.1016/j.chiabu.2008.05.010\n1455\n. Panel on Antiretroviral Therapy and Medical Management of HIV-\nInfected Children. Guidelines for the use of antiretroviral agents in \npediatri..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0377", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1132, "preview": "ersity \nof Michigan, Ann Arbor, Michigan; Anna-Barbara Moscicki, MD, University of California Los Angeles, Los Angeles, California; Christina A. Muzny, MD, \nUniversity of Alabama at Birmingham, Birmingham, Alabama; Natalie Neu, MD, Columbia University, New York, New York; Paul Nyirjesy, MD, Sidney \nKimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania; Jeff Peipert, MD,..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0378", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 499, "preview": "hesda, \nMaryland; Eric Garges, MD, U.S. Department of Defense, Arlington, Virginia, and Uniformed Services University, Bethesda, Maryland; Brent Gibson, MD, \nNational Commission on Correctional Health Care, Chicago, Illinois; William A. Glover, II, PhD, Association of Public Health Laboratories, Silver Spring, \nMaryland; W . David Hardy, MD, HIV Medical Association, Johns Hopkins University, Balti..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0379", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 491, "preview": "Spring, Maryland, and Johns Hopkins University, Baltimore, Maryland; Maria T rent, MD, Society for Adolescent \nHealth and Medicine, Chicago, Illinois, and Johns Hopkins University, Baltimore, Maryland; Julie Vaishampayan, MD, Infectious Disease Society of America, \nArlington, Virginia; Barbara Van Der Pol, PhD, American Sexually T ransmitted Diseases Association, Research T riangle Park, North Car..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0380", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 1124, "preview": "St. Louis, Missouri; Sancta St. Cyr, MD; Mona Saraiya, MD; Julie Schillinger, MD; Virginia Senkomago, PhD; Philip Spradling, \nMD; Phoebe Thorpe, MD; Mark Weng, MD; Jonathan Zenilman, MD, Johns Hopkins University, Baltimore, Maryland.\nCDC, Division of Sexually Transmitted Disease Prevention Treatment Guidelines, 2021, Project Coordinator: Kimberly A. Workowski, MD, National \nCenter for HIV/AIDS, Vi..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0381", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 183, "preview": "ution). Arlene Seña serves on a speaker’s bureau and scientific advisory board for M. genitalium at Hologic, works with the Gilead \nFocus grant for hepatitis C testing and linkage to care, and mentored Sancta St. Cyr, MD, at the University of North Carolina Division of Infectious Diseases \nbefore employment at CDC. Anne Spaulding received consulting fees or honoraria (either directly or through th..."}
{"chunk_id": "sexually_transmitted_infections_treatment_guidelines_2021__0382", "doc_id": "sexually_transmitted_infections_treatment_guidelines_2021", "title": "Sexually Transmitted Infections Treatment Guidelines, 2021", "url_or_doi": "https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:sexual_health", "possible:sti", "triage:see_gp_routine", "access:oa_pdf"], "text_path": "corpus/text/sexually_transmitted_infections_treatment_guidelines_2021.txt", "n_tokens_est": 383, "preview": "Molecular Diagnostics and received a speaker honorarium from Roche Molecular Diagnostics. Karen Wendel has stock ownership in Pfizer.\nISSN: 1057-5987 (Print)\nThe Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC) and is available free \nof charge in electronic format. T o receive an electronic copy each week, visit MMWR at https:/..."}
{"chunk_id": "acog_endorsed_acog__0000", "doc_id": "acog_endorsed_acog", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog.txt", "n_tokens_est": 994, "preview": "ACOG Endorsed | ACOG\nWe Use Cookies\nACOG uses cookies, pixels and similar technologies to personalize your website experience. By clicking “continue” or continuing to use our site, you agree to our\nPrivacy Policy\nContinue\nSkip to main content\nClinical Guidance\nACOG Endorsed\nClinical Consensus\nClinical Practice Guideline\nClinical Practice Update\nCommittee Opinion\nCommittee Statement\nObstetric Care ..."}
{"chunk_id": "acog_endorsed_acog__0001", "doc_id": "acog_endorsed_acog", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog.txt", "n_tokens_est": 754, "preview": "merica, March 2019. (Endorsed April 2019, Reaffirmed February 2024)\nSociety for Maternal-Fetal Medicine Consult Series #44: Management of Bleeding in the Late Preterm Period\n(Endorsed March 2018, Reaffirmed February 2024)\nNational Commission on Correctional Health Care: Breastfeeding in Correctional Settings (2023)\n(Endorsed February 2024)\nNational Commission on Correctional Health Care: Addressin..."}
{"chunk_id": "acog_endorsed_acog__0002", "doc_id": "acog_endorsed_acog", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog.txt", "n_tokens_est": 1145, "preview": "d to support the provision of person-centered contraceptive counseling and services in a noncoercive manner. Health care providers should always consider the individual clinical circumstances of each person seeking contraceptive services. This report is not intended to be a substitute for professional medical advice for individual patients; when needed, patients should seek advice from their healt..."}
{"chunk_id": "acog_endorsed_acog__0003", "doc_id": "acog_endorsed_acog", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog.txt", "n_tokens_est": 1134, "preview": "actice for Cervical Cancer Prevention in the United States\n. The American Society for Colposcopy and Cervical Pathology. (Endorsed October 2017, Reaffirmed May 2024)\nNorth American Society for Pediatric and Adolescent Gynecology and Society for Adolescent Health and Medicine Statement: The 21st Century Cures Act and Adolescent Confidentiality\n. (Endorsed March 2021, Reaffirmed May 2024)\nSociety fo..."}
{"chunk_id": "acog_endorsed_acog__0004", "doc_id": "acog_endorsed_acog", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog.txt", "n_tokens_est": 1150, "preview": "s #58: Use of Antenatal Corticosteroids for Individuals at Risk for Late Preterm Delivery\n. (Endorsed October 2021)\nScreening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. US Preventive Services Task Force.\nJAMA 2021;325:1965-77. doi: 10.1001/jama.2021.6238 [doi]. (Endorsed September 2021)\nSociety for Maternal-Fetal Medicine Consult Series #56, Hepatitis C in P..."}
{"chunk_id": "acog_endorsed_acog__0005", "doc_id": "acog_endorsed_acog", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog.txt", "n_tokens_est": 197, "preview": "rformance of Limited Obstetric Ultrasound Examinations by Advanced Clinical Providers\n. American Institute of Ultrasound in Medicine, July 2018. (Endorsed November 2018,\nReaffirmed July 2024\nCenters for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults\n. Centers for Disease Control and Prevention, February 2014. (Endorsed September 2018)\nNASPAG C..."}
{"chunk_id": "clinical_recommendation_vulvovaginitis__0000", "doc_id": "clinical_recommendation_vulvovaginitis", "title": "Clinical Recommendation: Vulvovaginitis", "url_or_doi": "https://doi.org/10.1016/J.JPAG.2016.08.002", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "status:paywalled_or_unresolved"], "text_path": "corpus/text/clinical_recommendation_vulvovaginitis.txt", "n_tokens_est": 2, "preview": "Redirecting"}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0000", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 988, "preview": "Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults - Volume 20, Number 2—February 2014 - Emerging Infectious Diseases journal - CDC\nSkip directly to site content\nSkip directly to page options\nSkip directly to A-Z link\nSkip directly to A-Z link\nSkip directly to A-Z link\nEmerging Infectious Disease journal\nISSN: 1080-6059\nVolume 20, Numb..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0001", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1085, "preview": "ciated with different forms of anthrax\n•     Distinguish the preferred antimicrobial regimen for anthrax meningitis\n•     Assess other treatments of the patient with severe anthrax\n•     Evaluate appropriate postexposure prophylaxis for adults exposed to\nBacillus anthracis\nCME Editor\nThomas J. Gryczan, MS,\nTechnical Writer/Editor,\nEmerging Infectious Diseases. Disclosure: Thomas J. Gryczan, MS, ha..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0002", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1145, "preview": "pert panel meetings to review available scientific information and update previous guidelines for prevention and treatment of anthrax. Meeting attendees (see end of article) included clinicians with experience caring for the most recently hospitalized patients with naturally occurring cases of inhalation, gastrointestinal, or injection anthrax and academic and federal civilian and military researc..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0003", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1136, "preview": "f anthrax, occurs in ≤77% of animals studied (\n10\n). Autopsy findings for persons who died from inhalation anthrax in Sverdlovsk and in the United States (\n) are consistent with findings from the NHP studies. Persons who died had extensive amounts of serosanguinous fluid in pleural cavities and edema and hemorrhage of the mediastinum and surrounding soft tissues, and 48% had cerebral edema, 21% ha..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0004", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1148, "preview": "ry distress or airway protection for persons with altered mental status, some patients with anthrax might require respiratory support for airway edema. Substantial edema with fatal outcome can occur with cutaneous lesions involving the head, neck, or thorax, and with oropharyngeal lesions (\n20\n). Thus, aggressive monitoring for airway compromise is warranted in patients with such lesions.\nIn inhal..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0005", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1144, "preview": "rations for Prevention and Treatment\nThe approach to prevention and treatment of anthrax differs from that for other bacterial infections. The production of toxin, potential for antimicrobial drug resistance, frequent occurrence of meningitis, and presence of latent spores must be taken into account when selecting postexposure prophylaxis (PEP) or a combination of antimicrobial drugs for treatment..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0006", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1004, "preview": "decreases with delay in implementation. In 2009, the US Advisory Committee on Immunization Practices recommended 60 days of antimicrobial drug prophylaxis for immediate protection and a 3-dose series of Anthrax Vaccine Adsorbed (AVA) BioThrax (Emergent Biosolutions Inc., Rockville, MD, USA) for long-term protection after exposure to anthrax (\n37\n). To ensure adequate and continued protection, ever..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0007", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1136, "preview": "rnatives to carbapenems.\nAt least 1 antimicrobial drug that inhibits protein synthesis should be used to reduce exotoxin production. Linezolid is preferred as the first-line protein synthesis inhibitor. It is preferred over clindamycin because it is likely to provide better CNS penetration (\n39\n), although randomized controlled trials on treatment for CNS infections with either agent are lacking. ..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0008", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1030, "preview": "te is known to be susceptible to penicillin. However, adequate dosages must be used because of the potential for development of drug resistance during treatment with subtherapeutic dosing.\nDuration of treatment for localized or uncomplicated cutaneous disease depends on the\nB. anthracis\nexposure source. If naturally acquired (e.g., animals with anthrax, products such as hides from animals with ant..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0009", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1113, "preview": "headache, pharyngolaryngeal pain, and nausea. A total of 19 patients with anthrax have received AIGIV as an adjunct to antimicrobial drugs: 3 had inhalation anthrax, 15 had injection anthrax, and 1 had gastrointestinal anthrax. All patients appeared to tolerate the antitoxin, and 13 survived: 2 with inhalation anthrax (\n30\n), 10 with injection anthrax (W.A. Bower, unpub. data), and 1 with gastroin..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0010", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1150, "preview": "some of which are FDA approved for other indications, are efficacious in animal models of anthrax infection. Such agents might be of use in patients in the fulminant phase of disease. When research needed to change the anthrax mortality rate is conducted,\nB. anthracis\nwill become a less competent, and therefore less desirable, bioweapon.\nDr Hendricks is a medical officer in the Bacterial Special P..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0011", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1149, "preview": "l\nMS\nGalbraith\nBioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.\nEmerg Infect Dis\n2001\n933\n44\nDOI\nPubMed\nGoogle Scholar\nWalsh\nJJ\nPesik\nQuinn\nCP\nUrdaneta\nDykewicz\nCA\nBoyer\nAE\nA case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor.\nClin Infect Dis\n2007\n44\n968\n71\nDOI\nPubMed\nGo..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0012", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1150, "preview": "re sepsis and septic shock in adults: a systematic review.\nJAMA\n2009\n301\n2362\n75\nDOI\nPubMed\nGoogle Scholar\nHolty\nJE\nBravata\nDM\nLiu\nOlshen\nRA\nMcDonald\nKM\nOwens\nDK\nSystematic review: a century of inhalational anthrax cases from 1900 to 2005.\nAnn Intern Med\n2006\n144\n270\n80\nDOI\nPubMed\nGoogle Scholar\nBinkley\nCE\nCinti\nSimeone\nDM\nColletti\nLM\nBacillus anthracis as an agent of bioterrorism: a review emphas..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0013", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 1150, "preview": "nd side of the website to register. Only one answer is correct for each question. Once you successfully answer all post-test questions you will be able to view and/or print your certificate. For questions regarding the content of this activity, contact the accredited provider, CME@medscape.net. For technical assistance, contact CME@webmd.net. American Medical Association’s Physician’s Recognition ..."}
{"chunk_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a__0014", "doc_id": "centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a", "title": "Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.", "url_or_doi": "https://doi.org/10.3201/eid2002.130687", "tags": ["tier:B_peer_reviewed", "source:Journal", "type:journal_article", "topic:womens_health_general", "access:oa_landing"], "text_path": "corpus/text/centers_for_disease_control_and_prevention_expert_panel_meetings_on_prevention_a.txt", "n_tokens_est": 449, "preview": "ch articles by the topic country.\nArticle Type Search\n– Search articles by article type and issue.\nTop\nComments\nPlease use the form below to submit correspondence to the authors or contact them at the following address:\nWilliam A. Bower, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop A30, Atlanta, GA 30333, USA\nReturn Address\nSend To\nSend To\nAuthors\nEditors\nComments\n10000..."}
{"chunk_id": "acog_endorsed_acog_2__0000", "doc_id": "acog_endorsed_acog_2", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog_2.txt", "n_tokens_est": 994, "preview": "ACOG Endorsed | ACOG\nWe Use Cookies\nACOG uses cookies, pixels and similar technologies to personalize your website experience. By clicking “continue” or continuing to use our site, you agree to our\nPrivacy Policy\nContinue\nSkip to main content\nClinical Guidance\nACOG Endorsed\nClinical Consensus\nClinical Practice Guideline\nClinical Practice Update\nCommittee Opinion\nCommittee Statement\nObstetric Care ..."}
{"chunk_id": "acog_endorsed_acog_2__0001", "doc_id": "acog_endorsed_acog_2", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog_2.txt", "n_tokens_est": 754, "preview": "merica, March 2019. (Endorsed April 2019, Reaffirmed February 2024)\nSociety for Maternal-Fetal Medicine Consult Series #44: Management of Bleeding in the Late Preterm Period\n(Endorsed March 2018, Reaffirmed February 2024)\nNational Commission on Correctional Health Care: Breastfeeding in Correctional Settings (2023)\n(Endorsed February 2024)\nNational Commission on Correctional Health Care: Addressin..."}
{"chunk_id": "acog_endorsed_acog_2__0002", "doc_id": "acog_endorsed_acog_2", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog_2.txt", "n_tokens_est": 1145, "preview": "d to support the provision of person-centered contraceptive counseling and services in a noncoercive manner. Health care providers should always consider the individual clinical circumstances of each person seeking contraceptive services. This report is not intended to be a substitute for professional medical advice for individual patients; when needed, patients should seek advice from their healt..."}
{"chunk_id": "acog_endorsed_acog_2__0003", "doc_id": "acog_endorsed_acog_2", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog_2.txt", "n_tokens_est": 1134, "preview": "actice for Cervical Cancer Prevention in the United States\n. The American Society for Colposcopy and Cervical Pathology. (Endorsed October 2017, Reaffirmed May 2024)\nNorth American Society for Pediatric and Adolescent Gynecology and Society for Adolescent Health and Medicine Statement: The 21st Century Cures Act and Adolescent Confidentiality\n. (Endorsed March 2021, Reaffirmed May 2024)\nSociety fo..."}
{"chunk_id": "acog_endorsed_acog_2__0004", "doc_id": "acog_endorsed_acog_2", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog_2.txt", "n_tokens_est": 1150, "preview": "s #58: Use of Antenatal Corticosteroids for Individuals at Risk for Late Preterm Delivery\n. (Endorsed October 2021)\nScreening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. US Preventive Services Task Force.\nJAMA 2021;325:1965-77. doi: 10.1001/jama.2021.6238 [doi]. (Endorsed September 2021)\nSociety for Maternal-Fetal Medicine Consult Series #56, Hepatitis C in P..."}
{"chunk_id": "acog_endorsed_acog_2__0005", "doc_id": "acog_endorsed_acog_2", "title": "ACOG Endorsed | ACOG", "url_or_doi": "https://www.acog.org/clinical/clinical-guidance/acog-endorsed", "tags": ["tier:A_patient_info", "source:Other", "type:patient_page", "triage:see_gp_routine", "topic:womens_health_general"], "text_path": "corpus/text/acog_endorsed_acog_2.txt", "n_tokens_est": 197, "preview": "rformance of Limited Obstetric Ultrasound Examinations by Advanced Clinical Providers\n. American Institute of Ultrasound in Medicine, July 2018. (Endorsed November 2018,\nReaffirmed July 2024\nCenters for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults\n. Centers for Disease Control and Prevention, February 2014. (Endorsed September 2018)\nNASPAG C..."}
